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Neuropeptides are neuronal signaling molecules that regulate many 
physiological and behavioural processes in vertebrates and invertebrates. Investigation 
of neuropeptide signaling in echinoderms (e.g. starfish) can provide insights into the 
evolution of neuropeptide systems because as deuterostomian invertebrates they occupy 
an “intermediate” phylogenetic position between vertebrates and protostomian 
invertebrates. Recent analysis of neural transcriptome data from the starfish Asterias 
rubens has identified 40 transcripts encoding neuropeptide precursors. Here the 
expression and function of neuropeptides derived from four of these precursors was 
investigated: relaxin-like gonad-stimulating peptide precursor (AruRGPP), relaxin-like 
peptide precursor 2 (AruRLPP2), pedal peptide-like neuropeptide precursors 1 and 2 
(ArPPLNP1 and ArPPLNP2). 
AruRGP induces spawning of ovarian fragments from A. rubens. Analysis of the 
expression of AruRGPP in A. rubens using mRNA in situ hybridization revealed 
expression by cells in the radial nerve cords, circumoral nerve ring and tube feet. 
Furthermore, a band of AruRGPP-expressing cells was also identified in the body wall 
epithelium lining the cavity that surrounds the sensory terminal tentacle and optic 
cushion at the tips of the arms. Discovery of these cells is important because they are 
candidate physiological mediators for hormonal control of starfish spawning in response 
to environmental cues. Interestingly, AruRLPP2 is also expressed in the same region of 
the arm tip as AruRGPP but the physiological role(s) of AruRLP2 is not yet known. 
Analysis of the expression of ArPPLNP1 and ArPPLNP2 using mRNA in situ 
hybridization revealed a widespread pattern of expression in A. rubens. Furthermore, 
immunohistochemical localization of peptides derived from these precursors revealed 
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immunostaining in neuronal processes innervating muscles. Consistent with this pattern 
of expression, peptides derived from ArPPLNP1 and ArPPLNP2 act as muscle relaxants 
in starfish. Interestingly, this contrasts with previous findings from protostomian 
invertebrates, where pedal peptide/orcokinin-type neuropeptides act as muscle 
contractants. 
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ORF open read frame 
Os ossicle 
PAM peptidyl-alpha-amidating monooxygenase 
Pa papulae 
PBS Phosphate-buffered saline 
PBST PBS/0.1% Tween-20 
PC pyloric caeca 
PC1 prohormone convertase 1 
PD pyloric duct 
PDF pigment dispersing hormone 
Pe pedicellariae 
PM peristomial membrane 
PP Pedal peptide 
PS pyloric stomach 
RC rectal caeca 
Re rectum 
RHS radial hemal strand 
RLN relaxin 
RNC radial nerve cord 
RO reticular ossicles 
RSP regulated secretory pathway 
SMP starfish myorelaxant peptide 
SNP sub-epithelial nerve plexus 
Sp spine 
SpPPLNP Strongylocentrotus purpuratus pedal peptide-like neuropeptide  
Su sucker 
TB Tiedemann's body 
TF tube feet 
TIM transverse infra-ambulacral muscle 
TM transmembrane 
TRH thyrotropin releasing hormone 
TSM transverse supra-ambulacral muscle 
TT terminal tentacle 




1 General Introduction 
1.1 What are neuropeptides? 
Neuropeptides are small polypeptides ranging from 3 to 100 amino acid residues 
(Malenka, 2010) that are synthesized by the nervous system, endocrine system and gut, 
and are involved in regulation of many types of physiological and behavioral processes 
in vertebrates and invertebrates (Fricker, 2012). Bioactive neuropeptides are produced 
from their corresponding precursor proteins after a series of modifications. 
Neuropeptides are one of the largest groups of neurotransmitters and they mediate 
communication between neurons and other cells by binding to specific receptors 
(Fricker, 2012), which are typically G protein-coupled receptors (Gomes et al., 2013). 
1.1.1 Neuropeptide precursor structural characteristics 
A bioactive neuropeptide is not generated directly from mRNA but is derived 
from a larger specific precursor protein (Figure 1.1). Neuropeptide precursors contain a 
20-30 amino acid residue N-terminal signal peptide, which is followed by one or more 
copies of physiologically active neuropeptides (Sossin et al., 1989). The signal peptides 
are comprised of three structurally dissimilar regions: N-terminal region (n-region), 
central hydrophobic region (h-region) and C-terminal region (c-region) (von Heijne, 
1985). The n-region is variable both in length and amino acid composition, but it 
usually has a positive net charge, which is thought to interact with the “docking protein” 
catalyzed release of the “signal recognition particle (SRP)” induced block (Hall et al., 
1983; Vlasuk et al., 1983; von Heijne, 1985). The h-region is a seven or eight-residue 
long sequence in the “minimal” signal peptide, sandwiched between the n-region and c-
region, and is thought to be the target site of the SRP (von Heijne, 1985). The c-region 
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is consistent in length, 5 or 6 amino acid residues, and is a more polar region that 
determines the cleavage site (von Heijne, 1984). Online software is available now to 
predict the signal peptides of neuropeptide precursors (SignalP 4.1 Server, 
http://www.cbs.dtu.dk/services/SignalP/). 
 
Figure 1.1 Processing of a neuropeptide precursor. 
A signal peptidase cleaves the signal peptide from a preprohormone to generate a 
prohormone. Prohormone convertase cleaves at dibasic/monobasic cleavage sites to 
produce a peptide hormone (neuropeptide). Endopeptidase furin and carboxypeptidase 
cleave dibasic/monobasic cleavage sites, giving rise to a bioactive peptide hormone. 
The signal peptide is represented in blue, neuropeptides are represented in red and 
dibasic/monobasic cleavage sites are represented in green. Figure is based on Fricker 
(2012) and Semmens (2015). 
The cleavage sites are usually composed of dibasic/monobasic amino acids 
lysine (K) and/or arginine (R), which are recognized by prohormone convertase 
cleaving enzymes (Rholam et al., 1995; Steiner, 1998; Veenstra, 2000; Southey et al., 
2006). Rules have been proposed based on experimentally verified or published 
cleavage data to predict the cleavage sites in vertebrate neuropeptide precursors 
(Rholam et al., 1995; Rouille et al., 1995) and insect (Veenstra, 2000). In vertebrates, 
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pairs of basic residues, Lys-Arg or Arg-Arg, are generally used, although single Arg, 
dibasic Arg-Lys or Lys-Lys are also found to be processed (Rouille et al., 1995). There 
are differences in the cleavage sites between vertebrates and insects (Veenstra, 2000). 
There is more knowledge about the cleavage sites of insect neuropeptide precursors. 
Firstly, the cleavages of the Lys-Arg pairs in insects are not often followed by an 
aliphatic or basic amino acid residue. Moreover, Lys-Lys pairs are not frequently used 
for processing in insects. Thirdly, it is not clear whether Lys-Arg/Arg-Arg pairs 
followed by either an aliphatic or a basic amino acid residue are processed or not in 
insect neuropeptide precursors. Arg-Lys pair has not been reported as cleavage site so 
far in insects. But processing at single Arg residue occurs in insect under limited 
conditions, with an Arg, Lys or His residues being in the position -4, -6, or -8. 
Several prohormone convertases, including furin, PC1/3, PC2, PC4, PACE4 and 
PC5, have been characterized for the proteolytic cleavage, which will be discussed in 
more detail below (Veenstra, 2000; Southey et al., 2006). The rules mentioned above 
are quite helpful to predict potential cleavage sites in neuropeptide precursors identified 
in genome/transcriptome sequences, but ambiguous processing sites still exist to allow 
differential cleavage of the same precursor to produce different peptides (Veenstra, 
2000). Approaches used for prediction of cleavage sites in neuropeptide precursors have 
been developed based on reported cleavage motifs, for example NeuroPred 
(http://stagbeetle.animal.uiuc.edu/cgi-bin/neuropred.py) (Southey et al., 2006). 
1.1.2 Neuropeptide biosynthesis, release and inactivation 
Physiologically active neuropeptides are generated via a series of enzymatic 
cleavages of their precursor proteins within the regulated secretory pathway (RSP) 
(Figure 1.1, 1.2). Bioactive neuropeptides produced and secreted from neurons then 
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bind to receptor proteins before being removed from the extracellular space, as shown 
in Figure 1.2. After being directed into the lumen of the endoplasmic reticulum (ER) by 
the signal peptide, the first proteolytic cleavage of the prohormone occurs with a non-
specific signal peptidase removing the signal peptide (Sossin et al., 1989; Fricker, 2012). 
Following the signal peptide cleavage, complex carbohydrate chains can be added to 
asparagine (N) residues (if present) located within N-linked glycosylation sequences 
(NxS/T, where x is any amino acid except Pro) in the ER (Schwarz and Aebi, 2011). 
Then the prohormones are transferred to the Golgi apparatus for further modification, 
such as the removal and addition of carbohydrate units, phosphorylation and sulfation 
(Sossin et al., 1989; Beisswanger et al., 1998; Fricker, 2012). In the late Golgi, known 
as the trans-Golgi network, the neuropeptides are sorted into so-called large dense core 
vesicles or secretory granules together with processing enzymes under low pH (Sossin 
et al., 1989; van den Pol, 2012). Neuropeptide proteolytic cleavages are performed by 
prohormone convertases, prohormone convertase 1 (PC1, also known as PC3, and often 
referred to as PC1/3) and prohormone convertase 2 (PC2), generating intermediates that 
contain basic residues (lysine (K) and arginine (R)), which are removed by 
carboxypeptidase E (CPE) (Sossin et al., 1989; Fricker, 2012). Some neuropeptide 
proteolytic cleavages are processed in the trans-Golgi network by furin. PC1/3 and PC2 
are distributed within secretory granules throughout neurons and endocrine and 
neuroendocrine cells but absent from non-neuroendocrine tissues (Fricker, 2012). Both 
PC1/3 and 2 are able to cleave substrates at the following sites: XXKR, RXXR, and 
RXXXXR (Seidah, 2011; Hoshino and Lindberg, 2012). PC4, PACE4 and PC5 have 
restricted expression, with PC4 only in germ cells and PACE4 and PC5 in several 
tissues (Veenstra, 2000). Furin is broadly expressed among different tissues and is most 
localized in the trans-Golgi network (Fricker, 2012). The cleavage occurs after the last 
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Arg of the consensus site RXXR, especially a basic residue in the P2 position, such as 
RXK/RR (Nakayama, 1997; Thomas, 2002). Further neuropeptide proteolytic 
processing occuring in the trans-Golgi network is mediated by the exopeptidase 
carboxypeptidase D (CPD) or carboxypeptidase E (CPE) (Fricker, 2012). In some cases, 
additional enzymatic modifications of the final mature peptide occur to protect the 
peptide from exopeptidases. A common post-translational modification is C-terminal 
amidation, where a C-terminal glycine residue is converted to an amide group through 
the action of the enzyme known as peptidyl-alpha-amidating monooxygenase (PAM) 
(Fricker, 2012). 
 
Figure 1.2 Neuropeptide biosynthesis, processing and degradation.  
Neuropeptide precursors/preneuropeptides are synthesized on ribosomes in the rough 
endoplasmic reticulum (ER) and processed through the Golgi apparatus. Neuropeptides 
are packaged into secretory vesicles (Sec Ves), which are axonally transported to the 
site of release. Neuropeptides are degraded by extracellular peptidases to amino acids 
after activating the receptor, usually a G protein-coupled receptor (GPCR). Figure is 
modified from Fricker 2012. 
Although the peptide synthesis can be regulated at several steps, the mature 
peptides are stored in secretory vesicles, which is the most important mechanism for 
regulation of the extracellular levels of the neuropeptides (Fricker, 2012). 
Neuronal depolarization triggers fusion of secretory vesicles with the cell 
membrane to release the peptides into the extracellular environment to bind to a 
receptor protein to influence activity of other cells. An increase in cytoplasmic calcium 
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concentration induced by spike bursts is a key to the enhanced probability of 
neuropeptide release (Bondy et al., 1987; Jackson et al., 1991; Muschol and Salzberg, 
2000; Tallent, 2008). Calcium is important as regulator of the release of both fast amino 
acid transmitters and peptides, but a greater increase in cytoplasmic calcium and 
neuronal activity is required for peptide release than amino acid secretion (Tallent, 
2008). It has been reported that the increase in cytoplasmic calcium in axon terminals 
may enhance the probability of dense core vesicle exocytosis, which is induced by spike 
bursts (Bondy et al., 1987; Jackson et al., 1991; Muschol and Salzberg, 2000; van den 
Pol, 2012). 
The sites of neuropeptide release, mostly from non-synaptic regions, are 
different from that of amino acid transmitter release. Thus, peptides typically diffuse 
over longer distances than amino acid transmitters to exert their effects, which are 
typically mediated by activation of G protein-coupled receptors (van den Pol, 2012). 
Finally, after increasing or decreasing the activity of other cells, neuropeptides are 
degraded by extracellular peptidases into amino acids. 
1.1.3 G protein-coupled receptors (GPCRs) as mediators of the effects of 
neuropeptides 
Neuropeptides exert their effects through the activation of corresponding 
receptors on the surface of nearby cells or, in the case of hormones, distant cells. Most 
neuropeptides bind to G protein-coupled receptors (GPCRs) that are responsible for 
converting these extracellular stimuli into intracellular responses (Gomes et al., 2013). 
GPCRs can be divided into three domains: an extracellular domain, a transmembrane 
(TM) core and an intracellular domain as shown in Figure 1.3 (Gomes et al., 2013). The 
extracellular domain contains the N-terminal tail and the extracellular loops (e1, e2, e3) 
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and this domain is involved in binding the neuropeptide, leading to activation of the 
receptor. The TM core comprises seven α-helical regions (TM1 to TM7), which convey 
conformational changes induced by ligand binding to the extracellular domain of the 
receptor to the intracellular domain of the receptor. Similar to the extracellular domain, 
the intracellular domain is formed by the C-terminal tail and the intracellular loops (i1, 
i2, i3) of the TM core.  
When the association between intracellular domain and the TM core changes, 
affecting the G proteins – dissociated into α and β-γ, the signal is processed and 
amplified to elicit the intracellular response and exert the neuropeptide’s physiological 
effect. G-proteins are trimeric protein complexes including an α, β, and γ subunit, which 
are used to modulate the activity of effectors, such as adenylyl cyclase or phospholipase 
(Fricker, 2012). Based on the type of α subunit, Gs, Gi, Go, and Gq, G proteins can be 
divided into different subfamilies. 
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Figure 1.3 Characteristics of G protein-coupled receptors (GPCRs).  
A GPCR includes extracellular, transmembrane (TM) and intracellular domains. The 
extracellular domain contains the N-terminal tail and the extracellular loops (e1, e2, e3). 
The TM core comprises seven α-helical regions (TM1 to TM7, shown in green). The 
intracellular domain is formed by the C-terminal tail and the intracellular loops (i1, i2, 
i3) of the TM core. G-proteins are made up of an α (pink), β (yellow), and γ (orange) 
subunit. Adenylyl cyclase and phospholipase are examples of G-protein effectors. 
Schematic diagram was prepared using Illustrator for Biological Sequences (IBS, 
version 1.0.3) software based on Gomes et al. (2013). 
As highlighted above, neuropeptides play their roles in physiological processes 
via specific receptors. There are at least four patterns in the interaction between 
neuropeptides and receptors (Figure 1.4) (Fricker, 2012). The simplest is the classic 
“lock and key” model, in which one peptide binds to only one receptor (Gomes et al., 
2013). But usually, one neuropeptide can bind to several receptors or different 
neuropeptides can activate the same receptor or a combination of these two patterns. 
The complicated interaction between neuropeptide and receptor makes it possible that 
one neuropeptide can have several functions (Fricker, 2012). 
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Figure 1.4 Diversity of peptide-receptor signaling.  
The simplest model is that one peptide binds only to one receptor (A). But frequently, 
one peptide can bind to multiple receptors (B) or different peptides can bind to a single 
receptor (C), or a combination of these two patterns (D). 
1.1.4 The physiological roles of neuropeptides 
Neuropeptides are involved in the regulation of different types of physiological 
and behavioral processes in animals and a variety of methods have been developed to 
study the functions of neuropeptides. Initially, radioimmunoassay, 
immunohistochemistry, bioassays and electrophysiology were used, and later on 
modern molecular biological methods have contributed greatly to our knowledge of the 
diversity of neuropeptides (Hökfelt et al., 2000). Radioimmunoassay and 
immunohistochemistry are used to detect the expression of neuropeptides and receptors, 
which is helpful to predict their functions. An example is provided by research on 
neuropeptide-Y (NPY). Anatomical and physiological studies suggested a variety of 
functions of NPY in the mammalian nervous system (Gray and Morley, 1986). NPY 
immunoreactivity is detected widely in the central and peripheral nervous systems using 
radioimmunoassay. The increase in ingestive behaviors caused by NPY administration 
is related to the NPY-immunoreactivity in the hypothalamus. The effect of NPY in 
modulating luteinizing hormone release and sexual behavior is thought to be related to 
an NPY-immunoreactive pathway from the arcuate nucleus to the medial preoptic area. 
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The NPY-immunoreactivity in a dense plexus around cerebral vessels is consistent with 
NPY's effect in causing vasoconstriction of cerebral vessels. 
In vitro and in vivo pharmacological techniques are the main methods for 
functional studies. The isolated hindgut preparation of the cockroach, Leucophaea 
maderae, has contributed a lot for the isolation and functional characterisation of many 
insect myotropic peptides (Holman et al., 1991); for example, the isolation and 
characterization of two novel tachykinin-related peptides from the crab Cancer borealis 
nervous system (Christie et al., 1997). The following reports about GnRH and PDF 
prove that in vivo methods are quite helpful for physiological study. Continuous low-
dose administration of a GnRH analogue can produce reversible, long-term suppression 
of reproductive function of male and female domestic dogs (Trigg et al., 2001). PDF 
was found to serve as an output regulator of locomotor circadian rhythm in the German 
cockroach via RNAi, a kind of molecular biotechnique, to silence this gene (Lee et al., 
2009). 
Neuropeptides can be involved in more than one physiological process, and a 
behavioral change may not be caused by only one neuropeptide. Melanin-concentrating 
hormone (MCH) was initially found to induce body colour changes (Kawauchi et al., 
1983). Subsequently, it was discovered that MCH also played key roles in feeding 
(Georgescu et al., 2005) and sleeping behaviour (Willie et al., 2008). Sulfakinin is 
another important neuropeptide to regulate food intake in multiple insect species (Wei 
et al., 2000). 
1.1.5 Two approaches to neuropeptide discovery: function first or neuropeptide 
first 
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With the development of biological research techniques, more and more 
methods have been applied to identify new neuropeptides, which can be divided into 
two approaches, namely “function first” and “neuropeptide first”, respectively (Fricker, 
2012). Neuropeptides were first discovered due to their physiological effects, and this 
bioassay method is still an important tool, with the bioactivity of a tissue extract being 
identified first and then the bioactive neuropeptide being purified later to determine its 
molecular structure. The discovery of substance P is a good example, with its effect in 
stimulating contraction of the intestinal smooth muscles and lowering blood pressure 
discovered in 1931 (Euler and Gaddum, 1931). But its sequence was not determined 
until 1971 (Chang et al., 1971). 
The “neuropeptide first” approach starts with the application of techniques to 
identify the peptides or the genes encoding neuropeptide precursors. Once the existence 
of the predicted peptides has been confirmed, using techniques such as peptide 
sequencing and mass spectrometry, pharmacological tests are performed to determine 
the actions of the identified peptide(s). With the publication of genomic, transcriptomic 
and proteomic data, numerous putative neuropeptides have been identified based on the 
structural characteristics of neuropeptide precursors, such as the N-terminal signal 
peptide and specific cleavage sites (e.g. KR or RR). Rising numbers of neuropeptide 
precursors have been predicted via BLAST by using the homologues identified in other 
animals as queries. In model organisms, 32 Caenorhabditis elegans genes encoding 
neuropeptides were identified after searching its genome (Nathoo et al., 2001) and 119 
neuropeptide genes have been predicted in Drosophila melanogaster (Clynen et al., 
2010). Andrew E. Christie has contributed a lot to neuropeptide gene discovery by 
mining genome/transcriptome databased. For example, Andrew E. Christie has 
identified 39 ESTs encoding putative peptide precursors from four aphid species (14 in 
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Acyrthosiphon pisum, 4 in Aphis gossypii, 20 in Myzus persicae and 1 in Toxoptera 
citricida) (Christie, 2008). 
The two main approaches to neuropeptide discovery take advantage of similar 
techniques but in different orders. There are some limitations for each method, so 
several techniques are applied together to confirm the finding. Since the first 
neuropeptide substance P was discovered by van Euler and Gaddum in 1931 (Euler and 
Gaddum, 1931) and sequenced in 1971 (Chang et al., 1971), 5949 non-redundant 
neuropeptide entries originating from 493 organisms belonging to 65 neuropeptide 
families have been identified, 3455 and 2406 in invertebrates and vertebrates, 
respectively, although the physicochemical properties of some peptides are still not 
clear (Wang et al., 2015). 
1.1.6 Evolutionary relationships of neuropeptides in the animal kingdom 
Neuropeptides and their receptors have a widespread phylogenetic distribution 
in the animal kingdom, ranging from cnidarians (e.g. Hydra), which have a very simple 
nervous system, to mammals. For many neuropeptide families, the members are highly 
diverse because of the relatively short sequences of the mature peptides, and it is 
common that the number of neuropeptide copies is not consistent between species 
(Jekely, 2013). But many neuropeptides belonging to the same neuropeptide family 
have been identified in different animal species, such as the FMRFamide family 
(Hökfelt et al., 2000). 
Olivier Mirabeau assessed the evolutionary relationship between protostomian 
and deuterostomian peptidergic systems (PSs) by analyzing the sequences of rhodopsin 
and secretin-type G protein-coupled receptors of 15 bilaterian species (Mirabeau and 
Joly, 2013). In some cases, there is high conservation between the sequences of 
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invertebrate and vertebrate neuropeptides. The insulin/insulin-like growth factor 
(IGF)/relaxin superfamily is a good example, which contains a signature sequence of a 
cysteine motif “CCxxxCxxxxxxxxC” (Mita et al., 2009b). Analyzing the evolution of 
neuropeptides and receptors should be helpful to gain novel insights into neuropeptide 
function and to predict ancestral neuron types that were probably present in the last 
common bilaterian ancestor. 
As discussed above, many neuropeptides have been identified but sequence 
similarity is often not satisfactory for phylogenetic analysis (Wang et al., 2015). 
However, most neuropeptides exert their effects via GPCRs, which are much more 
conserved among different animal species and could be useful for analyzing the 
evolutionary relationships of neuropeptides. The superfamily of GPCRs has been 
divided into five main families (glutamate, rhodopsin, adhesion, frizzled/taste2, and 
secretin) with phylogenetic analyses of 342 unique functional non-olfactory human 
GPCR sequences (Fredriksson et al., 2003). The rhodopsin family is the largest GPCRs 
family including four main groups (α, β, γ, δ) according to the analysis of Fredriksson et 
al (Fredriksson et al., 2003). Especially, the β group receptors all react with peptides, 
such as neuropeptide Y (NPY), thyrotropin releasing hormone (TRH), gonadotropin-
releasing hormone (GnRH) receptors. Neuropeptides belonging to the same 
neuropeptide family interact with members of the same GPCR family, while different 
neuropeptide families can act via GPCRs belonging to different families (Mirabeau and 
Joly, 2013), for example, vasopressin receptors and corticoliberin receptors belonging to 
the rhodopsin and secretin families, respectively. The relationships of GPCRs can be 
helpful to investigate the evolutionary relationships of neuropeptides in the animal 
kingdom. For example, the receptors of protostomian allatotropin (p-AT)-type peptides 
and deuterostomian orexin-type peptides are closely related orthologs, indicating that 
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the neuropeptides that activate these receptors are also orthologous (Mirabeau and Joly, 
2013). Furthermore, by identifying the receptor for a neuropeptide, potential roles of 
that neuropeptide can be predicted based on insights from orthologous neuropeptides in 
other phyla. 
Neuropeptide signaling systems have been analyzed in great detail in vertebrates 
and in model invertebrates such as Caenorhabditis elegans and Drosophila 
melanogaster (Broeck, 2001). In C. elegans, over 250 signaling molecules are derived 
from neuropeptide precursor  (Li et al., 1999; Nathoo et al., 2001; Pierce et al., 2001; 
Frooninckx et al., 2012). And more than 1100 GPCRs have been identified, in which 
approximately 100 thought to be specific for neuropeptides (Bargmann, 1998). In D. 
melanogaster, 119 neuropeptide genes being divided into 46 neuropeptide families have 
been predicted (Clynen et al., 2010). About 160 GPCRs were found in D. melanogaster 
(Hewes and Taghert, 2001). Most families of known neuropeptides have been matched 
to receptors in D. melanogaster (Hewes and Taghert, 2001; Johnson et al., 2003; 
Clynen et al., 2010). Research about D. melanogaster neuropeptide and GPCRs extends 
our understanding of certain neuropeptides physiological action (Bendena et al., 2012). 
For example, allatostatin-like peptides appear to influence foraging behavior in D. 
melanogaster. However, because vertebrates and Drosophila are evolutionarily 
distantly related, it can be difficult to identify relationships between their neuropeptide 
systems.  Therefore, analysis of a phylum located “between” the vertebrates and the 
protostomian invertebrates in animal phylogeny could provide important insights into 
neuropeptide evolution and neuropeptide relationships, as discussed below with 
echinoderms as an example. 
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1.2 Echinoderms as model systems for neuropeptide research 
The phylum Echinodermata is a group of marine invertebrates that include five 
extant classes: Asteroidea (starfish), Ophiuroidea (brittle stars), Echinoidea (sea urchins, 
sand dollars), Holothuroidea (sea cucumbers) and Crinoidea (feather stars and sea lilies) 
(Figure 1.5) (Peterson and Eernisse, 2016; Semmens et al., 2016). They are 
deuterostomian invertebrates, which occupy an “intermediate” position between the 
chordates, including vertebrates, and the protostomian invertebrates, such as Arthropoda 
(Drosophila melanogaster) and Nematoda (Caenorhabditis elegans) (Figure 1.6) 
(Turbeville et al., 1994; Lowe and Wray, 1997; Halanych, 2004). 
 
Figure 1.5 Phylogenetic tree showing relationships of the five extant echinoderm 
classes, based on Peterson and Eernisse (2016).  
The Asteroidea (e.g. starfish) and Ophiuroidea (e.g. brittle stars) form the asterozoan 
clade. The Echinoidea (e.g. sea urchins) and holothuridea (e.g. sea cucumbers) form the 
echinozoan clade. The crinoidea (e.g. feather stars and sea lilies) are a sister group to 
the eleutherzoan clade that comprises echinozoans and asterozoans. Images of 
representative animals for Asteroidea, Ophiuroidea and Echinoidea are from 
http://phylopic.org. Images of representative animals for Holothuroidea and Crinoidea 
are produced by author of this thesis. 
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Figure 1.6 Animal phylogeny.  
Phylogenetic diagram showing the position of the phylum Echinodermata (shown in red; 
e.g. starfish) in the deuterostomian branch of the animal kingdom. The Bilateria 
comprise two super-phyla, the deuterostomes and the protostomes. The deuterostomes 
comprise the chordates (vertebrates, urochordates and cephalochordates) and the 
ambulacrarians (hemichordates and echinoderms). The protostomes comprise the 
lophotrochozoans (molluscs and annelids) and the ecdysozoans (arthropods and 
nematodes). The Cnidaria (e.g. sea anemones) are basal to the Bilateria. Images of 
representative animals for each phylum were obtained from http://phylopic.org. This 
figure is modified from Semmens, Mirabeau et al. 2016. 
Adult echinoderms are characterized by exhibiting pentaradial symmetry. By 
analyzing the expression pattern of three important developmental regulatory genes 
(distal-less, engrailed and orthodenticle) (Duboule, 1995), it has been demonstrated that 
the reorganization of echinoderm body architecture involved extensive changes in the 
deployment and roles of homeobox genes, which include modifications of expression 
domains and the evolution and loss of developmental roles of these genes (Lowe and 
Wray, 1997). These changes occurred at different time in the evolutionary history of 
echinoderms, leading to the current morphological characters of adult echinoderms. 
Other notable and distinct traits of echinoderms are their ability to autotomize and 
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regenerate body parts. Additionally, the mutability of their collagenous tissue, changing 
between stiff and soft states, is another unusual feature of echinoderms (Mo et al., 2016).  
With the completion of genome and transcriptome data analysis, potential 
neuropeptide precursors have been identified in several echinoderm species. Matthew 
Rowe and Maurice Elphick (Rowe and Elphick, 2012) identified 28 cDNAs encoding 
neuropeptide precursors in the sea urchin Strongylocentrotus purpuratus, which 
provided new insights into neuropeptide evolution (Semmens and Elphick, 2017). For 
example, the S. purpuratus thyrotropin-releasing hormone-type precursor is the first one 
identified in invertebrate. Discovery of NG peptides in sea urchins bridged the gap 
between neuropeptide S in tetrapod vertebrates and crustacean cardioactive peptide in 
protostomes (Semmens et al., 2015). Later on, a total of 17 neuropeptide precursors 
have been identified in sea cucumber Apostichopus japonicus transcriptome sequence 
data by using homologs predicted in Strongylocentrotus purpuratus as queries for 
BLAST searches (Rowe et al., 2014). Recently, 40 transcripts encoding neuropeptide 
precursors were identified in the starfish Asterias rubens (Semmens et al., 2016). 
Transcriptome sequence data from three brittle star species, Ophionotus victoriae, 
Amphiura filiformis and Ophiopsila aranea, have also been analyzed to identify 
neuropeptide precursors (Zandawala et al., 2017). 
1.3 The common European starfish A. rubens 
Asterias rubens is one of the most abundant starfish species in the eastern and 
western regions of north Atlantic. It can be found throughout the coasts of the UK from 
intertidal rocky shores to deep water area. A. rubens on the south-west coast of Britain 
has a relatively clear annual reproductive cycle with the gonad growth in autumn and 
winter and spawning in spring to early summer after the gonad reaching full size 
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(Barker and Nichols, 1983). Fertilization occurs soon after spawning of eggs and sperm 
and the larval development of A. rubens takes about 87 days to 140 days, which 
provides enough time to allow for wide dispersal and geographical distribution before 
the larvae settle (Barker and Nichols, 1983). The growth of A. rubens larvae and 
juveniles is affected by water temperature, food abundance and other factors, but after 
the completion of metamorphosis, the juvenile A. rubens is free from the attachment and 
feed carnivorously on algae (Barnes and Powell, 1951; Barker and Nichols, 1983). 
1.3.1 The anatomy of A. rubens 
The adult A. rubens is a five-rayed starfish, with each arm radiating from the 
central disk region. The upper or aboral side is orange, purple or pale brown, depending 
on geographical location and/or environmental conditions. The aboral body wall has 
numerous appendages, including spines, pedicellariae and papulae (Figure 1.7). The 
spines and pedicellariae are mainly involved in the passive and active defense of starfish 
(Dubois and Ameye, 2001). The papulae have a respiratory function, enabling gas 
exchange between seawater externally and the coelomic fluid internally (Cobb, 1978). 
On the aboral surface of the central disk is the madreporite (Figure 1.7), a disc-like plate 
that connects the water vascular system to the external environment. On the lower or 
oral side of the central disk is located the mouth, surrounded by the peristomial 
membrane. On the oral side of each arm is the ambulacral groove, which comprises 
rows of tube feet extending from the peristome to the arm tips (Figure 1.7). Tube feet 
are fleshy, extendable and movable fluid-filled tubes with a disc-like sucker (Figure 1.7, 
1.8) that have important roles in locomotion, attachment and feeding (Hennebert, 2010). 
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Figure 1.7 The anatomy of starfish Asterias rubens.  
A: Photograph of five-rayed adult A. rubens with each arm radiating from the central 
disk region from the aboral side feeding on mussels (Mytilus edulis). B: Photograph of a 
living specimen of A. rubens showing the arm tip region viewed from the underside 
(oral) of the animal, taken using a Leica DFC420 C camera linked to a Leica S8 APO 
microscope. The most prominent feature is the pigmented optic cushion, which is 
located at the base of the terminal tentacle. The terminal tentacle and optic cushion are 
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bounded on each side by spines and rows of tube feet can be seen adjacent to the optic 
cushion. C: Photograph of a partially dissected starfish without the aboral body wall of 
the arm showing gonads (white), pyloric caeca (brown), radial canal (RaC), ampulla 
(Am) and tube feet (TF) from the aboral side. D: Photograph of A. rubens central disk 
without the aboral body wall showing the cardiac stomach (CS), pyloric stomach (PS), 
pyloric caeca (PC) and ampulla (Am) from the aboral side. E: Photograph of A. rubens 
showing mouth (Mo) in the middle of the central disk and rows of tube feet radiating 
from the central disk region from the oral side. 
 
Figure 1.8 Trichrome stained sections of A. rubens.  
A: This section runs transversely across the middle of the central disk region and 
parasagittally through two arms. B: Transverse section of an arm. C-E: Horizontal 
sections through the central disk and arms of a juvenile specimen, with C at the level of 
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the esophagus, D at the level of the circumoral nerve ring and E at the level of the 
highly-folded pouches of the cardiac stomach. ADO, adambulacral ossicle; AM, apical 
muscle; Am, ampulla; AMO, ambulacral ossicle; CE, coelomic epithelium; CO, carinal 
ossicle; CONR, circumoral nerve ring; CS, cardiac stomach; Es, esophagus; MO, 
marginal ossicles; Pa, papulae; PC, pyloric caeca; PD, pyloric duct; Pe, pedicellariae; 
PM, peristomial membrane; PS, pyloric stomach; RC, rectal caeca; Re, rectum; RNC, 
radial nerve cord; RO, reticular ossicles; Sp, spine; TF, tube feet. Scale bars: 500 µm in 
A, B; 200 µm in C, D, E. 
The body wall of starfish consists of an external epithelial layer and an internal 
coelomic epithelium. Sandwiched between these epithelia calcareous ossicles (Figure 
1.8) form an endoskeleton, with individual ossicles surrounded and/or linked by 
collagenous tissue composed of collagen fibers (dermis) and small bundles of muscle 
(myocytes) (Lawrence, 2013). 
At the tip of each arm is the terminal tentacle and optic cushion (Figure 1.7), 
which have important sensory functions. The terminal tentacle is tube foot-like structure 
and it is involved in detecting environmental changes (Hennebert et al., 2013). The 
optic cushion (a red spot) is located at the oral base of the terminal tentacle and is 
composed of a cluster of pigment-cup ocelli that form a simple “eye”. Evidence has 
been obtained recently that the coral-reef-associated starfish Linckia laevigata optic 
cushions are involved in negative phototaxis (Garm and Nilsson, 2014). 
When it comes to the internal anatomy of A. rubens, it can be divided into the 
nervous system, digestive system and circulatory system. The nervous system of A. 
rubens comprises radial nerve cords, which are located on the oral side of each arm with 
two rows of tube feet on either side (Figure 18B, C), and a circumoral nerve ring 
located in the central disk that links the five radial nerve cords (Figure 18A, D). Linked 
to each tube foot is an associated contractile ampulla that is located internal to the body 
wall (Figure 18A, B). The circumoral nerve ring is located at the periphery of the 
peristomial membrane (Figure 1.8). The V-shaped radial nerve cords in transverse 
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section (Figure 1.8B) run along with the length of each arm in the middle of the 
ambulacral groove, bordered on each side by two rows of tube feet (Moore and 
Thorndyke, 1993). Both the circumoral nerve ring and radial nerve cord are comprised 
of ectoneural and hyponeural regions. The ectoneural region occupies a superficial 
position in the oral epidermis and is the predominant part of the nervous system 
(Mashanov et al., 2016). It is continuous with the subepidermal plexus, which covers 
almost the whole body (Cobb, 1970). The ectoneural neurons are thought to comprise 
motoneurons, interneurons sensory neurons (Cobb, 1970; Cobb, 1987; Moore and 
Thorndyke, 1993). The hyponeural region is located at the aboral surface of the 
respective ectoneural cords as a thinner nervous tissue layer (Mashanov et al., 2016). 
Hyponeural neurons are thought to be motoneurons exclusively (Cobb, 1970; Cobb, 
1987; Moore and Thorndyke, 1993).  
The digestive system is a prominent part of the internal anatomy of A. rubens, 
including the mouth, cardiac stomach, pyloric stomach, pyloric duct, pyloric caeca, 
rectum and anus, as illustrated in Figure 1.7 and Figure 1.8. During the feeding 
processes, the mouth in the middle of central disc opens first, and the oral voluminous 
and foldable cardiac stomach is everted outside the mouth to surround digestible parts 
of prey (Figure 1.8A). Digestion occurs largely externally through the actions of 
enzymes secreted by the stomach. Then the cardiac stomach is retracted back and 
digested particles are transported to the smaller flattened aboral pyloric stomach and 
pyloric caeca through the pyloric ducts for further digestion, absorption and storage. 
Waste material is passed from the pyloric caeca to the rectum, via the pyloric duct, and 
expelled through the anus in the center of the aboral central disk (Ruppert et al., 2004). 
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The circulatory system of starfish is complex, including the coelom, the hemal 
system and the water vascular system. The coelom comprises a single cavity in the disc 
and five arm cavities, which are filled with circulating coelomic fluid. The hemal 
system is comprised of three pairs of hemal rings (hyponeural hemal ring, gastric hemal 
ring and genital hemal ring) and the connecting axial sinus located in the coelomic 
cavity of the disk (Broertjes and Posthuma, 1978; Beijnink and Voogt, 1986). A simple 
heart is located on top of the axial sinus, above the three hemal rings and the same side 
as the madreporite (Ruppert et al., 2004). The hemal system is mainly used for 
transporting nutrients derived from the digestive system. It is not clear whether the A. 
rubens hemal system is also responsible for the transportation of hormones (e.g. 
neuropeptides). The water vascular system, containing a ring canal, five radial canals 
and ampullae (Figure 1.8), is used to control the movement of fluid required for the 
hydraulic tube feet. External seawater enters the body wall to the stone canal via the 
madreporite and then fluid moves into the ring canal around the mouth and along the 
radial canals in each arm to reach the ampullae, which by contracting or relaxing control 
the extension or retraction of tube feet (Smith, 1950; Hennebert et al., 2013). 
1.3.2 A. rubens: a model system for neuropeptide research 
1.3.2.1 Identification of transcripts encoding neuropeptide precursors and 
neuropeptide receptors in the starfish A. rubens 
Sequencing of the neural transcriptome of A. rubens has enabled the most 
comprehensive identification of neuropeptide precursor proteins in an echinoderm to 
date, with 40 transcripts encoding neuropeptide precursors identified (Semmens et al., 
2016). Some of these neuropeptide precursors are the first to be discovered in a non-
chordate species, such as kisspeptin-type and melanin-concentrating hormone-type 
 43 
precursors. The starfish tachykinin-type, somatostatin-type, pigment-dispersing factor-
type and corticotropin-releasing hormone-type precursors are the first to be identified in 
an echinoderm. A. rubens neuropeptide precursors that are homologues of 
neuropeptides identified in other animal types include vasopressin/oxytocin-type, 
gonadotropin-releasing hormone-type, thyrotropin-releasing hormone-type, calcitonin-
type, cholecystokinin/gastrin-type, orexin-type, luqin-type, pedal peptide/orcokinin-type, 
glycoprotein hormone-type, bursicon-type, relaxin-type and insulin-like growth factor-
type precursors (Semmens et al., 2016). Discovery of all these neuropeptide precursor 
transcripts has provided a basis for functional analysis of neuropeptides in A. rubens. 
However, more experimental work is now necessary to confirm the sequences of 
predicted peptides and to investigate their physiological roles. 
1.3.2.2 Functional characterisation of neuropeptides in the starfish A. rubens 
A. rubens has been a model system for functional characterisation of 
neuropeptides since the detection of FMRFamide-like immunoreactivity in the radial 
nerve and circumoral nerve ring (Elphick et al., 1989). Furthermore, the first 
neuropeptides to be identified in an echinoderm, the SALMFamides S1 (GFNSALMF-
NH2) and S2 (SGPYSFNSGLTF-NH2), were isolated from A. rubens based on their 
cross-reactivity with antibodies to FMRFamide-like peptides (Elphick et al., 1991a). 
The expression of S1 and S2 in the radial nerve cords, the tube feet, apical muscle and 
cardiac stomach was visualised using specific antisera to S1 or S2, respectively (Elphick 
et al., 1991b; Elphick et al., 1995; Newman et al., 1995b). The function of S1 and S2 in 
starfish has been investigated using in vitro and in vivo  pharmacological methods, 
revealing that both peptides cause relaxation of cardiac stomach, tube foot and apical 
muscle preparations in vitro (Elphick et al., 1995; Melarange et al., 1999; Melarange 
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and Elphick, 2003) and trigger cardiac stomach eversion in vivo (Elphick et al., 1995; 
Melarange et al., 1999). 
RT-PCR and mRNA in situ hybridization have been used to investigate the 
expression of neuropeptide precursor transcripts; for example, transcripts encoding the 
precursor of relaxin-like gonad-stimulating peptide (RGP) in the starfish Patiria 
pectinifera (Mita et al., 2009a; Mita et al., 2009b). However, to obtain a detailed of 
knowledge of neuropeptide function in starfish, a range of approaches are required that 
combine anatomical studies employing mRNA in situ hybridization and 
immunohistochemistry with in vitro and in vivo pharmacological methods. 
In addition to the above, there are several other reasons why A. rubens is a good 
experimental animal for neuropeptide research. Firstly, it is relatively easy to collect 
and maintain this species as it has a widespread distribution around the coast of the UK 
and Europe. Secondly, as a member of the starfish order Forcipulatida, which includes 
at least 5 starfish species (Janies, 2001), research about A. rubens (the most common 
and familiar starfish in the north-east Atlantic) is representative and can provide global 
interest. Thirdly, although starfish are sometimes eaten as a snack food (e.g. in China), 
they can also be harmful to marine resources by eating economical important shellfish 
or destroying coral reefs (Dare, 1982; Dolmer, 1998; Agüera et al., 2012; Magnesen and 
Redmond, 2012; Uthicke et al., 2015). Research on starfish neuropeptides, especially 
those involved in regulation of feeding and reproduction behavior, may be helpful for 
developing novel approaches to control starfish species that have negative impacts 
economically or ecologically. 
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1.4 Aims and objectives 
The general aim of the work reported in this thesis was to investigate the 
expression and functions of neuropeptides derived from four predicted neuropeptide 
precursor proteins in Asterias rubens: relaxin-like gonad-stimulating peptide precursor 
(AruRGPP), relaxin-like peptide precursor 2 (AruRLPP2), pedal peptide-type 
neuropeptide precursors 1 and 2 (ArPPLNP1 and ArPPLNP2), respectively. 
Chapter 2 reports experimental analysis of relaxin-like gonad-stimulating 
peptide precursor (AruRGPP) and relaxin-like peptide precursor 2 (AruRLPP2), which 
were originally identified by analysis of A. rubens radial nerve cord transcriptome 
sequence data (Semmens et al., 2016). The sequences of these two precursors are 
confirmed by cDNA cloning and sequencing and the structure of the neuropeptide 
derived from AruRGPP is characterized using mass spectrometry. The expression of 
both precursors in A. rubens are analysed using mRNA in situ hybridization and the 
physiological roles of AruRGP are investigated using an in vitro assay. Importantly, this 
is the first study to characterize in detail the expression patterns of relaxin-type peptides 
in an echinoderm. 
Chapters 3 and 4 report experimental analysis of two pedal peptide-type 
neuropeptide precursors in A. rubens, ArPPLNP1 and ArPPLNP2. A partial sequence of 
ArPPLNP2 has been reported previously based on analysis of A. rubens radial nerve 
cord transcriptome sequence data (Semmens et al., 2016). Here full length cDNAs 
encoding ArPPLNP1 and ArPPLNP2 are cloned and sequenced, providing templates for 
production of probes that are used for analysis of their expression patterns in A. rubens 
using mRNA in situ hybridization. Mass spectrometry is used to determine the 
structures of peptides derived from ArPPLNP1 and ArPPLNP2. Then antibodies to 
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peptides derived from ArPPLNP1 and ArPPLNP2 are generated and characterized to 
enable analysis of the expression of these peptides in A. rubens using 
immunohistochemical techniques. Finally, in vitro and in vivo pharmacology methods 
are used to investigate the physiological roles in A. rubens of peptides derived from 
ArPPLNP1 and ArPPLNP2. Importantly, this is the first study to characterize the 
expression patterns of pedal peptide-type peptides in an echinoderm and to compare the 
pharmacological actions of peptides derived from different pedal peptide-type 
precursors in an echinoderm. 
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2 Cellular localization of the expression of two relaxin-type 
neuropeptide precursors in Asterias rubens: new insights into 
neurohormonal control of spawning in starfish Asterias rubens 
2.1 Introduction 
Relaxin-type peptides include relaxin and insulin/relaxin-like peptides, which 
belong to the insulin/IGF/relaxin superfamily. The insulin/IGF/relaxin superfamily 
includes insulin, IGFs, relaxin and insulin/relaxin-like peptides, which is divided into 
two subfamilies: the insulin and insulin-like growth factor (IGF) subfamily and the 
relaxin (RLN) and relaxin/insulin-like (INSL) subfamily based on evolutionary 
relationships that are reflected in precursor structure (Figure 2.1 A) (Steiner et al., 1985; 
Lu et al., 2005). The focus of the work reported in this chapter are two starfish 
neuropeptides that are relaxin-type neuropeptides (Semmens et al., 2016). Therefore, 
here relaxin-type peptides are introduced. 
 
Figure 2.1 General structure of relaxin, insulin and IGF precursors (A) and predicted 
dimeric structure of relaxin/insulin (B). 
The signal peptide (SP) is shown with a grey rectangle. A to E chains are shown in 
green, blue, black, turquoise and purple, respectively. Cysteines and disulfide bridges 
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are shown with red lines. Schematic diagrams were prepared using Illustrator for 
Biological Sequences (IBS, version 1.0.3) software. 
All members in the relaxin subfamily are synthesized as an immature precursor 
with an N-terminal signal peptide and a B-C-A domain (Figure 2.1 A). The mature and 
bioactive peptide is produced after the cleavage of the signal peptide and C chain, and 
the formation of two disulfide bridges between A and B chains and one disulfide bridge 
within A chain (Steinetz et al., 2009) (Figure 2.1 B). Since the initial discovery of 
relaxin as a relaxant of pubic ligaments (Hisaw, 1926), it has been reported that relaxin-
type peptides are involved in regulation of a variety of physiological processes. 
Consistent with the multiple functions of this neuropeptide family, relaxin-type peptides 
are detected not only in reproductive tissues but also in the nervous system and in other 
peripheral organs/tissues (Bathgate et al., 2013). 
2.1.1 The relaxin-type neuropeptide family in vertebrates and the evolution of 
relaxin-type neuropeptides 
2.1.1.1 Discovery and determination of the structure of relaxin 
Relaxin was initially discovered in guinea pig due to its effect on the female 
reproductive system (Hisaw, 1926). It was purified and named as relaxin because it 
causes relaxation of interpubic ligaments (Fevold et al., 1930). The amino-acid 
sequences of relaxins were determined in more than twenty animal species between the 
1970s and 1990s and the precursors of these peptides all have the signal peptide-B-C-A 
structure (Figure 2.1 A) (Schwabe et al., 1976; Schwabe and McDonald, 1977a; John et 
al., 1981; Hudson et al., 1984; Evans et al., 1993; Bryant-Greenwood and Schwabe, 
1994; Bathgate et al., 2002). The tertiary structure of relaxin was investigated by X-ray 
crystallography in 1991 and its dimer structure was confirmed (Eigenbrot et al., 1991). 
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2.1.1.2 Evolution of relaxins in vertebrates 
Rising numbers of relaxin or insulin/relaxin-like neuropeptide precursors have 
been identified in mammals and other vertebrates (Good-Avila et al., 2009; Hoffmann 
and Opazo, 2011), including INSL3 (Burkhardt et al., 1994a; Zimmermann et al., 1999), 
INSL4 (Chassin et al., 1995; Koman et al., 1996; Conklin et al., 1999), INSL5 (Conklin 
et al., 1999; Hsu, 1999), and INSL6 (Hsu, 1999; Kasik et al., 2000; Lok et al., 2000), 
since the initial discovery of relaxin in 1926 (Hisaw, 1926). Although these more 
recently identified peptides are named insulin/relaxin-like peptides (INSL), they are 
more closely related to relaxin from physiological and evolutionary perspectives, as 
discussed below. Genes encoding relaxin-type peptide precursors have a similar 
structure with two exons interrupted by an intron, which is situated in the middle of the 
C chain sequence (Bathgate et al., 2013). Members of the relaxin-type family are all 
synthesized as a preprohormone, which contains four sequential parts: N-terminal signal 
peptide, B chain, C chain and C-terminal A chain. The cleavage sites are located at the 
two ends of the C chain. The bioactive mature relaxin-type peptides are all heterodimers 
consisting of A and B chains linked via two inter chain disulfide bridges and an intra 
chain disulfide bridge in the A chain (Steinetz et al., 2009; Bathgate et al., 2013). 
Moreover, there are characteristic cysteine motifs in the A and B chains, which are 
CCxxxCxxxxxxxxC or CxxxxxxxxxxxC, respectively (Semmens et al., 2016). The B 
chain in vertebrate relaxin-like peptides also contains a relaxin-specific receptor-binding 
motif - RxxxRxxI/V (Bullesbach and Schwabe, 2000; Semmens et al., 2016). 
According to phylogenetic and genomic analysis of the predicted relaxin-type 
neuropeptide precursors, whole genome duplication during early vertebrate evolution 
gave rise to the diversity of the genes encoding relaxin-type peptides (Yegorov and 
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Good, 2012; Semmens et al., 2016). It used to be thought that relaxin-3 is the ancestral 
peptide of the vertebrate relaxin family peptides (Wilkinson et al., 2005). Recently, it 
was demonstrated that the vertebrate relaxin-type neuropeptide genes are products of an 
ancestral system that originally consisted of three genes, two of which trace their origins 
back to the invertebrates (Yegorov and Good, 2012). 
2.1.1.3 Physiological roles of relaxins - reproductive and non-reproductive 
functions 
The relaxin-type peptides regulate many physiological processes. Relaxin acts 
on the cervix, pubic symphysis, vagina, uterus and mammary apparatus, as well as 
mediating the cardiovascular changes to manage the increased blood volume during 
pregnancy (Callander and Bathgate, 2010; Klein, 2016). Relaxin softens the cervix 
(Bathgate et al., 2006), mediates the increased flexibility and elasticity of the interpubic 
ligament (O'Connor et al., 1966; Steinetz et al., 1983), influences the growth of the 
vagina (Hall, 1960; Schink and Struck, 1968; Burger and Sherwood, 1995; Zhao et al., 
1996; Zhao et al., 2001) and influences uterine contractility (Krantz et al., 1950) and 
growth (Steinetz et al., 1957) during pregnancy. When it comes to the reproductive 
physiology of relaxin in males, relaxin is involved in regulation of prostate growth, 
spermatogenesis, sperm motility and penetration into oocytes (Weiss, 1989; Braun et al., 
2015; Elkhawagah et al., 2015). The INSLs are also involved in reproductive processes 
(Koman et al., 1996), with for example targeted disruption of the Insl3 gene causing 
bilateral cryptorchidism (absence of both testes from the scrotum) (Zimmermann et al., 
1999). However, relaxin also has non-reproductive physiological functions (Bathgate et 
al., 2013).  
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The non-reproductive functions of relaxin include inhibition of inflammation, 
wound healing, fluid balance and body homeostasis with its ability to reduce matrix 
synthesis and increase extracellular matrix (ECM) degradation (Samuel et al., 2007; 
Shabanpoor et al., 2009), regulating the collagenous tissue through its antifibrotic 
effects (Samuel et al., 2016) and modulating stress responses through interactions with 
corticotropin releasing factor (Ma et al., 2009; Bathgate et al., 2013). It has been 
demonstrated that relaxin gene therapy improves diastolic function in pressure-
overloaded rats via phospholamban by activating Protein kinase B (Shuai et al., 2016). 
Relaxins in the nervous system stimulate food intake in male wistar rats (McGowan et 
al., 2005) and alcohol consumption is increased in relaxin-3 deficient male mice 
(Shirahase et al., 2016). Moreover, relaxin may contribute to the regulation of the 
proximal colon motility by the nitric oxide/cGMP/cGMP-dependent protein kinase 
pathway (Squecco et al., 2015). Recently, it has been reported that relaxin participates 
in bone remodeling by stimulating the activity of both osteoblast and osteoclasts and 
facilitates muscle healing by enhancing the recruitment of satellite cells, improving 
vascular perfusion, inhibiting fibrosis and promoting neo-angiogenesis (Ferlin et al., 
2016). 
2.1.1.4 G protein-coupled receptors for vertebrate relaxin-type peptides 
Four highly conserved family A G protein-coupled receptors (GPCRs), relaxin 
family peptide receptors 1 - 4 (RXFP1 - 4), mediate the physiological effects of 
vertebrate relaxin family peptides (Bathgate et al., 2013). RXFP1 (LGR7) and RXFP2 
(LGR8), two GPCRs with N-terminal leucine-rich repeats, are the cognate receptors of 
relaxin-2 and INSL3, respectively. Activation of these receptors leads to generation of 
second messengers such as cAMP and nitric oxide to activate downstream signaling 
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pathways. RXFP3 (GPCR135) and RXFP4 (GPCR142) are activated by relaxin-3 and 
INSL5 to inhibit cAMP production and activate MAP kinases (Bathgate et al., 2013). 
RXFP1 and RXFP2 both couple to Gαs and to GαOB to exert their effects, but RXFP1 is 
also able to couple to Gαi3 to produce a delayed surge in cAMP accumulation. Gαi/GαO 
proteins are coupled to RXFP3/RXFP4 depending on the cell type the receptor being 
expressed (Bathgate et al., 2013). 
The genes for RXFP1 and RXFP2 are very large, containing 18 exons. A large 
number of RXFP1 and RXFP2 splice variants have been described (Muda et al., 2005; 
Scott et al., 2006; Kern et al., 2008) with potential physiological functions as 
endogenous antagonists (Scott et al., 2005). However, the genes encoding RXFP3 and 
RXFP4 are intronless and have no splice variants (Bathgate et al., 2013). 
2.1.1.5 Expression patterns of relaxin genes in mammals 
As mentioned above, relaxin has a variety of roles in reproduction and other 
physiological processes. Relaxin has been detected not only in reproductive tissues, 
such as the corpus luteum (Yki-Jarvinen et al., 1983), uterus (Bond et al., 2004), 
mammary gland, testis and prostate of mammals (Gunnersen et al., 1995; Bathgate et al., 
2002), but also in the brain and peripheral tissues such as the heart, kidney, lung, liver 
and pancreas (Gunnersen et al., 1995) based upon Northern blotting, RT-PCR, southern 
blotting or immunohistochemistry (Bathgate et al., 2013). Relaxin-3 mRNA is only 
detected in the brain, especially the nucleus incertus (NI), (Bathgate et al., 2002; Liu et 
al., 2003; Ma and Gundlach, 2007), but the genes encoding relaxin-1 and 2 are 
expressed in the ovarian corpus luteum during pregnancy and in the deciduas 
trophoblast (Hudson et al., 1981; Hudson et al., 1984; Hansell et al., 1991). Moreover, 
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there is clear level peak during pregnancy of mammals (Bathgate et al., 2006). These 
expression patterns are consistent with the functions of relaxins. 
Turning to the expression of insulin/relaxin-like peptides, INSL3 is highly 
expressed in the testis Leydig cells of every mammalian species so far examined 
(Adham et al., 1993; Bathgate et al., 2013; Pitia et al., 2015) and in the ovary as 
determined by RT-PCR (Tashima et al., 1995; Ivell et al., 1997), Northern blotting 
(Adham et al., 1993; Burkhardt et al., 1994b; Tashima et al., 1995), in situ hybridization 
(Pusch et al., 1996; Ivell et al., 1997; Balvers et al., 1998; Klonisch et al., 1999; Teerds 
et al., 1999; Paust et al., 2002) and immunohistochemistry (Balvers et al., 1998; 
Bamberger et al., 1999; Klonisch et al., 1999; Gnessi et al., 2000; Paust et al., 2002), 
but in other tissues at much lower levels (Bathgate et al., 2013). The mRNA of INSL4 
has been identified in the differentiated syncytiotrophoblast (Laurent et al., 1998), 
amniotic fluid and maternal serum during normal pregnancy (Mock et al., 1999). The 
expression of INSL5 has been detected in the rectum, colon, uterine tissue and thymus 
at high levels (Conklin et al., 1999; Liu et al., 2005) and in the brain and testis (Conklin 
et al., 1999) at lower levels, by northern blot analysis or RT-PCR. Northern blotting and 
in situ hybridization analysis has shown that INSL6 is highly expressed in human testis 
(Lok et al., 2000; Lu et al., 2006) and mouse (Kasik et al., 2000) and in other tissues 
such as kidney, small bowel, heart, brain and thymus but at lower levels (Kasik et al., 
2000). 
2.1.2 Discovery of relaxin-type neuropeptides in invertebrates 
Relaxin and/or insulin/relaxin-like peptides have also been identified in 
invertebrates. Phylogenetic analysis shows that four putative members (sequence ID 
100967, 72897, 74371 and 97394, (Holland et al., 2008)) of the insulin-relaxin 
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superfamily in the cephalochordate amphioxus belong to the same cluster as vertebrate 
relaxins but not with the insulin/IGF subfamily (Lecroisey et al., 2015). Amphioxus 
insulin-like peptide sequences consist of a well-supported group close to both vertebrate 
insulin and IGFs (Lecroisey et al., 2015). Insulin-like peptides have also been identified 
in protostomes, including 40 in Caenorhabditis elegans (Li C and K, 2008) and 7 in 
Drosophila melanogaster (Brogiolo et al., 2001). However, according to molecular 
evolution and functional characterization analysis, they are more likely to belong to the 
insulin/IGF subfamily (Gronke et al., 2010). Relaxin-type neuropeptides have, however, 
been identified in echinoderms (Mita et al., 2009b; Mita et al., 2015; Haraguchi et al., 
2016; Mita and Katayama, 2016; Semmens et al., 2016) and it is these peptides that are 
the focus of this chapter, building upon the discovery that starfish gonad-stimulating 
substance is a relaxin-type neuropeptide (Mita et al., 2009b). 
2.1.2.1 Starfish gonad-stimulating substance is a relaxin-type neuropeptide 
2.1.2.1.1 The discovery of starfish gonad-stimulating substance 
The first report of a gonadotropic substance in an invertebrate was the 
observation of Chaet and McConnaughy (1959) that extracts of radial nerve cords from 
the starfish Asterias forbesi induce shedding of gametes when injected into this species 
without sex specificity (Chaet and McConnaughy, 1959; Kanatani and Ohguri, 1966). 
This substance was also found in other starfishes and was named “gamete shedding 
substance” initially (Chaet and Smith, 1962; Kanatani, 1964). In vivo or in vitro cross 
experiments among different starfishes have shown that the substance acts non-species 
specifically within the same starfish genera (Hartman and Chaet, 1962; Chaet, 1964a; 
1966b; a; Kanatani and Shirai, 1967). Some exceptions have been found among 
different starfish orders, such as the nerve extract of Asterina can induce spawning in 
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Asterias but that of Asterias does not work in Asterina (Chaet, 1964a; Kanatani, 1973). 
GSS induces oocyte maturation within the ovary by acting directly on the ovary and 
diffusing rather slowly within the ovarian tissues (Kanatani, 1964; Kanatani and Shirai, 
1969). The active substance was renamed as gonad-stimulating substance (GSS) after 
further investigation of the GSS mechanism and was characterized biochemically as a 
peptide hormone (Kanatani and Shirai, 1969; Kanatani and Shirai, 1970). 
2.1.2.1.2 The mechanism of starfish gonad-stimulating substance action 
With respect to the mechanism of GSS in inducing oocyte maturation and 
gamete release of the starfish, GSS acts on the follicular cells around the oocyte to 
stimulate the production of 1-methyladenine (Kanatani, 1983). Then 1-methyladenine 
induces the synthesis of a third mediator called maturation-promoting factor (MPF), 
which induces germinal vesicle breakdown and the subsequent processes of oocyte 
maturation. However, the action of GSS on Asterina pectinifera spawning can be 
antagonized by L-glutamic acid (Ikegami et al., 1967) and asterosaponin A can inhibit 
1-methyladenine but not GSS from inducing spawning of isolated ovarian fragment 
(Ikegami, 1976). 
By investigating the concentration of GSS in the coelomic fluid, an annual peak 
has been observed before spawning (Kanatani and Ohguri, 1966; Kanatani and Shirai, 
1969), demonstrating that GSS/RGP acts as hormonal regulator of gamete maturation 
and release physiologically. The starfish radial nerve cords have been thought to be the 
source of this hormone to regulate starfish reproduction since it was first reported in 
1959 (Chaet and McConnaughy, 1959). But the level of GSS in starfish nerves remains 
constant throughout the year (Chaet, 1966a; b; Mita, 2013). Is there any substance in the 
coelom reducing GSS after the breeding season or does the GSS that triggers starfish 
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spawning come from another tissue? These are questions that will be addressed in 
experiments reported in this chapter. 
2.1.2.1.3 The structural and functional characterization of starfish gonad-
stimulating substance 
It was proposed that GSS is a polypeptide due to the observation that its activity 
is destroyed by proteolytic enzymes such as trypsin, chymotrypsin, pepsin and pronase 
(Kanatani and Noumura, 1962; Chaet, 1964c; Kanatani and Shirai, 1967; Schuetz, 
1969). Lots of work has been done to purify this substance (Chaet, 1967; Kanatani and 
Shirai, 1971) but it was not until 2009 that the molecular identify of GSS was finally 
determined (Mita et al., 2009b), fifty years after its activity was first reported. Using the 
Japanese starfish species Patiria pectinifera as an experimental system, GSS was 
purified and identified as a heterodimer comprising two polypeptides - A and B chains. 
The A and B chains are linked by two disulfide bridges, with the A chain also having a 
single intramolecular disulfide bridge. Furthermore, the A chain contains a cysteine 
motif CCxxxCxxxxxxxxC, which is a signature sequence of the relaxin/insulin/IGF 
superfamily (Mita et al., 2009b). More specifically, phylogenetic sequence analysis 
revealed that P. pectinifera GSS is a member of the relaxin-type peptide subfamily. 
Therefore, the GSS identified in P. pectinifera has been designated as relaxin-like 
gonad-stimulating peptide (RGP) (Haraguchi et al., 2016). Subsequently, orthologues of 
P. pectinifera RGP (PpeRGP) have been identified in other starfish species, including 
Asterias amurensis, Asterias rubens and Aphelasterias japonica (Mita et al., 2015; Mita 
and Katayama, 2016; Semmens et al., 2016). Cross-experiments among different 
starfish have been performed to test the specificity of RGP identified from P. 
pectinifera, A. amurensis and A. japonica (Mita et al., 2015; Mita and Katayama, 2016). 
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AamRGP and AjaRGP can induce oocyte maturation and ovulation in the ovaries of A. 
japonica and A. amurensis, respectively. Similar results were obtained in A. amurensis 
and A. japonica ovarian fragments after incubation with PpeRGP. However, neither 
AamRGP nor AjaRGP is active on P. pectinifera ovary (Mita et al., 2015; Mita and 
Katayama, 2016). These results are consistent with the findings of experiments on GSS, 
as discussed above, that were performed before its molecular identity was determined. 
2.1.2.1.4 The expression of starfish relaxin-like gonad-stimulating peptide 
precursor 
It has been found that GSS is present in the ectoneural part of the radial nerve 
cords, cardiac stomach, tube feet and body wall of starfish (Kanatani and Ohguri, 1966), 
although it was found to be mainly detected in the neurosecretory granules of the 
circumoral nerve ring and radial nerve cord based on performic acid-alcian blue, 
paraldehyde-fuchsin, chromalum-hematoxylin-phloxine and azan staining (Imlay and 
Chaet, 1967; Atwood and Simon, 1971). 
Quantitative PCR revealed expression of RGP in the radial nerve cords, 
consistent with the original discovery of GSS in this tissue. However, expression was 
also detected, albeit at much lower levels, in the cardiac stomach and tube feet (Mita et 
al., 2009a), which suggests that RGP may have non-reproductive functions in starfish. 
Analysis of RGP expression in P. pectinifera at the cellular level, using mRNA in situ 
hybridization techniques, has revealed that it is expressed by a population of cells 
located in ectoneural epithelium of the radial nerve cords (Mita et al., 2009b). However, 
a wider analysis of RGP expression in the starfish body using mRNA in situ 
hybridization techniques has, as yet, not been conducted. This is of interest, because it is 
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not confirmed if the radial nerve cord is the physiological source of RGP that triggers 
gamete maturation and release in starfish. 
2.1.2.2 Identification of two relaxin-type neuropeptide precursor transcripts in the 
starfish A. rubens 
Sequencing of the Asterias rubens radial nerve transcriptome enabled 
identification of 40 neuropeptide precursors (Semmens et al., 2016), including two 
precursors of relaxin-type neuropeptides. The first one was named A. rubens relaxin-
like gonad-stimulating peptide precursor (AruRGPP), based on its sequence similarity 
with RGP precursor discovered in P. pectinifera (Mita et al., 2009b). AruRGPP is a 
109-residue protein (GenBank: KT60172) comprising a 26-residue N-terminal signal 
peptide followed by a 20-residue polypeptide comprising two cysteine residues (B 
chain), a 25-residue polypeptide comprising four cysteine residues (A chain) at the C-
terminal, and a connecting peptide (C peptide) domain sandwiched between the B and 
A chain. The second precursor is A. rubens relaxin-like peptide precursor 2 (AruRLPP2, 
GenBank: KT601729), a 119-residue protein with a primary structure similar to 
AruRGPP. According to the sequences of these two predicted neuropeptides, both the A 
chains and B chains have the cysteine motifs CCxxxCxxxxxxxxC or CxxxxxxxxxxxC, 
respectively, which are characteristic of the insulin/insulin-like growth factor 
(IGF)/relaxin superfamily. So the predicted mature product of AruRGPP and 
AruRLPP2 are heterodimeric proteins comprising A and B chains, with two inter-chain 
disulfide bridges and an intra-chain disulfide bridge in the A chain. However, evidence 
is required to prove the prediction. 
2.1.3 Aims and objectives 
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The aim of the work reported in this chapter was to confirm the sequences of the 
two A. rubens relaxin-type neuropeptide precursors and investigate the expression 
pattern of these two genes. The sequences of the precursors were determined by cDNA 
cloning and sequencing and the structures of neuropeptides derived from them were 
investigated using mass spectrometry. In situ hybridization was performed to explore 
the cellular localization of these two relaxin-type neuropeptide precursors in A. rubens 





Starfish (A. rubens) were collected at low tide from the Thanet coast (Kent, UK) 
or obtained from a fisherman based at Whitstable (Kent, UK). The animals were 
maintained in a circulating seawater aquarium at ~12oC in the School of Biological and 
Chemical Sciences at Queen Mary University of London and were fed on mussels 
(Mytilus edulis). 
2.2.2 cDNA cloning and sequencing 
Two contigs (1122961, 1055767) encoding a 109 residue RGP-type precursor 
protein (AruRGPP, GenBank: KT601728) and a 119 residue relaxin-like peptide 
precursor protein (AruRLPP2, GenBank: KT601729), respectively, have been identified 
via BLAST analysis of A. rubens neural transcriptome sequence data using the PpeRGP 
precursor as a query (Semmens et al., 2016). Here cDNAs encoding AruRGPP and 
AruRLPP2 have been cloned and sequenced to confirm the contig sequences, which 
were obtained by assembly of Illumina HiSeq reads, and to obtain templates for probe 
synthesis. 
Total RNA was extracted from radial nerve cords of A. rubens using the SV 
Total RNA Isolation System (Promega) and cDNA was synthesized using the 
QuantiTect Rev. Transcription Kit (QIAGEN). The cDNAs encoding the entire coding 
region of the AruRGPP and AruRLPP2 transcripts were amplified by PCR using 
Phusion high-fidelity PCR master mix (New England Biolabs) with the following 
oligonucleotide primers: AruRGPP: forward 5’-ATGGCAAACTACCGTCTCAT-3’, 
reverse 5’-GCCACCCATGAAATAGTCAA-3’ and AruRLPP2: 5’-
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ATGACATCGTGCAGCCAC-3’, reverse 5’-TCAGCAAATTCCTGAGTTGGTTA-3’, 
which were synthesized by Sigma-Aldrich.  
The PCR products were gel-extracted and purified using a QIAquick gel 
extraction kit (QIAGEN). Then part of the purified AruRGPP and AruRLPP2 cDNA (7 
µL) were cloned into pBluescript SKII (+) vector (Agilent Technologies) separately, 
which was cut with the EcoRV-HF restriction endonuclease (New England Biolabs) for 
sequencing. 
2.2.3 Analysis of cDNA sequences and genes encoding relaxin-type precursors in 
starfish  
The cDNA sequences of the two A. rubens relaxin-type precursors were 
translated to protein sequences using the ExPASy translate tool 
(http://web.expasy.org/translate/). SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP/) 
was used to predict the signal peptide. Multiple sequence alignment tool T-Coffee 
(http://www.ebi.ac.uk/Tools/msa/tcoffee/) was used to compare the sequences of the 
two A. rubens relaxin-type neuropeptide precursors with other RGP precursors and A 
and B chains identified previously in different starfish species (Mita et al., 2009a; Mita 
et al., 2015; Mita and Katayama, 2016). ClustalW (Thompson et al., 1994) and the 
neighbor-joining method (Zuckerkandl and Pauling, 1965; Felsenstein, 1985; Saitou 
and Nei, 1987) in MEGA 7.0.14 (Kumar et al., 2016) were used to investigate the 
phylogenetic relationships of the starfish relaxin-type precursors with 
relaxin/insulin/IGF-type precursors from other taxa. 
The protein sequences of the AruRGPP and AruRLPP2 were used to identify 
genes encoding homologous proteins in the Patiria miniata genome 
(http://www.echinobase.org/Echinobase/pm) and the Acanthaster planci genome 
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(http://marinegenomics.oist.jp/cots/viewer/info?project_id=46). Then online gene 
prediction software FGENESH 
(http://www.softberry.com/berry.phtml?topic=fgenesh&group=programs&subgroup=gf
ind) was used to predict the potential open reading frame to find the exon regions, 
selecting organism-specific gene-finding parameters of Strongylocentrotus purpuratus. 
The related human relaxin/insulin-like neuropeptide precursors were used to search the 
human genome database (https://www.ncbi.nlm.nih.gov/projects/genome/guide/human/) 
to identify coding regions and compare the gene structures of the members of this 
neuropeptide family. Schematic diagrams were prepared using Illustrator for Biological 
Sequences (IBS, version 1.0.3) software or Photoshop CC (2015.0.0; Adobe Systems, 
San Jose, CA) running on a MacBook Pro computer (13-inch, with OS X EI Capitan). 
2.2.4 Mass spectrometry 
Preparation of A. rubens radial nerve cord extracts was performed by members 
of the Elphick research group. Chemical modification and mass spectroscopic analysis 
of the extracts was performed by Dr Cleidiane G. Zampronio and Dr Alexandra M. 
Jones at the University of Warwick as described below. More detailed protocols can be 
found in appendix 9.1 and 9.2.  
2.2.4.1 Preparation of A. rubens radial nerve cords extracts for mass spectrometry 
Extracts of A. rubens radial nerve cords were prepared to enable use of mass 
spectrometry to investigate the presence and structure of AruRGP and AruRLP2 in this 
tissue. Radial nerve cords were dissected from specimens of A. rubens as described 
previously (Chaet, 1964b) and then transferred into 90% methanol / 9% acetic acid with 
or without the addition of protease inhibitors (pepstatin A [0.01 mM]; 
phenylmethylsulfonyl fluoride [PMSF; 0.1mM]). The tissue was sonicated (two 2-min 
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pulses with 15-sec intervals) and homogenized to lyse cells. The extract was centrifuged 
(10,000g for 5min at 4oC) and the supernatant transferred to a glass vial. Finally, the 
solvent was bubbled off using nitrogen gas before being stored at -20oC. 
Aliquots of 10 µl of radial nerve extract were diluted using 50 µl of 1mM 
ammonium bicarbonate (Sigma Aldrich) to neutralize the high concentration of acetic 
acid used for extraction. Some aliquots were also subject to reduction to break disulfide 
bridges followed by alkylation of cysteine residues. For reduction, samples were treated 
with 5 µl of 100mM dithiothreritol (Sigma Aldrich) and heated at 60oC for 15 minutes. 
Alkylation was performed by adding 5 µl of 200 mM iodoacetamide (Sigma Aldrich) 
and incubated in the dark at room temperature for 30 minutes. Samples of both 
reduced/alkylated and nonreduced/nonalkylated material were also digested using 0.5 
µg trypsin (Promega) solution and incubated overnight at 37oC, with the digest arrested 
by addition of 10 µl of 10% formic acid (J.T. Baker, Phillipsburg, NJ). 
2.2.4.2 Mass spectrometry procedure 
NanoLC-ESI-MS/MS was used to analyze samples of radial nerve extracts, with 
a 3 µl aliquot of each sample separated by reversed phase chromatography prior to mass 
spectrometric analysis. Two columns were utilized, an Acclaim PepMap µ-pre-column 
cartridge (300 µm i.d. x 5mm 5 µm 100 Å) and an Acclaim PepMap RSLC (75 µm x 
25cm 2 µm 100 Å) (Thermo Scientific), installed on an Ultimate 3000 RSLCnano 
system (Dionex, Sunnyvale, CA). Mobile phase buffer A was 0.1% formic acid in water 
and mobile phase B was 0.1% formic acid in acetonitrile. Samples were loaded onto the 
µ-pre-column equilibrated in 2% aqueous acetonitrile containing 0.1% trifluoroacetic 
acid for 8 minutes at 10 µl min-1, after which peptides were eluted onto the analytical 
column at 300nl min-1 by increasing the mobile phase B concentration from 4% B to 25% 
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over 90 minutes then to 35% B over 10 minutes and 90% B over 5 minutes, followed by 
a 15-minute re-equilibration at 4% B. Peptides were injected directly from the LC 
(300nl min-1) via a Triversa Nanomate nanospray source (Advion Biosciences, NY) into 
a Thermo Orbitrap Fusion (Q-OT-qIT, Thermo Scientific, Pittsburgh, PA) mass 
spectrometer. Survey scans of peptide precursors from 400 to 1600 m/z were performed 
at 120K resolution (at 200 m/z) with automatic gain control (AGC) 5 x 105. Precursor 
ions with charge state 2-6 were isolated (isolation at 1.2 Th in the quadrupole) and 
subjected to HCD fragmentation with normalized collision energy of 35. Tandem mass 
spectrometry (MS/MS) data were analyzed using the Orbitrap at 30K resolution, AGC 
was set to 5.4 x 104, and the max injection time was 200 ms. Dynamic exclusion 
duration was set to 60 seconds with a 10ppm tolerance around the selected precursor 
and its isotopes. Monoisotopic precursor selection was turned on. The instrument was 
run in top speed mode with 2-second cycles. 
2.2.4.3 Mass spectrometry data analysis 
Raw data were converted to mascot generic format using MSConvert in 
ProteoWizard Toolkit (v. 3.0.5759) (Kessner et al., 2008). MS spectra were searched 
with Mascot engine (Matrix Science, v. 2.4.1) (Nesvizhskii et al., 2003) against a 
database comprising 40 A. rubens neuropeptide precursor proteins (Semmens et al., 
2016), all proteins in GenBank from species belonging to the family Asteriidae and the 
common Repository of Adventitious Proteins Database (http:// 
www.thegpm.org/cRAP/index.html). Theoretical peptides were generated from a tryptic 
digestion allowing up to two missed cleavages and variable modifications; 
carbamidomethyl on cysteine, oxidation on methionine, amidation (by modification of 
C-terminal glycines), and pyroglutamate (by modification of N-terminal glutamines). A 
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no-enzyme search was performed for samples not treated with trypsin. Precursor mass 
tolerance was 10 ppm and product ions were searched at 0.05 Da tolerances. Scaffold (v. 
Scaffold_4.6.1, Proteome Software) was used to validate MS/MS-based peptide and 
protein identifications. Peptide identifications were accepted if they could be established 
at greater than 95.0% probability by the Scaffold Local FDR algorithm. Protein 
identifications were accepted if they could be established at greater than 95.0% 
probability and contained at least two identified peptides. Protein probabilities were 
assigned by the Protein Prophet algorithm (Nesvizhskii et al., 2003). Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis 
alone were grouped to satisfy the principles of parsimony. Proteins sharing significant 
peptide evidence were grouped into clusters. The program Stavrox (v. 3.6.0) was used 
to search for crosslinked spectra (Gotze et al., 2012). Default settings were used except 
that semitryptic digestion was permitted, disulfide bonds were specified as the 
crosslinker, and high mass accuracy data were used with precursor mass tolerance of 
5ppm and fragment mass tolerance of 15ppm. The full-length AruRGP precursor was 
used as the reference sequence. 
2.2.5 In vitro effects of AruRGP and PpeRGP on ovary fragments of A. rubens 
A. rubens RGP (AruRGP) and P. pectinifera RGP (PpeRGP) were synthesized 
commercially by Peptide Institute Inc. (Osaka, Japan) and their bioactivity was assayed 
using ovarian fragments from A. rubens, as described previously (Shirai, 1986). 
Modified van’t Hoff’s artificial seawater (ASW) adjusted to pH 8.2 with 0.02 M borate 
buffer was prepared (Kanatani and Shirai, 1970) and the ovaries of mature female 
starfish were excised and cut into small fragments containing only a few lobes using 
scissors. The ovarian fragments were then incubated in ASW containing synthetic 
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AruRGP or PpeRGP at a range of concentrations (5 x 10-8 – 4 x 10-10 M) for 1 h. The 
effective dose for inducing gamete spawning in 50% of ovarian fragments was 
determined. The data obtained were expressed as means ± SEM for four separate assays 
using ovaries from different animals and were then analyzed statistically using student’s 
t-tests (Mita et al., 2015). 
2.2.6 Localization of relaxin-type neuropeptide precursor transcripts in A. 
rubens using mRNA in situ hybridization 
2.2.6.1 Preparation of RNA probes 
The RNA probes were synthesized by using a PCR method according to 
protocol that can be found in appendix 9.3. 
A pBluescript SKII (+) vector containing the cloned and sequenced AruRGP or 
AruRLP2 precursor cDNAs were used to synthesize RNA probes. First, a routine PCR 
was performed using Taq DNA polymerase (Taq DNA Polymerase with Thermopol 
Buffer, New England Biolabs) and standard primer M13 (Forward: 5’-
GTAAAACGACGGCCAGTG-3’, Reverse: 5’-GGAAACAGCTATGACCATG-3’, 
Sigma-Aldrich) to linearize the plasmid and amplify the insert. The PCR product, which 
included the AruRGP or AruRLP2 precursor cDNA sequence and T3 and T7 RNA 
polymerase sites, was purified using a QIAquick gel extraction kit (QIAGEN). 
RNA probes were synthesized from the PCR product using a digoxygenin 
(DIG)-labeled nucleotide triphosphate mix (Roche) supplemented with dithiothreitol 
(Promega), a placental RNase inhibitor (Promega) and RNA polymerases (New 
England Biolabs), according to the manufacturer’s instructions. T3 or T7 RNA 
polymerase (New England Biolabs) was used for synthesis of the antisense or sense 
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probes, respectively. Reaction products were digested with RNase free DNase (New 
England Biolabs) to remove template DNA and then stored at -20oC in 25% formamide 
made up in 2X saline-sodium citrate (SSC) buffer. 
2.2.6.2 Tissue fixation 
Specimens of A. rubens (diameter 4-6 cm) were fixed in 4% paraformaldehyde 
(PFA) in phosphate-buffered saline (PBS, pH 7.4) overnight at 4°C. Different protocols 
(appendix 9.4) were used to prepare paraffin-embedded sections or frozen sections of 
fixed tissue.  
To prepare specimens for embedding in paraffin wax, fixed starfish were cut 
with scissors to separate the five arms from the central disk region. Tissues were 
washed in autoclaved PBS for 10 min and then transferred to Morse’s solution (10 % 
sodium citrate; 20% formic acid in autoclaved water) for decalcification (typically 3 h 
for arms and 8 h for central disk). Then tissues were washed in distilled water for 10 
min and dehydrated through a graded series of ethanol (50%, 70%, 90%, 3 x 100%; 30 
min for each step). After clearing in xylene (1 x 5 min and 1 x 8 min) (VWR 
Chemicals), the tissue was incubated in molten paraffin wax (3 x 1 h) in an oven at 
~58oC. The tissue was embedded in wax using L-shaped brass molds and stored at room 
temperature for sectioning. 
To enable visualization of the pigmented eye spot located at the tips of the arms, 
frozen sections of arm tips were also prepared because the pigment is lost with the wax 
embedding method. After fixation, arm tips were washed in PBS (3 x 5 min) and then 
cryoprotected by incubation in sucrose solutions of ascending concentration (10%, 20%, 
30% sucrose for 3 h each step, at room temperature). The arm tips were embedded in 
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RA Lamb OCT embedding cryoembedding Matrix (Fischer Scientific) and immediately 
frozen on dry ice. 
2.2.6.3 Tissue sectioning 
The arms and central disks from at least three starfish were embedded in wax 
and sectioned (12 µm) using a Leica RM2145 microtome and then the sections were 
placed on poly-L-lysine coated slides (Polysine®; VWR) covered with dH2O. After 
about 10 minutes, the excess dH2O was removed and the slides were left to completely 
dry for further usage. The arm tips placed into frozen embedding matrix were cut into 
12 µm thick serial sections by using Leica CM3050 S cryomicrotome. The sections 
were placed on poly-L-lysine coated slides (Polysine®; VWR) and stored at -20 oC until 
used for mRNA in situ hybridization. 
2.2.6.4 Probe hybridization and immunodetection 
To increase adherence of sections, slides with paraffin wax embedded sections 
were placed in the oven at 65 oC for 45 min followed by 15 min at room temperature to 
cool down. Slides were then incubated in xylene (3 x 7 min) (VWR Chemicals) to 
remove the wax and rehydrated through a descending ethanol series (2 x 7 min 100%, 1 
x 7 min 90%, 1 x 7 min 70%, 1 x 7 min 50%, 1x 7 min 30%). The slides were then 
washed in PBS (2 x 7 min) and post-fixed in 4% PFA/PBS for 20 min at room 
temperature. Following washes in PBS/0.1% Tween-20 (National Diagnostics) (3 x 5 
min), sections were incubated at 37 oC for 12 min in Proteinase K (QIAGEN) solution 
at a concentration of 10 µg/ml in a buffer containing 50 mM Tris-HCl (pH 7.5) and 6.25 
mM EDTA. Sections were post-fixed in 4% PFA/PBS for 5 min at room temperature 
and washed in PBS/0.1% Tween-20 (National Diagnostics) (3 x 5 min). Sections were 
then acetylated for 10 min in 1.325% triethanolamine (pH 7-8) (VWR Chemicals), 0.25% 
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acetic anhydride (VWR Chemicals) and 0.175% acetic acid (VWR Chemicals) made up 
in distilled water, with continuous stirring. After washes in PBS/0.1% Tween-20 (2 x 5 
min) (National Diagnostics) and 5X SSC (5 min) at room temperature, slides were pre-
hybridized in hybridization buffer (50% formamide (Amresco, Inc.); 5X SSC; 500 
µg/ml yeast total RNA (Sigma-Aldrich); 50 µg/ml heparin (Sigma-Aldrich); 0.1% 
Tween-20 (National Diagnostics) in distilled water) in a humid chamber for 2 hours. 
Hybridization was performed overnight in a humid chamber at 65oC by incubation of 
slides in hybridization buffer containing 800 ng/ml of denatured DIG-labeled mRNA 
antisense or sense probes (100 µl per slide) with a coverslip made of Parafilm (Bemis 
Company, Inc.). 
The following day the slides were incubated in 5X SSC with slight shaking until 
the parafilm coverslip had floated off. Then slides were washed in 0.2X SSC (2 x 40 
min at 65oC followed by 10 min at room temperature) followed by buffer B1 (10 mM 
Tris-HCl, pH 7.5; 150 mM NaCl in autoclaved water) for 10 min at room temperature. 
After blocking slides with 5% goat serum (Sigma-Aldrich)/B1 buffer in a humid 
chamber for 2 hours at room temperature, slides were incubated with alkaline 
phosphatase (AP)-conjugated anti-DIG antibody (Roche) at 1:3000 dilution in 2.5% 
goat serum (Sigma-Aldrich)/B1 buffer in a humid chamber overnight at 4oC. 
On the third day, slides were washed in B1 buffer (3 x 5 min at room 
temperature) followed by buffer B3 (100 mM Tris-HCl, pH 9.5; 100 mM NaCl; 50 mM 
MgCl2 in distilled water) for 10 min at room temperature. Alkaline phosphatase 
substrate was prepared in buffer B3 by adding 4.5 µl/ml of nitro-blue tetrazolium 
chloride (NBT) (Amresco, Inc.) stock solution (75 mg/ml) in 70 % dimethylformamide 
(Avantor formerly Mallinkrodt Baker) and 3.5 µl/ml of 5-bromo-4-chloro-3'-
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indolyphosphate p-toluidine (BCIP) (Panreac AppliChem) stock solution (50 mg/ml in 
70% dimethylformamide) and applied to slides (500 µl per slide). Slides were then 
incubated in a humid chamber and checked regularly. Once strong staining was 
observed, the reaction was terminated by washing slides in distilled water (3 x 5 min). 
Slides were then dried on a hotplate and then incubated in 100% ethanol (2 x 10 sec) 
followed by clearing in HistoClear® (National Diagnostics) for 2 x 7 min. Finally, slides 
were mounted with HistoMountTM (National Diagnostics) and cover-slipped. 
The method used for mRNA in situ hybridization on sections of frozen tissue 
was the same as described above but with the following modifications. The initial oven-
drying, dewaxing and hydration steps were not necessary, so these steps were omitted 
and instead slides were dried at room temperature prior to washing in PBS (2 x 7 min). 
Following staining of sections, slides were mounted with an aqueous mounting medium 
(Hydromount; Natural Diagnostics) and cover-slipped. Mounted slides were left at room 
temperature to dry for 1-2 hours and then stored kept at 4 oC. 
2.2.7 Immunohistochemistry using monoclonal antibody 1E11 
To facilitate interpretation of the expression pattern of AruRGP transcripts in 
starfish arm tips revealed using mRNA in situ hybridization methods, adjacent frozen 
sections were processed for immunohistochemical analysis using monoclonal antibody 
1E11, which was generously provided by Dr. Robert D. Burke (University of Victoria, 
Canada; RRID AB_2617214). 1E11 is a neuron-specific antibody to synaptotagmin B 
and is a marker of neural structures in echinoderms, including starfish (Burke et al., 
2006; Saha et al., 2006). Importantly, the specificity of 1E11 for synaptotagmin B has 
been demonstrated by Western blot analysis of radial nerve extracts from the sea urchin 
Strongylocentrotus purpuratus and comparison of immunostaining patterns observed 
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with 1E11 and with antibodies to S. purpuratus synaptotagmin B. Further evidence of 
the specificity of 1E11 has been obtained by comparison of the distribution of 1E11 
immunoreactivity with the distribution of synaptotagmin B mRNA in sea urchin 
revealed using mRNA in situ hybridization methods (Burke et al., 2006). 
For immunohistochemistry with monoclonal antibody 1E11, starfish arm tips 
were lightly fixed (up to 30 minutes in 4% PFA/PBS; pH 7.4) because immunostaining 
with the 1E11 antibody is fixation-sensitive (R.D. Burke, pers. commun.). Frozen 
sections of starfish arm tips mounted on slides were washed in PBS and then incubated 
for 20 minutes in PBS containing 1% hydrogen peroxide to quench endogenous 
peroxidases. Following washing with PBST, slides were blocked with 5% goat 
serum/PBST for 2 hours at room temperature. The slides were then incubated overnight 
at 4oC with the 1E11 antibody, diluted 1:3 with 5% goat serum/PBST. After washing 
with PBST, slides were then incubated for 3 hours at room temperature with goat-
antimouse horseradish peroxidase conjugated secondary antibodies immunoglobulins 
(Jackson ImmunoResearch, West Grove, PA) diluted 1:500 in PBST containing 2% 
goat serum. After washing in PBST, staining buffer (0.05% diaminobenzidine, 0.05% 
nickel chloride, 0.015% hydrogen peroxide in PBS) was applied to each slide until 
staining was observed. Slides were washed sequentially in PBS and autoclaved water 
and then coverslips were mounted using Hydromount (Natural Diagnostics). Detailed 
protocol can be found in appendix 9.6. Photographs of immunostained sections and 
adjacent sections processed for AruRGP mRNA in situ hybridization were obtained as 
described below.  
2.2.8 Documentation and data analysis 
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Photographs of sections were captured with a QIClick™ CCD Camera (01-
QICLICK-R-F-CLR-12; QImaging) linked to a DMRA2 light microscope (Leica), 
using Volocity® v.6.3.1 image analysis software (Perkin-Elmer) running on an iMac 
computer (27-inch with OS X Yosemite, version 10.10). Images were compiled into 
montages and labeled using Photoshop CC (2015.0.0; Adobe Systems, San Jose, CA), 
including use of cropping and contrast adjustment tools, running on a MacBook Pro 




2.3.1 Cloning and sequencing of two A. rubens relaxin-type neuropeptide 
precursors 
Two A. rubens relaxin-type neuropeptide precursors have been cloned and 
sequenced, one of which is named as A. rubens relaxin-like gonad-stimulating peptide 
precursor (AruRGPP, Figure 2.2A), a 560 base cDNA encoding a 109 amino acid 
protein including a 26 amino acid signal peptide followed by the B (20 amino acids), C 
(38 amino acids) and A chain (25 amino acids). Two putative dibasic proteolytic sites 
(KR) are located at either end of the C chain, and one more is contained inside the C 
chain. The other one is called relaxin-like peptide precursor 2 (AruRLPP2, Figure 2.2B), 
a 360 base cDNA encoding a 119 amino acid neuropeptide precursor with a 30-residue 
N-terminal signal peptide. AruRLPP2 has a similar structure to AruRGPP, with a B-
chain (26 amino acids) following the signal peptide, A chain (26 amino acids) located at 
the C-terminal and C chain (35 amino acids) sandwiched between the B and A-chains. 
Two cleavage sites (KR) are predicted between the A/B chains and C chain. Alignment 
of the AruRGPP, AruRLPP2 with RGP precursors from A. amurensis (AamRGPP, 
GenBank accession number LC040882), A. japonica (AjaRGPP, GenBank accession 
number LC104980), and P. pectinifera (PpeRGPP, GenBank accession number 
AB496611) shows that amino acid sequence identity is mainly conserved in the A and 
B chains (Figure 2.2C). More specifically, more amino acid residues are shared by these 
five precursors in the A chain (10) than in B chain (5), with sequence identity of 40% 
and 25%, respectively. 
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Figure 2.2 A. rubens relaxin-like gonad-stimulating peptide precursor (AruRGPP), 
relaxin-like peptide precursor 2 (AruRLPP2) and comparison with RGP precursors from 
other starfish species.  
A: The AruRGPP cDNA sequence (lowercase, 560 bases) encoding the AruRGP 
precursor protein (uppercase, 109 amino acid residues) is shown. AruRGP (with 
cysteine [C] residues underlined) are shown in red, with the A and B chains highlighted 
in green and blue, respectively. B: The AruRLPP2 cDNA sequence (lowercase, 360 
bases) encoding the AruRLP2 precursor protein (uppercase, 119 amino acid residues) is 
shown. AruRLP2 (with cysteine [C] residues underlined) are shown in red, with the A 
and B chains highlighted in green and blue, respectively. The predicted signal peptide is 
shown in blue and predicted dibasic cleavage sites are shown in green. Nucleotide 
sequences that were used as primers for cDNA cloning are shown in red within red 
boxes and the asterisk shows the position of the stop codon. Nucleotides and amino 
acids that differ from the previously reported AruRGPP cDNA and protein sequence 
that was assembled from transcriptome sequence data (GenBank accession number 
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KT601728; Semmens et al., 2016) are highlighted in gray. C: Alignment of the 
AruRGPP, AruRLPP2 with RGP precursors from A. amurensis (AamRGPP, GenBank 
accession number LC040882), A. japonica (AjaRGPP, GenBank accession number 
LC104980), and P. pectinifera (PpeRGPP, GenBank accession number AB496611) 
using T-Coffee. Regions of the precursors corresponding to the A and B chains are 
labeled green and blue, respectively. The B chain amino acid residues of AruRLPP2 are 
underlined. Amino acid residues that are identical in all five precursors are highlighted 
in yellow. 
Alignment the A and B chains of AruRLP2 and RGP from A. rubens, A. 
amurensis, A. japonica and P. pectinifera was performed (Figure 2.3). It was found that 
the mature RGPs sequences comprising the A and B chains in A. rubens and A. 
amurensis (AamRGP) (Mita et al., 2015) are exactly the same (100% identity). AruRGP 
shares less similarity with A. japonica relaxin-like gonad-stimulating peptide (AjaRGP) 
(Mita and Katayama, 2016) and P. pectinifera relaxin-like gonad-stimulating peptide 
(PpeRGP) (Mita et al., 2009b), 84% and 90% identity for A and B chain of AjaRGP and 
58% and 73% identity for A and B chains of PpeRGP. The similarity between AruRGP 
and AruRLP2 is even lower than that among the RGPs, 50% and 27% for A and B 
chains, respectively. Compared with AruRGP, the evolutionary relationship between 
AruRLP2 and other RGPs is more distant. Because the identity between AruRGP and 
AamRGP is 100%, AruRLP2 shares 50% and 27% identity for A and B chains of 
AamRGP. But AruRLP2 is more similar to AjaRGP and PpeRGP, 52% and 35% 




Figure 2.3 Alignment the A and B chains of AruRLP2 and RGP from A. rubens, A. 
amurensis, A. japonica and P. pectinifera.  
A: Alignment the A chains of AruRLP2 and RGP from A. rubens, A. amurensis, A. 
japonica and P. pectinifera. Ten amino acide residues 
(YxGxxxYCCxxGCTxxxLxxxxxC) are conserved among these five sequences, 
including the CCxxxCxxxxxxxxxxC motif. B: Alignment the B chains of AruRLP2 and 
RGP from A. rubens, A. amurensis, A. japonica and P. pectinifera. Amino acid residues 
that are identical in all five chains are highlighted in yellow. Five amino acide residues 
(CxxxFxxAVxxxC) are conserved among these five sequences, including the 
CxxxxxxxxxxxC motif.  
2.3.2 Phylogenetic and gene structural analysis indicate that AruRGP and 
AruRLP2 are both relaxin-type neuropeptides 
Phylogenetic analysis of the relaxin-type neuropeptide precursors has been 
performed including several insulins, IGFs, and protostome insulin-like peptide 
precursors (Figure 2.4). As expected, the phylogenetic tree is divided into two clusters, 
one containing the relaxin-type neuropeptide precursors and the rest forming another 
branch. According to the evolutionary tree including AruRLPP2, the RGPPs and 
RLPP2s from different starfish species and other members of relaxin/insulin/IGF 
neuropeptide family, AruRLPP2 and the starfish RGPs RLP2s are closer to the relaxin-
type neuropeptide precursors. Although RLPP2s belong to same clade as the RGPs, the 
RGPs are more closely related to each other. AruRLPP2 is located in the same branch 
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as PmiRLPP2 and AplRLPP2, which is clearly different from the branch made up of the 
starfish RGPPs. Moreover, within these two branches, the evolutionary relationship of 
the starfish RGPPs and RLPP2s is consistent with the different orders/families they 
belong to, A. rubens belonging to Order Forcipulatida while P. miniata (Family: 
Asterinidae) and A. planci (Family: Acanthasteridae) belonging to the same Order 
Valvatida but different families. 
 
Figure 2.4 Neighbour joining tree showing the relationships of starfish relaxin-type 
peptide precursors with precursors of other members of the relaxin/insulin/insulin-like 
growth factor (IGF) peptide family. 
The A. rubens RGP (AruRGP) precursor (blue arrow) and other starfish RGP precursors 
form a distinct clade within the relaxin/insulin-like precursor family, which is 
highlighted in pink to distinguish it from the insulin/IGF precursor family that is 
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highlighted in purple. A second A. rubens relaxin-type precursor (AruRLP2; green 
arrow) is a paralog of the AruRGP precursor that is also positioned within the 
relaxin/insulin-like clade of precursors. The starfish RGPs and RLPs form different 
branches. The full names and accession numbers of the 45 protein sequences included 
in the tree are as follows: AruRGP, relaxin-like gonad-stimulating peptide (ALJ99970.1, 
Asterias rubens); AruRLP2, relaxin-like peptide precursor 2 (ALJ99971.1, Asterias 
rubens); AamRGP, relaxin-like gonad-stimulating peptide precursor (BAR40315.1, 
Asterias amurensis); AjaRGP, relaxin-like gonad-stimulating peptide precursor 
(BAU20369.1, Aphelasterias japonica); PpeRGP, relaxin-like gonad-stimulating 
peptide precursor (BAI44654.1, Patiria pectinifera); AplRGP, relaxin-like gonad-
stimulating peptide precursor (gbr_scaffold8, Acanthaster planci); AplRLP2, relaxin-
like peptide precursor 2 (gbr_scaffold3, Acanthaster planci); PmiRGP, relaxin-like 
gonad-stimulating peptide precursor (LC057656.1, Patiria miniata); PmiRLP2, relaxin-
like peptide precursor 2 (this study, Patiria miniata); RLN1 Human, relaxin 1 precursor 
(NP_008842.1, Homo sapiens); RLN2 Human, relaxin 2 precursor (NP_604390.1, 
Homo sapiens); RLN3 Human, relaxin 3 precursor (NP_543140.1, Homo sapiens); 
RLN1 Mouse, relaxin 1 precursor (NP_035402.2, Mus musculus); RLN3 Mouse, 
relaxin 3 precursor (NP_775276.1, Mus musculus); RLN3 Alligator, relaxin 3 precursor 
(XP_006023546.1, Alligator sinensis); INSL3 Alligator, insulin-like 3 
(XP_006017481.1, Alligator sinensis); RLN3a Zebrafish, relaxin 3a precursor 
(NP_001032892.1, Danio rerio); RLN3b Zebrafish, relaxin 3b precursor 
(NP_001108535.1, Danio rerio); RLN3c Zebrafish, relaxin 3c precursor 
(NP_001108525.2, Danio rerio); INS Human, insulin precursor (NP_000198.1, Homo 
sapiens); INSL3 Human, insulin-like peptide 3 precursor, (NP_005534.2, Homo 
sapiens); INSL4 Human, insulin-like peptide 4 precursor (NP_002186.1, Homo 
sapiens); INSL5 Human, insulin-like peptide 5 precursor (NP_005469.2, Homo 
sapiens); INSL6 Human, insulin-like peptide 6 precursor (NP_009110.2, Homo 
sapiens); INSL3 Mouse, insulin-like 3 precursor (NP_038592.3, Mus musculus); INSL5 
Mouse, insulin-like peptide precursor (NP_035961.1, Mus musculus); INSL6 Mouse, 
insulin-like peptide precursor (NP_038782.1, Mus musculus); INSL5 Zebrafish, insulin-
like 5 precursor (NP_001122028.1, Danio rerio); INSL3 Deer, relaxin-like peptide 
(AAR25542.1, Capreolus capreolus); IGF1a Human, insulin-like growth factor 1 
precursor (NP_000609.1, Homo sapiens); IGF2 Human, insulin-like growth factor 2 
precursor (NP_000603.1, Homo sapiens); IGF1 Mouse, insulin-like growth factor 1 
precursor (NP_001104745.1, Mus musculus); IGF2 Mouse, insulin-like growth factor 2 
precursor (NP_034644.2, Mus musculus); INS1 Mouse, insulin-1 precursor 
(NP_032412.3, Mus musculus); RLNL BRAFL, relaxin-like peptide (EEA41967.1, 
Branchiostoma floridae); ILPl BRAFL, insulin-like peptide 1 precursor ((Mita et al., 
2009b), Branchiostoma floridae); ILP2 BRAFL, insulin-like peptide 2 precursor ((Mita 
et al., 2009b), Branchiostoma floridae); DmeIlp1, insulin-like peptide 1 precursor 
(NM_140102.2, Drosophila melanogaster); DmeIlp2, insulin-like peptide 2 precursor 
(NM_079288.3, Drosophila melanogaster); DmeIlp3, insulin-like peptide 3 precursor 
(NM_140103.3, Drosophila melanogaster); DmeIlp4, insulin-like peptide 4 precursor 
(NM_140104.3, Drosophila melanogaster); DmeIlp5, insulin-like peptide 5 precursor 
(NM_206315.2, Drosophila melanogaster); DmeIlp6, insulin-like peptide 6 precursor 
(NM_001201609.1, Drosophila melanogaster); DmeIlp7, insulin-like peptide 2 
precursor (NM_130714.2, Drosophila melanogaster); CelILP1, insulin-like peptide 1 
precursor (AF070472.1, Caenorhabditis elegans). Bootstrap values for selected nodes 
are shown. 
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Homologues of AruRGPP and AruRLPP2, named PmiRGPP (AKZP01031377.1) 
(Supplementary figure 2.1A), AplRGPP (gbr_scaffold8) (Supplementary figure 2.1B) 
and PmiRLPP2 (AKZP01053386.1) (Supplementary figure 2.1C), AplRLPP2 
(gbr_scaffold3) (Supplementary figure 2.1D), have been identified by analysis of the 
Patiria miniata and Acanthaster planci genome sequences, respectively. As shown in 
Figure 2.5, the relaxin/insulin-like neuropeptide precursors including PmiRGPP, 
PmiRLPP2, AplRGPP and AplRLPP2 are encoded by two exons, one for the signal 
peptide, B chain and part of C chain and the other for the rest of the C chain and A 
chain, while the insulin-like growth factor precursors comprise four exons. The IGF 
first exon is mainly responsible for the signal peptide. The B chain is encoded by both 
the second and the third exons and the third exon also includes the A chain region. 
There are also differences in the relaxin/insulin-like neuropeptide precursors. Human 
RLN1 and RLN2 have the longest C chains in the precursors selected, and the human 
INSL5 and RLN3 have the medium sized C chains. These four precursors form two 
groups, which is consistent with phylogenetic analysis (Figure 2.4). 
 
Figure 2.5 A simplified phylogenetic tree of the relaxin/insulin/insulin-like growth 
factor (IGF) peptide family showing the gene structure of starfish relaxin-like gonad-
stimulating peptide precursors and relaxin-like peptide precursor 2 with precursors of 
other members of this peptide family.  
 80 
The exons are shown as rectangles with the region encoding the signal peptide in gray, 
B chain in blue, C chain in black and A chain in green. The introns are shown by 
uncontinuous black lines. The full names and accession numbers of these 10 protein 
sequences included in the tree are as follows: PmiRGPP, relaxin-like gonad-stimulating 
peptide precursor (AKZP01031377.1, Patiria miniata); PmiRLPP2, relaxin-like peptide 
precursor 2 (AKZP01053386.1, Patiria miniata); AplRGPP, relaxin-like gonad-
stimulating peptide precursor (gbr_scaffold8, Acanthaster planci); AplRLPP2, relaxin-
like peptide precursor 2 (gbr_scaffold3, Acanthaster planci); RLN1 Human, relaxin 1 
precursor (NP_008842.1, Homo sapiens); RLN2 Human, relaxin 2 precursor 
(NP_604390.1, Homo sapiens); RLN3 Human, relaxin 3 precursor (NP_543140.1, 
Homo sapiens); INSL5 Human, insulin-like peptide 5 precursor (NP_005469.2, Homo 
sapiens); IGF1a Human, insulin-like growth factor 1 precursor (NP_000609.1, Homo 
sapiens); IGF1 Mouse, insulin-like growth factor 1 precursor (NP_001104745.1, Mus 
musculus). 
2.3.3 Mass spectrometric detection of AruRGP and AruRLP2 in A. rubens radial 
nerve extracts 
To determine if the AruRGP and AruRLP2 precursors (Figure 2.2) are processed 
to form mature peptides in a manner consistent with other relaxin-type peptides (Figure 
2.1B) (Schwabe and McDonald, 1977b; Sherwood, 2004), A. rubens radial nerve 
extracts with and without reduction/alkylation and with and without trypsin digestion 
were analyzed. The AruRLP2 A and B chains were not detected by mass spectrometry 
in the radial nerve cord extract sample, which may reflect the expression pattern of 
AruRLPP2 (2.3.6). Mass spectrometric data were, however, obtained for AruRGP. 
In samples subjected to reduction and alkylation, the A chain and B chain of 
AruRGP were identified by LC-MS/MS, while in the absence of reduction these 
peptides were not detected, indicating that the A and B chains are linked by disulfide 
bridges. The A chain (PETYVGMGSYCCLVGCTRDQLSQVC) was observed as 3+ 
ions (980.75 m/z; Figure 2.6B) and the B chain (AEKYCDEDFHMAVYRTCTEH) was 
observed as 3+ ions (860.02 m/z; Figure 2.6C) and 4+ ions, with and without oxidized 
methionine. Although these long and highly charged peptides had significant Mascot 
scores (Figure 2.6B, C), they fragmented poorly. Therefore, to obtain further 
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confirmation of the sequences of A chain and B chain peptides, radial nerve extract 
samples incubated with trypsin were analyzed, which cleaves after lysine and arginine 
residues to yield peptides that could be completely sequenced using MS/MS. Trypsin 
was used with or without prior reduction of the peptides and therefore in principle 
masses and spectra for both disulfide bridge crosslinked and unlinked peptides could be 
detected under the relevant conditions. In samples subjected to reduction followed by 
trypsin treatment, the expected fragments of the A chain (PETYVGMG- 
SYCCLVGCTR [2+ 1055.44; Figure 2.6D]) and B chain (YCDEDFHMAVYR [2+ 
541.22; Figure 2.6E]) were detected and sequenced, respectively.  
Treatment of non-reduced samples of radial nerve extracts with trypsin would be 
expected, based on the predicted structure of AruRGP (Figure 2.6A), to produce two 
dimeric peptides linked by single disulfide bridges. The larger of these predicted 
peptides comprising the N-terminal region of the A chain 
(PETYVGMGSYCCLVGCTR) linked to the central region of the B chain 
(YCDEDFHMAVYR) were unable to be detected. However, the smaller dimeric 
peptide comprising the C-terminal regions of the A chain (DQLSQVC) and B chain 




Figure 2.6 Mass spectrometric identification of AruRGP A chain and B chain in 
extracts of A. rubens radial nerve cords.  
A: Predicted dimeric structure of AruRGP, showing the sequences of the A chain and B 
chain. The positions of disulfide bridges are shown with red lines and tryptic cleavage 
sites are marked with arrowheads. B, C: MS/MS data for the A chain and B chain, 
respectively, from reduced and alkylated samples of radial nerve extract without tryptic 
digestion. The b series of peptide fragment ions are shown in red, the y series in blue 
and additional identified peptide fragment ions in green. The amino acid sequence 
identified in the mass spectrum is highlighted at the top of the figures. C+57 represents 
cysteine modified by carbamidomethylation and M+16 represents oxidized methionine. 
The observed m/z of the precursor ion for the A chain 
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(PETYVGMGSYCCLVGCTRDQLSQVC; B) is 980.75 with a charge state 3+ and an 
error of 0.41 ppm between the experimentally determined and predicted values (Mascot 
score = 57). The observed m/z of the precursor ion for the B chain 
(AEKYCDEDFHMAVYRTCTEH; C) is 860.02 with a charge state of 3+ and an error 
of 0.65 ppm between the experimentally determined and predicted values (Mascot score 
= 31). D, E: MS/MS data for the complete sequences of fragments of the A chain and B 
chain, respectively, derived from reduced and alkylated samples of radial nerve extract 
subjected to tryptic digestion, with annotations in the same format as in B and C. The 
observed m/z of the precursor ion for the A chain fragment 
(PETYVGMGSYCCLVGCTR; D) is 1055.44 with a charge state of 2+ and an error of -
4.7 ppm between the experimentally determined and predicted values (Mascot score = 
98). The observed m/z of the precursor ion for the B chain fragment 
(YCDEDFHMAVYR; E) is 541.22 with a charge state of 3+ and an error of -0.83 ppm 
between the experimentally determined value and predicted value (Mascot score = 45). 
 
Figure 2.7 Mass spectrometric identification of a dimeric fragment of AruRGP in an 
extract of A. rubens radial nerve cords.  
The mass spectrum of a disulfide bridge linked dimeric peptide comprising DQLSQVC 
from the AruRGP A chain and TCTEH from the AruRGP B chain is shown. This 
dimeric peptide was detected in samples of radial nerve extract that were subjected to 
tryptic digestion without reduction. Peptide fragments from the A chain are shown in 
green and peptide fragments from the B chain are shown in blue. The observed m/z of 
the precursor ion is 690.28 with a charge state 2+ and an error of -0.73 ppm between the 
experimentally determined value and predicted value (Stavrox score = 145). 
2.3.4 AruRGP is more potent than PpeRGP in causing spawning of ovarian 
fragments from A. rubens 
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AruRGP and PpeRGP were synthesized to test their effects on A. rubens ovarian 
fragments (Figure 2.8A). AruRGP induced oocyte maturation and ovulation in ovarian 
fragments from A. rubens within 30 minutes (Figure 2.8B), which is consistent with 
effects of RGPs in other starfish species. PpeRGP cause dose-dependent induction of A. 
rubens ovarian fragment spawning (Figure 2.8C), but the concentration required was 
much higher than AruRGP. The median effective concentration (EC50) to induce 
spawning for AruRGP was 1.33 ± 0.09 nM, while it was 14 ± 1 nM for PpeRGP, over 




Figure 2.8 Comparison of the in vitro bioactivity of AruRGP and PpeRGP as inducers 
of spawning in A. rubens.  
A: Isolated ovary from A. rubens. B: AruRGP-induced spawning of an ovary fragment 
from A. rubens. C: Graph showing the dose-dependent effects of AruRGP (●) and 
PpeRGP (▲) in causing spawning of ovarian fragments. +++ denotes spawning 
occurred and most of oocytes were matured, ++ denotes about 50% oocytes were 
matured, + denotes a few oocytes were matured, and - denotes no spawning occurred. 
Means ± SEM for five separate assays using ovarian tissue from different animals are 
shown. The median effective concentration (EC50) of AruRGP required to induce 
spawning (1.33±0.09nM) is approximately 10-fold lower than for PpeRGP (14 ± 1nM). 
2.3.5 AruRGPP is expressed by cells in the radial nerve cords, circumoral nerve 
ring and tube feet in A. rubens 
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According to the in situ hybridisation results, limited expression of AruRGP 
precursor mRNA was detected in the radial nerve cord (Figure 2.9A-D), circumoral 
nerve ring (Figure 2.9E, F) and tube feet (Figure 2.10). Sense probes were used for 
control experiments to confirm the specificity of the staining with anti-sense probes 
(Figure 2.9A inset). Longitudinal and transverse sections were analysed to detect the 
expression of AruRGP precursor mRNA in the radial nerve cord (Figure 2.9A-D). The 
transverse sections show two or three stained cells are present on both sides of the “V” 
shaped radial nerve in the ectoneural region (Figure 2.9A, B). When it comes to the 
longitudinal sections, dispersed stained cells are mainly present in the epithelium of the 
ectoneural region along the length of the radial nerve cord, separated by gaps of 20 - 80 
µm (Figure 2.9C, D). No staining was detected in the hyponeural region in the 
transverse or longitudinal sections (Figure 2.9A-D). AruRGPP was also expressed in 
the circumoral nerve ring (Figure 2.9E, F). Stained cells were only detected in the 
ectoneural layer of the circumoral nerve ring (Figure 2.9E, F), which is similar to the 
result in radial nerve cord (Figure 2.9A-D). Stained cells were also observed in the 
lateral region of the tube feet (Figure 2.10C) proximal to radial nerve cord and 
circumoral nerve ring and in the subepithelial plexus along the shaft of the tube feet 
(Figure 2.10A, B) and near the tube foot sucker (Figure 2.10D, E). 
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Figure 2.9 Localization of AruRGP precursor mRNA in the radial nerve cord and 
circumoral nerve ring of A. rubens using in situ hybridization. 
A, B: Transverse sections of radial nerve cord incubated with antisense probes (main 
panels of A and B) showing a bilaterally symmetrical group of 2-3 stained cells 
(arrowheads) in the epithelium of the ectoneural region of the nerve cord. Panel B 
shows a high-magnification view of the rectangular region highlighted in panel A. The 
inset of panel A shows the absence of staining in a transverse section of radial nerve 
cord incubated with sense probes, demonstrating the specificity of staining observed 
with antisense probes. C, D: Longitudinal parasagittal sections of the radial nerve cords 
incubated with antisense probes showing groups of cells interspersed along the length of 
the nerve cord in the ectoneural epithelium. Panel D shows a high-magnification view 
of the rectangular region highlighted in panel C. E, F: Transverse section of the disk 
region in A. rubens incubated with antisense probes, showing the circumoral nerve ring 
and tube feet. Stained cells can be seen in the ectoneural epithelium of the nerve cord, 
highlighted by the rectangle in E and shown at higher magnification in F. CONR, 
circumoral nerve ring; Ec, ectoneural region of radial nerve cord; Hy, hyponeural region 
of radial nerve cord; TF, tube foot. Scale bars: 50 µm in A and A inset; 10 µm in B, D; 
25 µm in C; 200 µm in E; 20 µm in F. Refer to Figure 1.7 (page 38) and 1.8 (page 39) 
for details of starfish anatomy. 
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Figure 2.10 Localization of AruRGP precursor mRNA in tube feet of A. rubens using 
in situ hybridization.  
A: Longitudinal section of a tube foot showing three stained cells (arrowheads and 
rectangle) in the subepithelial layer of the stem. B: The region highlighted with a 
rectangle in A is shown here at higher magnification, with a stained cell located 
between the external epithelium and collagenous tissue layer. C: Stained cells 
(arrowheads) located in the subepithelial layer near to the base of adjacent tube feet. D: 
A group of stained cells (see rectangle) in the tube foot subepithelial layer just above the 
sucker. E: The region highlighted with a rectangle in D is shown here at higher 
magnification. CT, collagenous tissue layer; Ep, epithelium; ML, muscle layer; Su, 
sucker TF: tube foot. Scale bars: 100 µm in A; 10 µm in B; 25 µm in C; 50 µm in D; 10 
µm in E. Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
2.3.6 Both AruRGPP and AruRLPP2 transcripts are expressed by cells in the 
arm tip epithelium in A. rubens 
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AruRGPP and AruRLPP2 transcripts share a similar expression pattern in the 
arm tips of A. rubens. These two genes are both highly expressed by neuron-like cells in 
the starfish arm tips epithelium that surround the terminal tentacle and optic cushion 
(Figure 2.11-14). 
2.3.6.1 The AruRGPP transcript is highly expressed by neurons in the arm tip 
epithelium of A. rubens 
The most striking expression of AruRGP transcripts was revealed in the tip 
regions of the arms (Figure 2.11). To facilitate interpretation of the staining shown in 
Figure 2.11, a labeled photograph of the arm tip region of a live specimen of A. rubens 
is shown in Figure 2.11A. The most prominent feature of the arm tip is the pigmented 
optic cushion, which is located at the base of a tube foot-like organ specialized for 
sensory functions that is known as the terminal tentacle (Figure 2.11A, B). Consistent 
with expression of AruRGP in tube feet (Figure 2.10), cells expressing AruRGP 
transcripts were also revealed in the terminal tentacle (Figure 2.11C, D). However, 
more exten- sive expression of AruRGP is present in the body wall epithelium that lines 
the cavity containing the terminal tentacle and optic cushion. Here AruRGP-expressing 
cells are located in the epithelium forming the “ceiling” (Figure 2.11B) and “walls” 
(Figure 2.11C) of the cavity, extending right up to distal tip of the arm (Figure 2.11E). 
The staining observed in these cells is not observed in sections of arm tips incubated 
with sense probes, demonstrating the specificity of the labeling (Figure 2.11E, inset). 
Observation of clusters of AruRGP-expressing cells in the arm tip body wall epithelium 
at high magnification revealed a meshwork of stained processes, suggesting that these 
cells are neurons (Figure 2.11F). 
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Figure 2.11 Localization of AruRGP precursor mRNA in the arm tips of A. rubens 
using in situ hybridization. 
A: Photograph of a living specimen of A. rubens showing the arm tip region viewed 
from the underside (oral) of the animal, taken using a Leica DFC420 C camera linked to 
a Leica S8 APO microscope. The most prominent feature is the pigmented optic 
cushion, which is located at the base of the terminal tentacle. The terminal tentacle and 
optic cushion are bounded on each side by spines and rows of tube feet can be seen 
adjacent to the optic cushion. B: Section of the arm tip showing the pigmented optic 
cushion and terminal tentacle. Stained cells expressing AruRGP precursor transcripts 
(arrowheads) can be seen in the body wall epithelium lining a cavity that surrounds the 
terminal tentacle and optic cushion. C: Section of an arm tip showing the terminal 
tentacle cut obliquely. Stained cells can be seen in the terminal tentacle (rectangle and 
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arrowheads) and in the body wall epithelium at the base of the spines that surround the 
terminal tentacle (arrowheads). D: Detail of the region highlighted with a rectangle in 
panel C, showing stained cells (arrowhead) in the subepithelial layer of the terminal 
tentacle. E: Section through the distal region of the arm tip beyond the terminal tentacle, 
showing stained cells (arrowheads and rectangle) in the body wall epithelium at the base 
of two adjacent spines; the region highlighted with a rectangle is shown in panel F. The 
inset shows absence of staining (arrowhead) in a section of the arm tip adjacent to the 
section shown in the main panel and which was incubated with sense probes instead of 
the antisense probes used in the main panel E. F: Detail of the region highlighted with a 
rectangle in panel E, showing stained cells with processes (arrowheads) at high 
magnification. CT, collagenous tissue layer of terminal tentacle; Ep, epithelium of body 
wall; ML, muscle layer of terminal tentacle; OC, optic cushion; Sp, spine; TF, tube foot; 
TT, terminal tentacle. Scale bars: 400 µm in A; 100 µm in B, E inset; 50 µm in C, E; 10 
µm in D, F. Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
To more specifically investigate if the AruRGP-expressing cells in the arm tip 
body wall epithelium are neurons, both transverse and longitudinal sections of arm tips 
were analyzed at high magnification. This revealed example of solitary cells or pairs of 
cells that clearly have stained processes emanating basally from an intraepithelial cell 
body (Fig. 2.12A, B). Furthermore, double-labeling experiments using the neural-
specific antibody 1E11 revealed a layer of immunostained neural processes immediately 
beneath the layer of AruRGP-expressing cell bodies in arm tip epithelium (Figure 
2.12C-F). Therefore, collectively these observations indicate that AruRGP-expressing 
cells in the arm tip epithelium are neurons. 
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Figure 2.12 Neuron-like characteristics of cells expressing AruRGP in the arm tips of A. 
rubens.  
A: Transverse section of A. rubens arm tip showing two cells in the body wall 
epithelium that express the AruRGP precursor, as revealed by mRNA in situ 
hybridization, and that have stained axon-like processes (arrowheads). B: Longitudinal 
section of A. rubens arm tip showing a cell in the body wall epithelium that expresses 
the AruRGP precursor, as revealed by mRNA in situ hybridization, and that has a 
stained axon-like process (arrowhead). C, D: Transverse sections of A. rubens arm tip 
showing cells expressing AruRGP precursor transcripts, as revealed by mRNA in situ 
hybridization, in the body wall epithelium lining the cavity that contains the terminal 
tentacle (TT). E, F: Transverse sections of A. rubens arm tip adjacent to the sections 
shown in panels C and D, respectively, showing that the unstained region in panels C 
and D underlying the AruRGP expressing cells (see asterisks in panels C and D) is 
immunoreactive with monoclonal antibodies (1E11) to the axonal protein 
synaptotagmin B. This provides supporting evidence that the AruRGP expressing cells 
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in the arm tip epithelium are neurons. Scale bars: 5 µm in A, B; 20 µm in C, E; 10 µm in 
D, F. Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
2.3.6.2 AruRLPP2 transcript is only detected in the arm tips of A. rubens 
In situ hybridization was also used to investigate the expression of AruRLPP2 
transcripts in A. rubens. Although the cDNA of AruRLPP2 was cloned from the radial 
nerve cord, no signal was detected in the radial nerve cord and circumoral nerve ring. 
Expression of this precursor was only detected in the arm tips of A. rubens (Figure 2.13, 
14). AruRLPP2 transcript is expressed not only by the epithelial cells (Figure 2.13, 
2.14A, B, D, E) surrounding the terminal tentacle and optic cushion but also by cells in 
the terminal tentacle (Figure 2.14A, C). Because the neural processes of the epithelial 
and terminal tentacle cells are all stained by the neural-specific antibody 1E11 (Figure 
2.12E, F), the AruRLPP2-expressing cells are likely to be neurons. 
 
Figure 2.13 Localization of AruRLP2 precursor mRNA in the arm tips of A. rubens 
using in situ hybridization with paraffin sections.  
 94 
A: Section of an arm tip showing the terminal tentacle. Stained cells can be seen in the 
body wall epithelium at the base of the spines that surround the terminal tentacle 
(rectangle and arrowhead). The inset shows absence of staining in a section of the arm 
tip adjacent to the section shown in the main panel and which was incubated with sense 
probes instead of the antisense probes used in the main panel A. B: Detail of the region 
highlighted with a rectangle in panel A, showing stained cells in the subepithelial layer 
of the body wall. C: Section through the distal region of the arm tip beyond the terminal 
tentacle, showing stained cells (arrowheads and rectangle) in the body wall epithelium 
at the base of two adjacent spines; the region highlighted with a rectangle is shown in 
panel D. D: Detail of the region highlighted with a rectangle in panel C, showing 
stained cells in the subepithelial layer of the body wall at high magnification. Ep, 
epithelium of body wall; Sp, spine; TF, tube foot; TT, terminal tentacle. Scale bars: 50 
µm in A, A inset and C; 10 µm in B, D. Refer to Figure 1.7 (page 38) and 1.8 (page 39) 
for details of starfish anatomy. 
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Figure 2.14 Localization of AruRLP2 precursor mRNA in the arm tips of A. rubens 
using in situ hybridization with frozen sections.  
A: Section of the arm tip showing the pigmented optic cushion and terminal tentacle. 
Stained cells expressing AruRLP2 precursor transcripts (rectangle and arrowheads) can 
be seen in the terminal tentacle and body wall epithelium lining a cavity that surrounds 
the terminal tentacle and optic cushion. B: Detail of the region highlighted with a 
rectangle in panel A, showing stained cells in the body wall epithelium at high 
magnification. C: Detail of the region highlighted with a rectangle in panel A, showing 
stained cells in the terminal tentacle at high magnification. D: Section of the arm tip 
showing the pigmented optic cushion and terminal tentacle. Stained cells expressing 
AruRLP2 precursor transcripts (rectangle and arrowheads) can be seen in the body wall 
epithelium lining a cavity that surrounds the terminal tentacle and optic cushion. E: 
Detail of the region highlighted with a rectangle in panel D, showing stained cells in the 
body wall epithelium at high magnification. Ep, epithelium of body wall; OC, optic 
cushion; TT, terminal tentacle. Scale bars: 50 µm in A, D; 10 µm in B, C, E. Refer to 
Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
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2.4 Discussion 
The dimeric structure of PpeRGP has been described before by Mita et al in 
2009 (Mita et al., 2009b) via inferring the intrachain and interchain disulfide bridges 
from vertebrate relaxins (Schwabe and McDonald, 1977b; Sherwood, 2004). The fact 
that monomeric PpeRGP A/B chain or a mixture of these two chains lack gonadotropic 
bioactivity but synthetic PpeRGP with the predicted dimeric structure has the same 
effect as RGP purified from radial nerve extract confirmed the correct prediction of the 
disulfide bonds (Mita et al., 2009b). Here mass spectrometry was used to confirm the 
presence and sequences of both the A chain and B chain of AruRGP in A. rubens radial 
nerve extracts (Figure 2.6B-E). Furthermore, the presence of one of the two disulfide 
bridges that link the A chain and B chain was demonstrated (Figure 2.7). 
Informed by these findings and the conserved structure of relaxin-type peptides 
(Schwabe and McDonald, 1977b; Sherwood, 2004), dimeric AruRGP was synthesized 
with the structure shown in Figure 2.6A. The bioactivity of this synthetic AruRGP as a 
potent stimulator of spawning from A. rubens ovarian fragments was demonstrated here. 
Furthermore, as was found in a previous study on A. amurensis (Mita et al., 2015), 
AruRGP is 10-fold more potent than PpeRGP, consistent with the differences in the 
sequences of AruRGP and PpeRGP. Moreover, similar results were found with other 
cross-experiments using ovarian fragments of A. amurensis, A. japonica and P. 
pectinifera to test the specificity of AamRGP, AjaRGP and PpeRGP (Mita et al., 2015; 
Mita and Katayama, 2016). P. pectinifera is a member of the Order Valvatida, while A. 
rubens belongs to the Order Forcipulatida. So starfish RGPs tend to exhibit species 
specificity, which presumably reflects co-evolution of RGPs and their corresponding 
receptors (Mirabeau and Joly, 2013). 
 97 
The AruRLP2 was not detected in radial nerve extracts using mass spectrometry, 
which may be due to the low expression of this neuropeptide in the radial nerve cords. 
As the AruRLPP2 expression was only found in arms tips of A. rubens by in situ 
hybridization, it would be of interest to test arm tip extracts, especially the area 
including the terminal tentacle and optic cushion, to check for the presence and 
sequence of AruRLP2. 
The main novel objective of this study was to comprehensively analyze the 
expression of AruRGP and AruRLPP2 in A. rubens using mRNA in situ hybridization. 
Consistent with the original discovery of GSS/RGP in extracts of radial nerve cords 
(Chaet and McConnaughy, 1959), cells expressing AruRGP transcripts were revealed in 
the epithelium of the ectoneural region of the radial nerve cords. Along the length of the 
V-shaped radial nerve cord, two or three stained cells were found in bilaterally 
symmetrical groups. This is similar to findings in P. pectinifera, where four or five 
bilaterally symmetrical stained cells were observed in the radial nerve cords (Mita et al., 
2009b). However, the exact location of the RGP-expressing cells in the radial nerve 
cord is different in P. pectinifera and A. rubens. The mRNA of PpeRGPP was detected 
in the epithelium of ectoneural region, near the bottom of V-shaped radial nerve cord, 
while AruRGPP expression was observed more laterally on both sides of the radial 
nerve cord (Figure 2.9A, B). It is not clear whether this difference in location RGP-
expressing cells in the radial nerve cord reflect any differences in the functions of RGP 
in the two species. The circumoral nerve ring, connecting the radial nerve cords in the 
central disk region of starfish, shows similar AruRGPP expression pattern as in the 
radial nerve cord. 
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Previous studies have revealed that GSS/RGP expression/activity is also 
detected in the cardiac stomach and tube feet of P. pectinifera, albeit at much lower 
levels than in the radial nerve cords (Mita et al., 2009a). In this study, serial sections 
covering the whole animal were used for mRNA in situ hybridization, but no AruRGPP 
expression was found in the cardiac stomach. This may be because the expression is too 
low to be detected with the methods or there many be interspecies differences in the 
RGPP expression patterns. However, cells expressing AruRGPP were found in the sub-
epithelium plexus at the base of the stems and along the stem until near the tube foot 
sucker. 
The original discovery of GSS/RGP of starfish (Chaet and McConnaughy, 1959; 
Mita et al., 2009b) established a hypothesis that the radial nerve cords is the 
physiological source of GSS/RGP triggerring gamete maturation and release (Chaet, 
1966a; Kanatani, 1979; Mita, 2013). Moreover, GSS was thought to be synthesized by 
supporting cells before the identification of GSS as RGP (Kanatani, 1979). The 
supporting cells are radial glia-like cells located in the nerve cord extoneural epithelial 
layer with processes (fibers) extending across the ectoneural neuropile. There was an 
assumption that GSS are transported along the supporting cell fibers and released as 
hormones from the inner surface of the radial nerve in the form of secretory granules 
(Unger, 1962). But histochemical analysis of the radial nerve cords is inconsistent with 
this hypothesis because supporting cell fibers do not reach as far as the inner surface but 
terminate as the collagenous tissue boundary between the ectoneural and hyponeural 
regions of the radial nerve cords (Mashanov et al., 2016). Furthermore, supporting cells 
are present throughout entire ectoneural region of the radial nerve cords (Mashanov et 
al., 2016), but only limited numbers of cells express RGPP in P. pectinifera (Mita et al., 
2009b) and in A. rubens (this study). Although there is possibility that certain 
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supporting cells express RGP, it is more likely that neurons in the radial nerve cords 
express RGPP. But as with supporting cells, the processes of neuronal cell bodies 
located in the ectoneural epithelium are confined to neuropile of the ectoneural region 
(Moore and Thorndyke, 1993; Mashanov et al., 2016), and therefore it is hard to explain 
how RGP is transported to act as a hormone. The RGPP expression in the tube feet and 
radial nerve cords may be unrelated to reproduction, with roles in regulation of tube foot 
activity seeming more likely. Moreover, the concentration of GSS/RGP in the coelomic 
fluid has a clear annual peak before the spawning (Kanatani and Ohguri, 1966; Kanatani 
and Shirai, 1969) demonstrating that GSS/RGP acts as hormonal regulator of gamete 
maturation and release physiologically, while the expression of GSS/RGP in the radial 
nerve cords remains constant throughout the year (Chaet and Smith, 1962; Chaet, 1966a; 
Mita, 2013). What then is the source of GSS/RGP as a gonadotropic hormone in starfish 
if it is not the radial nerve cords? 
The most interesting discovery of this study is the detection of RGP expression 
in A. rubens arm tips, which contain two important sensory organs. The terminal 
tentacle is structurally similar to the locomotory tube feet but with non-locomotory 
sensory functions (Hennebert et al., 2013). The pigmented optic cushion containing 
photoreceptive cells at the base of the terminal tentacle works as a simple eye enabling 
visual orientation (Penn and Alexander, 1980; Garm and Nilsson, 2014). The AruRGP 
precursor was found highly expressed in the epithelium surrounding the terminal 
tentacle and optic cushion. This discovery makes the arm tips good candidates as the 
physiological source of RGP that triggers spawning in response to environmental cues. 
Furthermore, high magnification images show that RGP expressing cells and processes 
in the arm tips are neuron-like. However, the sites where RGP may be released from 
these cells is unknown and to address this issue antibodies against AruRGP should be 
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produced. An antiserum against PpeRGP has been produced, but it is so specific that 
AamRGP, an identical RGP to AruRGP, cannot be detected (Katayama and Mita, 2016; 
Yamamoto et al., 2016). However, the strategy used to develop antibodies to PpeRGP 
could be applied to AruRGP in the future. 
A variety of environmental factors are thought to be important in triggering 
spawning in starfish (Mercier and Hamel, 2013), including increasing day length 
(Pearse et al., 1986; Byrne et al., 1997), changes in water temperature (Pearse and 
Walker, 1986), and the release of gametes by conspecifics (Hamel and Mercier, 1995). 
The RGP-expressing cells in the arm tips are ideally positioned to detect and integrate 
such environmental cues, located as they are in the arm tip body wall epithelium and in 
close proximity to the sensory terminal tentacle and optic cushion. Identification of 
these cells provides a basis for experimental studies in which their role as putative 
sources of RGP as a gonadotropic hormone in starfish could be investigated. 
In this study, the expression of AruRLPP2 mRNA has also been described 
(Figure 2.13, 14) and it is similar to that of the AruRGP precursor. Nothing is yet 
known about RLP2 function. Here, the identification of RLP2-like neuropeptide 
precursors in P. miniata and A. planci genome provides evidence that RLP2 is a second 
relaxin-type neuropeptide not only in A. rubens but also in other starfish and potentially 
in other echinoderms. The discovery and localization of the expression of AruRLP2 in 
A. rubens provides a basis for investigating the physiological roles of a second relaxin-
like peptide in starfish.  
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3 Identification, localization and functional characterization of 
neuropeptides derived from pedal peptide-like neuropeptide precursor 
1 in the starfish Asterias rubens 
3.1 Introduction 
3.1.1 Discovery of pedal peptides in Aplysia californica and other mollusks 
The isolation and structural identification of neuropeptides was first 
accomplished through use of bioassays to monitor chromatographic purification of 
pharmacologically active components in neural extracts (O'Shea and Schaffer, 1985). 
For example, using this approach the cardioactive neuropeptide FMRFamide was 
discovered in bivalve mollusks (Price and Greenberg, 1977). A different approach to 
neuropeptide discovery was adopted by Lloyd and Connolly (1989) - they sought to 
identify neuropeptides in the mollusk Aplysia californica that are synthesized 
preferentially in particular ganglia. A neuropeptide that is synthesized by cell bodies in 
the pedal ganglia was purified and sequenced (PLDSVYGTHGMSGFA) and then 
appropriately named “pedal peptide” (Lloyd and Connolly, 1989). 
Immunohistochemical localization of pedal peptide in Aplysia revealed that it is 
synthesized by a population of neurons located mostly in the pedal ganglia with 
processes projecting peripherally and predominantly innervating the foot (Pearson and 
Lloyd, 1989; Hall and Lloyd, 1990). Consistent with this pattern of expression, pedal 
peptide causes an increase in the amplitude and relaxation rate of nerve-evoked 
contractions of Aplysia foot muscle (Hall and Lloyd, 1990). Furthermore, pedal peptide-
expressing neurons fire in phase with each pedal wave during locomotor activity and 
stop firing during defensive contractions of the foot (Hall and Lloyd, 1990). Thus, pedal 
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peptide-releasing neurons appear to modulate foot muscle contractility during 
locomotion. However, pedal peptide is not only involved in control of foot activity 
because pedal peptide-expressing neurons also innervate other organs (e.g. the 
hermaphroditic duct) (Hall and Lloyd, 1990). Furthermore, sequencing of the Aplysia 
neural transcriptome revealed that pedal peptide is just one of a large family of related 
neuropeptides in this species, which are derived from four precursor proteins (Moroz et 
al., 2006). 
Multiple pedal peptide-type neuropeptides and precursor proteins have also been 
identified in other mollusks, including the limpet Lottia gigantea (Veenstra, 2010) and 
the nudibranch Tritonia diomedia (Lloyd et al., 1996). Investigation of the 
pharmacological effects of pedal peptides in Tritonia revealed that they cause an 
increase in the ciliary beat frequency of cells in the pedal epithelium, again providing 
evidence of a physiological role in regulation of locomotor activity (Willows et al., 
1997). Furthermore, immunohistochemical analysis of pedal peptide expression in 
Tritonia indicated roles in a variety of other behavioral activities, including orientation, 
swimming and feeding (Gaston, 1998; Beck et al., 2000). Accordingly, a pedal peptide 
was found to cause an increase in the ciliary beat frequency of cells in the salivary duct 
of Tritonia, indicative of a physiological role in regulation of salivary transport 
associated with feeding (Gaston, 1998). 
3.1.2 Discovery of orcokinins in crustaceans and other arthropods  
Molluscan pedal peptide-type neuropeptides belong to a family of related 
neuropeptides that also occur in other phyla, including arthropod orcokinins (Rowe and 
Elphick, 2012; Jekely, 2013). Orcokinin was first identified in the crayfish Orconectes 
limosus as a neuropeptide (NFDEIDRSGFGFN) that is a potent stimulator of the hind-
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gut, enhancing the frequency and amplitude of spontaneous contractions (Stangier et al., 
1992). Molecular characterization of orcokinins in the crayfish Procambarus clarkia 
revealed that orcokinin and other orcokinin-like peptides are derived from two closely 
related precursor proteins - preproorcokinin-A and -B (Yasuda-Kamatani and Yasuda, 
2000). Furthermore, orcokinin-type neuropeptides have also been identified in other 
arthropods, including insects. This has revealed that multiple orcokinin isoforms occur 
in each species (Pascual et al., 2004) and, as in crustaceans, alternatively-spliced 
transcripts encoding preproorcokinin-A and -B have been identified in Drosophila 
melanogaster and other insects (Liu et al., 2006; Sterkel et al., 2012; Veenstra and Ida, 
2014). 
Immunohistochemical investigation of the expression of orcokinins in the 
crayfish Orconectes limosus revealed immunostained cell bodies in the sixth abdominal 
ganglion with axonal processes that innervate hind-gut muscles, consistent with the 
myoexcitatory effects of orcokinins on the hind-gut (Dircksen et al., 2000). Orcokinin-
expressing neurons have also been mapped in the stomatogastric nervous system of 
three crustacean species and accordingly orcokinins alter the rhythmic motor output of 
the stomatogastric nervous system (Li et al., 2002; Skiebe et al., 2002). Thus, 
orcokinins act as neuromodulators in the central nervous system and the peripheral 
neuromuscular system of crustaceans. 
Immunohistochemical localization of orcokinins in insects has revealed 
widespread patterns of expression in the brain (Hofer et al., 2005). More specifically, 
the presence of orcokinin-expressing neurons in a region of the optic lobes known as the 
accessory medulla was noted because this region of the insect brain houses the master 
circadian clock that controls circadian locomotor activity. Accordingly, injection of an 
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orcokinin into the accessory medulla of cockroaches causes a phase-dependent shift in 
circadian locomotor activity (Hofer and Homberg, 2006). More recent studies on 
orcokinin function, employing use of RNA interference-based gene knockdown 
methods, indicate that orcokinins are regulators of “awakening” behavior in the beetle 
Tribolium castaneum (Jiang et al., 2015) and regulators of ecdysis in the kissing bug 
Rhodnius prolixus (Wulff et al., 2017). 
3.1.3 Discovery of PP/OK-type neuropeptides in other phyla, including 
echinoderms 
Genome/transcriptome sequencing has enabled the discovery of pedal 
peptide/orcokinin (PP/OK)-type neuropeptides in other phyla, aside from mollusks and 
arthropods. Thus, two precursors of multiple pedal peptide-like neuropeptides were 
identified in the annelid Capitella teleta (Veenstra, 2011) and a precursor of orcokinin-
like peptides was identified in the tardigrade Milnesium tardigradum (Christie et al., 
2011). Furthermore, discovery of two genes encoding PP/OK-type precursors in an 
echinoderm species, the sea urchin Strongylocentrotus purpuratus, provided new 
insights on the evolution of this neuropeptide family (Rowe and Elphick, 2012). These 
were the first genes encoding PP/OK-type neuropeptides to be discovered in a 
deuterostome, which was an important finding because it revealed that the evolutionary 
history of PP/OK-type neuropeptides can be traced back to the common ancestor of 
protostomes and deuterostomes. Thus far, genes encoding PP/OK-type neuropeptides 
have not been identified in other deuterostomian invertebrates (i.e. hemichordates, 
cephalochordates, urochordates) or vertebrates. Therefore, it is possible that within the 
deuterostomian branch of the animal kingdom PP/OK-type neuropeptides have been 
retained only in the echinoderm lineage. Interestingly, it was the discovery of PP/OK-
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type neuropeptides in S. purpuratus that first enabled recognition that molluscan pedal 
peptides and arthropodan orcokinins are members of the same bilaterian neuropeptide 
family (Rowe and Elphick, 2012). Hitherto, research on pedal peptides in mollusks and 
orcokinins in arthropods had been pursued independently without reported recognition 
that these neuropeptides are related. Furthermore, identification of the PP/OK-type 
neuropeptide precursors in S. purpuratus also facilitated identification of two 
neuropeptide precursors (NLP14 (GI:392926792), NLP15 (GI:7498042)) in the 
nematode Caenorhabditis elegans (C. elegans Sequencing Consortium, 1998) as 
precursors of PP/OK-type neuropeptides. Thus, neuropeptides from lophotrochozoan 
protostomes (mollusks, annelids), ecdysozoan protostomes (arthropods, nematodes) and 
deuterostomes (echinoderms) were unified for the first time as members of a bilaterian 
family of PP/OK-type peptides (Rowe and Elphick, 2012). Subsequently, the 
relationship between pedal peptides and orcokinins was demonstrated independently 
using similarity-based clustering methods (Jekely, 2013). 
The discovery of two PP/OK-type neuropeptide precursors (SpPPLNP1 and 
SpPPLNP2) in an echinoderm, the sea urchin S. purpuratus, has provided a basis for 
investigation of the physiological roles of PP/OK-type neuropeptides in the 
deuterostomian branch of the animal kingdom.  The structures of PP/OK-type 
neuropeptides derived from SpPPLNP1 and SpPPLNP2 have been determined by mass 
spectroscopic analysis of extracts of S. purpuratus (Menschaert et al., 2010; Rowe and 
Elphick, 2012). Furthermore, one of the peptides derived from SpPPLNP1 (SpPPLN1c) 
has been tested for myoactivity on sea urchin tube foot and esophagus preparations, but 
no effects were observed (Rowe and Elphick, 2012). 
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A major advance in our knowledge of PP/OK-type neuropeptide function in 
echinoderms was accomplished recently with the discovery that a myorelaxant purified 
from the starfish species Patiria pectinifera is a member of the PP/OK-type 
neuropeptide family (Kim et al., 2016). Using the apical muscle of P. pectinifera as a 
bioassay for myoactive peptides, a peptide that causes relaxation of the apical muscle 
was purified and sequenced (FGKGGAYDPLSAGFTD) and named starfish 
myorelaxant peptide (SMP). Cloning and sequencing of a cDNA encoding the P. 
pectinifera SMP precursor revealed that it comprises 12 copies of SMP and 3 related 
peptides (7 copies in total). Furthermore, analysis of the sequence of SMP and the SMP 
precursor revealed that SMP is a PP/OK-type neuropeptide (Kim et al., 2016). 
Investigation of the expression of the SMP precursor in P. pectinifera using quantitative 
PCR revealed that it is widely expressed in this starfish species, with the highest levels 
of expression in the radial nerve cords and lower levels of expression in the apical 
muscle, tube feet, coelomic lining, cardiac stomach, pyloric stomach and pyloric caeca 
(Kim et al., 2016). Consistent with this widespread pattern of expression it was found 
that SMP, in addition to causing relaxation of the apical muscle, also causes relaxation 
of cardiac stomach and tube foot preparations from P. pectinifera. Further insights into 
the physiological roles of SMP could be obtained by investigating its anatomical pattern 
of expression in starfish. 
In this chapter, the cloning and sequencing of a cDNA encoding the SMP 
precursor in the common European starfish Asterias rubens is reported. This precursor 
is also referred to as A. rubens pedal peptide-like neuropeptide precursor 1 (or 
ArPPLNP1) because a partial sequence of a second pedal peptide-type precursor has 
also been identified in A. rubens (Semmens et al., 2016). This second precursor was 
originally named ArPPLNP (Semmens et al., 2016) but henceforth it is referred to as 
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ArPPLNP2 to distinguish it from the SMP-type precursor ArPPLNP1. A detailed 
functional characterization of ArPPLNP2 and peptides derived from this precursor is 
reported in the following chapter (chapter 4). 
3.1.4 Aims and objectives 
The main aim of the experimental work reported in this chapter was to use 
mRNA in situ hybridization and immunohistochemistry (employing use of novel 
antibodies) to investigate the expression patterns of ArPPLNP1 and neuropeptides 
derived from this precursor in A. rubens. This is the first study to examine the 
expression of PP/OK-type neuropeptides at the cellular level in a deuterostome. 
Informed by the anatomical data obtained, the in vitro pharmacological actions of one 
of the neuropeptides derived from ArPPLNP1 (ArSMP or ArPPLN1b) were also 
examined. Collectively, the findings reported in this chapter provide new insights into 
the physiological roles of PP/OK-type neuropeptides in starfish.  
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3.2 Methods  
3.2.1 Animals 
Starfish (A. rubens) with a diameter > 4 cm were collected at low tide from the 
Thanet coast (Kent, UK) or were obtained from a fisherman based at Whitstable (Kent, 
UK). These animals were maintained in a circulating seawater aquarium at ~12 oC in 
the School of Biological and Chemical Sciences at Queen Mary University of London 
and were fed on mussels (Mytilus edulis). Smaller juvenile specimens of A. rubens 
(diameter 0.5 - 1.5 cm) were collected at the University of Gothenberg Sven Lovén 
Centre for Marine Infrastructure (Kristineberg, Sweden) and were fixed in Bouin’s 
solution. 
3.2.2 cDNA cloning and sequence analysis 
To enable cloning and sequencing of a cDNA encoding an A. rubens 
SMP/PPLNP1-type precursor, A. rubens radial nerve cord transcriptome data (Semmens 
et al., 2016) was analysed using BLAST, with the P. pectinifera SMP precursor as a 
query sequence. A 444 bp A. rubens contig (1025452) comprising a partial sequence 
corresponding to the 3’ region of the P. pectinifera SMP precursor cDNA was identified. 
Then ovarian transcriptome sequence data obtained from multiple echinoderm species 
((Reich et al., 2015); http://www.echinobase.org/Echinobase/Blasts) was analysed and 
non-overlapping contigs encoding the 5’ region (GAUS01027726.1) and the 3’ region 
(GAUS01027727.1) of a SMP-type precursor transcript was identified from the starfish 
species Asterias forbesi. Combining these partial sequence data from A. rubens and A. 
forbesi, primers (forward: 5’-ATGCGGCTCATCATGCAC-3’; reverse: 5’-
TACACACCAAGCAGTGACA-3’) were designed to enable PCR amplification of the 
full-length PP/OK/SMP-type precursor coding sequence from A. rubens, as described 
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below. A part of this precursor (477 bases) was cloned and sequenced to provide a 
template for production of probes used for mRNA in situ hybridization (see below). The 
method employed was the same above but using the following pair of oligo primers: 5’-
GCTTCACAGACAAGCGTTT-3’ (forward); 5’-TACACACCAAGCAGTGACA-3’ 
(reverse). 
The methods used for total RNA extraction, cDNA cloning and analysis were 
similar to the those reported in chapter 2, with slight modifications. Zero Blunt TOPO 
PCR cloning kit (Invitrogen, Carlsbad, CA, USA) was used to ligate the PCR product 
into the pCR-Blunt II with TOPO vector for cloning of a cDNA encoding the complete 
ArPPLNP1 sequence, while pBluescript II SK (+/–) was used for cloning of a cDNA 
encoding a partial sequence of ArPPLNP1. 
3.2.3 Mass spectrometry 
Mass spectrometry was used to determine the structures of neuropeptides 
derived from ArPPLNP1 by analysis of A. rubens radial nerve cords extracted in 90% 
methanol / 9% acetic acid and then reduced and alkylated, as described in chapter 2. 
Therefore, here only a short overview of the methods is reported. The pH of the radial 
nerve cord extract was adjusted using ammonium bicarbonate and the extract was 
reduced with dithiothreitol (DTT) and then alkylated using iodoacetamide but not 
treated with trypsin or any other proteolytic enzyme. Samples of the extract were 
analysed by nanoLC-ESI-MS/MS using an Orbitrap Fusion (ThermoScientific) and data 
analysis was performed as described in chapter 2, except that more recent versions of 
Mascot (Matrix Science, London, UK; version 2.5.0) and Scaffold (version 
Scaffold_4.5.3, Proteome Software Inc., Portland, OR) were used to annotate spectra. 
Mascot was searched with a fragment ion mass tolerance of 0.050 Da and a parent ion 
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tolerance of 10.0 PPM. Conversion of Gln to pyro-Glu at the N-terminus, amidation of 
the C-terminus, oxidation of methionine residues and carbamidomethyl of cysteine 
residues were specified in Mascot as variable modifications. 
3.2.4 Localization of ArPPLNP1 using mRNA in situ hybridization 
A cDNA encoding a partial ORF (477 bases) was cloned in pBluescript SKII (+) 
vector and used as a template for production of digoxygenin (DIG)-labeled RNA probes. 
The methods employed for i) production of anti-sense and sense DIG-labeled RNA 
probes, ii) preparation of sections of fixed specimens of A. rubens and iii) visualization 
of ArPPLNP1 transcripts in sections of A. rubens were the same as those reported in 
chapter 2. 
3.2.5 Localization of ArPPLN1b using immunohistochemistry 
3.2.5.1 Production of antibodies to ArPPLN1b 
As ArPPLN1b (ArSMP) is the most abundant of the peptides derived from 
ArPPLNP1 (four out of nine peptide copies) it was selected as an antigen for generation 
of antibodies to be used for immunhistochemical localization of ArPPLN1-type 
peptides in A. rubens. A peptide comprising the C-terminal twelve amino acid residues 
of ArPPLN1b with the addition of an N-terminal lysine residue (KGAFDPLSAGFTD) 
was designed as an antigen (ag) peptide (ArPPLN1b-ag) and synthesized by Peptide 
Protein Research Ltd. (Hampshire, UK). ArPPLN1b-ag was conjugated to porcine 
thyroglobulin (Sigma-Aldrich) as a carrier protein, using 5% glutaraldehyde in 
phosphate buffer (PB, 0.1 M, pH 7.2) as a coupling reagent. Following dialysis in 
distilled water to remove glutaraldehyde and any uncoupled peptide, the conjugate 
solution was divided into aliquots containing approximately 50 nmol conjugated antigen 
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peptide per tube and then frozen. A rabbit was used for antibody production with 
immunization and serum collection performed by Charles River Labs (Margate, UK) 
according to the following protocol. On day 0 pre-immune serum was collected and the 
first immunization (~100 nmol of conjugated ArPPLN1b-ag in Freund’s complete 
adjuvant) was administered. Booster immunizations (~50 nmol of conjugated 
ArPPLN1b-ag in Freund’s incomplete adjuvant) were administered on days 28, 42 and 
56). Antiserum samples were collected on days 37 and 51 and a final bleed was 
collected on day 70. 
3.2.5.2 Characterisation of antisera to ArPPLN1b using ELISA 
To assess production of antibodies during the immunization protocol and 
following collection of a terminal bleed, antisera were tested for antibodies to 
ArPPLN1b-ag using Enzyme-Linked ImmunoSorbent Assays (ELISA) in two formats. 
Firstly, an assay where a fixed amount of ArPPLN1b-ag peptide (100 µl of 1 µM) was 
added to each well and then incubated with varying dilutions of pre-immune serum or 
antiserum (10-3 - 10-8 diluted in 5% goat serum/PBS; n =2). Secondly, an assay where 
varying amounts of ArPPLN1b-ag peptide (100 µl; 10-6 - 10-11 M; n = 2) was added to 
each well and then incubated with pre-immune serum or antiserum at a fixed dilution of 
10-4. For both assay formats the ArPPLN1b-ag peptide was dissolved in 
carbonate/bicarbonate buffer (25 mM anhydrous sodium carbonate, 25 mM sodium 
bicarbonate, pH 9.8) and added to wells of a polystyrene microtiter plate (Microlon®; 
Greiner Bio-One International), which was then covered with Parafilm M® (Starlab) and 
incubated overnight at 4°C. The following day the liquid contents of the plate were 
disposed of, the wells were rinsed with 200 µl PBS (3 x 10 min) and the plate was 
drained on blotting paper. Then 200 µl of a blocking solution containing 5% goat 
 112 
antiserum/PBS was added to each well and left at room temperature for 2 h. The 
blocking buffer was discarded and each well was washed with PBS containing 0.1% 
Tween20 (PBST; 200 µl, 3 x 10 min) and then the plate was drained, as above. 
Antiserum diluted in 5% goat antiserum (Sigma-Aldrich)/PBS was added to each well 
and incubated overnight at 4 oC. The antiserum was discarded and each well was 
washed with PBST (200 µl; 3 x 10 min) and then the plate was drained. Alkaline 
phosphatase-conjugated goat anti-rabbit IgG secondary antibodies (Vector Laboratories; 
diluted 1:3000 in 5% normal goat serum/PBST) were added to each well and incubated 
for 3 h at room temperature. After washing the plate with PBST (4 x 10 min), 100 µl p-
Nitrophenylphosphate Alkaline Phosphatase Substrate (pNPP, Vector Laboratories) 
prepared in carbonate/bicarbonate buffer was added to each well and after a 20 min 
incubation at room temperature the absorbance at 415 nm was measured using 
FLUOstar Omega (BMG LABTECH - The Microplate Reader Company). Mean 
absorbance values were calculated and plotted using Prism 6.0c. 
3.2.5.3 Localization of ArPPLN1b in A. rubens using immunohistochemistry 
For immunohistochemistry, small specimens of A. rubens (< 6 cm diameter) 
were fixed in Bouin’s solution (75ml saturated picric acid in seawater, 25ml 37% 
formaldehyde, 5ml acetic acid) at 4 oC for 2 days. Fixed starfish were decalcified in 2% 
ascorbic acid/0.15 M sodium chloride (~ 1 week at 4oC with regular changes of the 
solution), embedded in paraffin wax, sectioned (8-12 µm) using a Leica RM2145 
microtome and mounted on chrome alum-gelatin coated glass slides. 
Xylene was used to remove wax from sections (3 x 10 min at room temperature) 
and then slides were incubated in 100% ethanol (2 x 10 min). The slides were incubated 
in 1% hydrogen peroxide in methanol for 30 minutes to quench endogenous peroxidase 
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and then rehydrated through a graded series of ethanol (90%, 70%, 50%; 10 minutes for 
each) into distilled water. Subsequent steps were the same as those described previously 
in chapter 2 for immunohistochemistry with 1E11 monoclonal antibodies, with the 
exception of the primary antibodies (rabbit ArPPLN1b antiserum diluted to 10-5 in 5% 
goat serum/PBST) and secondary antibodies (goat anti-rabbit horseradish peroxidase 
conjugated immunoglobulins [Jackson ImmunoResearch via Stratech Scientific, 
Newmarket, Suffolk, UK] diluted 1:500 or 1:1000 in 2% goat serum/PBST) used. 
Immunostaining was visualised using diaminobenzidine (DAB, VWR Chemicals) and 
when intense immunostaining was observed, the DAB was washed off with distilled 
water (10 min). Following dehydration through an ethanol series (50%, 70%, 90%, 2 x 
100%; 10 min each), slides were cleared in xylene (2 x 10 min) and mounted with 
coverslips using DPX Mountant (VWR Chemicals). 
To assess the specificity of immunostaining, control experiments were 
performed where slides were incubated with antiserum pre-absorbed with the antigen 
peptide. Antiserum pre-absorption was performed by incubating the antiserum diluted to 
10-4 in PBS with ArPPLN1b-ag (200 µM) for 1-2 h on a rocking shaker at room 
temperature. Then the pre-absorbed antiserum was diluted ten fold to 10-5 in 5% goat 
antiserum/PBST and tested on starfish sections, as described above. 
To facilitate interpretation of immunostaining in some regions of the starfish 
body, sections adjacent to immunostained sections were stained using Masson’s 
trichrome staining, which differentiates collagenous (blue) from non-collagenous (red) 
tissue. The method employed for trichrome staining of starfish sections has been 
described recently (Blowes et al., 2017). The protocol for Masson’s trichrome staining 
can be found in appendix 9.7. 
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Photographs of immunostained and trichrome stained sections were obtained 
and assembled into montages, as described in chapter 2. A QIClick CCD Camera 
(QImaging) linked to a DMRA2 light microscope (Leica) and Volocity v.6.3.1 image 
analysis software (Perkin-Elmer, Boston, MA) running on an iMac computer (27-inch 
with OS X Yosemite, v. 10.10) were used to capture the photographs. Images were 
compiled into montages and labeled using Photoshop CC (2015.0.0; Adobe Systems, 
San Jose, CA), including use of cropping and contrast adjustment tools, on a MacBook 
Pro computer (13-inch, with OS X EI Capitan). 
3.2.6 In vitro and in vivo bioassay and pharmacology 
3.2.6.1 In vitro pharmacology 
ArPPLN1b or ArSMP (FGGKGAFDPLSAGFTD) was selected for in vitro 
pharmacological tests because it is the most abundant (4 copies) of the five 
neuropeptides derived from ArPPLNP1(Figure 3.2). The structure of this peptide having 
been confirmed by mass spectrometry (Figure 3.3c), it was synthesized commercially 
by Peptide Protein Research Ltd. (Hampshire, UK). ArPPLN1b was tested on apical 
muscle, tube foot and cardiac stomach preparations from A. rubens, with the 
SALMFamide neuropeptide S2 (SGPYSFNSGLTF-NH2) tested as a control peptide 
that causes relaxation of all three of these preparations (Elphick et al., 1995; Melarange 
and Elphick, 2003; Kim et al., 2016). 
Apical muscles were dissected from the aboral body wall of starfish arms and 
cut into segments approximately 1 cm in length (Melarange and Elphick, 2003) and 
cotton ligatures were tied at each end (Figure 3.1a). Tube foot preparations were 
obtained by dissecting from starfish arms a small square-shaped piece of ambulacral 
body wall containing a single intact tube foot stem and its associated ampulla. Cotton 
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ligatures were tied around the body wall and the tube foot sucker, as illustrated 
previously (Melarange and Elphick, 2003) and Figure 3.1b. Cardiac stomach 
preparations were dissected as described and illustrated previously (Elphick et al., 1995) 
and then cotton ligatures were tied around the esophagus and around the aboral region 
of the cardiac stomach (Figure 3.1c). 
Ligatures at one end of the preparation (body wall segment and esophagus for 
tube foot and cardiac stomach preparations, respectively) were attached to a fixed metal 
hook in a 20 ml glass organ bath containing artificial seawater at ~11oC. The other 
ligature was tied to a High Grade Isotonic Transducer (ADinstruments MLT0015) 
connected to PowerLab data acquisition hardware (ADinstruments PowerLab 2/26). 
Output from Powerlab was recorded using LabChart (v8.0.7) software installed on a 
laptop computer (Lenovo E540, Windows 7 Professional).   
The resting tension applied to preparations was adjusted to 0.25 g followed by 
an equilibration period in ASW of ~ 20 min. Then preparations were induced to contract 
by application of 10 µM acetylcholine (ACh; for apical muscle and tube foot 
preparations) or ASW containing 30 mM added KCl (cardiac stomach preparations). 
Once a stable baseline contracted state was reached, synthetic ArPPLN1b or S2 was 
added to sequentially achieve organ bath concentrations between 10-10 M and 10-5 M. 
Cumulative dose-response curves were constructed by expressing relaxation as a 
percentage reversal of the contraction induced by ACh or KCl. Each peptide 
concentration was tested on at least five preparations. 
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Figure 3.1 Diagram and images showing the in vitro preparation of apical muscle (a), 
tube foot (b) and stomach (c), respectively. 
The apical muscle and stomach are highlighted with a red arrow in (a) and (c), 
respectively. 
3.2.6.2 In vivo pharmacology 
Previous studies have revealed that an ArPPLN1b-like peptide (SMP) causes 
dose-dependent relaxation of in vitro preparations of the cardiac stomach from P. 
pectinifera (Kim et al., 2016). The SALMFamide neuropeptide S2 also causes dose-
dependent cardiac stomach relaxation in A. rubens (Elphick et al., 1995; Melarange et 
al., 1999) and in P. pectinifera (Kim et al., 2016). Furthermore, consistent with the in 
vitro actions of S2, in vivo injection of S2 into A. rubens triggers eversion of the cardiac 
stomach (Melarange et al., 1999). Therefore, here experiments were performed to 
investigate if injection of ArPPLN1b also triggers cardiac stomach eversion in A. rubens, 
employing the same method as reported previously for tests with S2 (Melarange et al., 
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1999). Specimens of A. rubens (6 - 12 cm in diameter) were starved for three days and 
then each starfish was moved one at a time to glass testing tank. Ten starfish were 
injected with 100 µl of 1 mM ArPPLN1b at two or three sites in the aboral body wall of 
the arms proximal to the junctions with the central disk region and then were observed. 




3.3.1 Cloning and sequencing of a cDNA encoding ArPPLNP1 
A cDNA encoding ArPPLNP1 was cloned and sequenced (GenBank accession 
number KT870153) as shown in Figure 3.2. The ArPPLNP1 transcript is a 948-base 
cDNA comprising an opening reading frame of 675 bases followed by a 273-base 3’ 
untranslated region (Figure 3.2). ArPPLNP1 is a 224 amino acid protein comprising a 
predicted 20-residue signal peptide and five putative SMP-like peptides (nine copies in 
total), which were referred to as ArPPLN1a (16 residues; 1 copy), ArPPLN1b (16 
residues; 4 copies), ArPPLN1c (17 residues; 2 copies), ArPPLN1d (18 residues; 1 copy) 
and ArPPLN1e (13 residues; 1 copy) (Figure 3.2, 3.3a). The C-terminal nonapeptide 
(DPLSAGFTD) of three of these peptides (ArPPLN1a-c) is identical to the 
corresponding region of P. pectinifera SMP (Kim et al., 2016). 
 
Figure 3.2 A. rubens pedal peptide-like neuropeptide precursor 1 (ArPPLNP1).  
The nucleotide sequence (lowercase, 948 bases) encoding ArPPLNP1 (uppercase, 224 
amino acid residues) including a 3’ untranslated region is shown above. The predicted 
signal peptide is shown in blue, 8 putative peptides are shown in red and putative 
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dibasic cleavage sites are shown in green. The nucleotide sequence used for primer 
design is highlighted in red within red boxes. Nucleotide sequences that were used as 
primers for cDNA cloning are shown in red and the asterisk shows the position of the 
stop codon. 
3.3.2 Mass spectrometric detection of ArPPLNP1-derived peptides in A. rubens 
radial nerve extracts 
All five of the PP/OK-type peptides predicted to be derived from ArPPLNP1 
were detected in extracts of A. rubens radial nerve cords using LC-MS/MS. Four 
peptides (ArPPLN1a-d) gave a good series of b fragment ions, as expected for peptides 
that do not contain a basic C-terminal amino acid. The fifth peptide (ArPPLN1e) gave 
nearly complete coverage of b and y ions. The following peptides were observed and 
selected for MS/MS (Figure 3.3b-f): ArPPLN1a (GFGMGAYDPLSAGFTD, 811.35 
m/z, 2+ ion); ArPPLN1b (FGGKGAFDPLSAGFTD, 793.88 m/z, 2+ ion); ArPPLN1c 
(FGGSRGAFDPLSAGFTD, 851.40 m/z, 2+ ion), ArPPLN1d 
(SFVHGDFDPLSTGFVDGD, 956.42 m/z, 2+ ion) and ArPPLN1e 
(AGFMNGVFHPLVA, 680.35 m/z, 2+ ion). 
 120 
 
Figure 3.3 Mass spectrometric identification of peptides derived from the ArPPLNP1 in 
an extract of A. rubens radial nerve cords.  
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(a) Amino acid sequence of ArPPLNP1 with the predicted signal peptide shown in blue, 
predicted cleavage sites shown in green and peptides derived from the precursor shown 
in orange (ArPPLN1a), red (ArPPLN1b), brown (ArPPLN1c), pink (ArPPLN1d) and 
purple (ArPPLN1e). (b-f) annotated MS/MS spectra for ArPPLN1a-e, respectively. The 
b series of peptide fragment ions are shown in red, the y series in blue and additional 
identified peptide fragment ions in green. The amino acid sequence identified in the 
mass spectrum is highlighted at the top of each figure and M + 16 represents oxidized 
methionine. (b) MS/MS spectrum for the ArPPLN1a (GFGMGAYDPLSAGFTD) 
observed at 811.35 m/z, 2+ ion, with precursor mass error -0.40 ppm (Mascot score 84). 
(c) MS/MS spectrum for ArPPLN1b (FGGKGAFDPLSAGFTD) observed at 793.88 
m/z, 2+ ion, with precursor mass error 0.99 ppm (Mascot score 61). (d) MS/MS 
spectrum for ArPPLN1c (FGGSRGAFDPLSAGFTD) observed at 851.40 m/z, 2+ ion, 
with precursor mass error -0.019 ppm (Mascot score 60). (e) MS/MS spectrum for 
ArPPLN1d (SFVHGDFDPLSTGFVDGD) observed at 956.42 m/z, 2+ ion, with 
precursor mass error -0.23 ppm (Mascot score 69). (f) MS/MS spectrum for ArPPLN1e 
(AGFMNGVFHPLVA) observed at 680.35 m/z, 2+ ion, with precursor mass error 1.0 
ppm (Mascot score 42). 
3.3.3 Localization of ArPPLNP1 transcripts in A. rubens using mRNA in situ 
hybridization 
Analysis of the distribution of ArPPLNP1 transcripts in A. rubens using mRNA 
in situ hybridization revealed a widespread pattern of expression, including stained cells 
in the radial nerve cords and circumoral nerve ring that form the main tracts of the 
nervous system (Figure 3.4), the tube feet (Figure 3.5), the terminal tentacle (Figure 3.6), 
the digestive system (Figure 3.7, 3.8) and the ceolomic epithelial lining of the body wall 
(Figure 3.9). 
In longitudinal sections of the radial nerve cord, stained cells can be seen in the 
hyponeural region (Figure 3.4a, b) and along the length of the ectoneural region in the 
sub-cuticular epithelium (Figure 3.4a, c). The specificity of the staining observed with 
anti-sense probes (Figure 3.4a) was demonstrated by control experiments where no 
staining was observed with sense probes (Figure 3.4a inset). Transverse sections of the 
radial nerve cords revealed that the stained cells in the ectoneural region are 
concentrated in the lateral regions of the radial nerve cords (Figure 3.4d) and this 
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population of cells extends into the epithelium of adjacent tube feet (Figure 3.4e). In 
contrast, stained cells are only sparsely distributed in the ectoneural epithelium at the 
apex of the V-shaped nerve cord (Figure 3.4d). By way of comparison, a dense 
population of stained cells is present throughout much of the hyponeural region of the 
radial nerve cord (Figure 3.4a, b, f). The pattern of expression in the circumoral nerve 
ring is consistent with that seen in the radial nerve cords. Thus, cells are present in both 
the hyponeural and ectoneural regions; however, in the ectoneural epithelium stained 
cells are concentrated in the region adjacent to the perioral tube feet and are sparser in 
the region adjacent to the peristomial membrane (Figure 3.4g, h). 
 123 
 
Figure 3.4 Localization of ArPPLNP1 mRNA in the radial nerve cord and circumoral 
nerve ring of A. rubens using in situ hybridization.  
(a) Longitudinal parasagittal section of the radial nerve cords incubated with antisense 
probes showing stained cells in the ectoneural (arrowheads) and hyponeural (arrows) 
regions. Higher magnification images of the boxed regions are shown in (b) and (c). 
The inset of panel (a) shows the absence of staining in a longitudinal parasagittal 
section of radial nerve cord incubated with sense probes, demonstrating the specificity 
of staining observed with antisense probes.  (b) High magnification image showing 
stained cells in the hyponeural region of the radial nerve cord. (c) High magnification 
image showing stained cells in the ectoneural region of the radial nerve cord. (d) 
Transverse section of radial nerve cord showing stained cells in the ectoneural 
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(arrowheads) and hyponeural (arrows) regions. Higher magnification images of the 
boxed regions are shown in (e) and (f). (e) High magnification image showing stained 
cells at the junction between the ectoneural region of the radial nerve cord and an 
adjacent tube foot. (f) High magnification image showing stained cells in the ectoneural 
(arrowheads) and hyponeural (arrows) regions of the nerve cord. (g) Transverse section 
of the circumoral nerve ring showing stained cells in the ectoneural (arrowheads) and 
hyponeural (arrow) regions. Stained cells can also be seen in the coelomic epithelial 
lining of the peristomial membrane (white arrowheads). (h) High magnification image 
of circumoral nerve ring showing stained cells in the ectoneural and hyponeural regions. 
CONR, circumoral nerve ring; CuL, cuticular layer; Ec, ectoneural region; Hy, 
hyponeural region; PM, peristomial membrane; RHS, radial hemal strand; RNC, radial 
nerve cord; TF, tube foot. Scale bars: 50 µm in (a), (a) inset, (d), (g); 10 µm in (b), (c), 
(e), (f), (h). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
In the tube feet, which enable locomotor activity in starfish, stained cells are 
present in a basiepithelial position at the junction between the tube feet and the radial 
nerve cord or circumoral nerve ring (Figure 3.5a), along the length of the tube foot stem 
(Figure 3.5a, b) and at the junction between adjacent tube feet (Figure 3.5c). Stained 
cells are also present in the tube foot sucker, in close proximity to the basal nerve ring 
(Figure 3.5d, e). 
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Figure 3.5 Localization of ArPPLNP1 mRNA in tube feet of A. rubens using in situ 
hybridization.  
(a, b) Longitudinal section of a tube foot showing stained cells (arrowheads) in the sub-
epithelial layer of the tube foot stem. The boxed region in panel (a) is shown at higher 
magnification in (b). (c) Stained cells located in the sub-epithelial layer at the junction 
between adjacent tube feet. (d) Stained cells (arrowheads) in the sub-epithelial layer just 
above the tube foot sucker. The boxed region is shown at higher magnification in (e). (e) 
Stained cells located near to the tube foot basal nerve ring. BNR, basal nerve ring; CT, 
collagenous tissue; Ep, epithelium; ML, muscle layer; Su, sucker; TF: tube foot. Scale 
bars: 100 µm in (a); 20 µm in (b), (c); 50 µm in (d); 10 µm in (e). Refer to Figure 1.7 
(page 38) and 1.8 (page 39) for details of starfish anatomy. 
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The terminal tentacle is a non-locomotory but tube foot-like sensory organ 
located at the tip of each starfish arm and, consistent with the expression of ArPPLNP1 
in tube feet, stained cells are also present in the terminal tentacle (Figure 3.6). Stained 
cells are present in the wall of the terminal tentacle (Figure 3.6) and in lateral lappets 
(Figure 3.6c, d), flaps of epithelial tissue that hang down from the body wall on both 
sides of the terminal tentacle. Stained cells are also present in the body wall epithelium 
that forms the roof and wall of the cavity containing the terminal tentacle (Figure 3.6a). 
However, no stained cells were observed in the pigmented photosensory optic cushion, 
which is located at the base of the terminal tentacle (Figure 3.6c). 
 
Figure 3.6 Localization of ArPPLNP1 mRNA in the arm tip region of A. rubens using 
in situ hybridization. 
(a, b) Transverse section of a paraffin wax embedded arm tip showing the terminal 
tentacle cut obliquely. Stained cells can be seen in the external epithelial layer of the 
terminal tentacle (arrowheads) and in the body wall epithelium (arrows) that surrounds 
the terminal tentacle. The boxed region in (a) is shown at higher magnification in panel 
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(b). (c) Transverse cryostat section of an arm tip showing the pigmented optic cushion 
and terminal tentacle. Stained cells can be seen in the terminal tentacle external 
epithelium (black arrowheads) and in the lateral lappets (white arrowheads). (d) A high-
magnification image of an arm tip showing stained cells in the terminal tentacle and 
lateral lappet. Ep, epithelium; LL, lateral lappet; OC, optic cushion; TT, terminal 
tentacle. Scale bars: 50 µm in (a), (c); 10 µm in (b); 20 µm in (d). Refer to Figure 1.7 
(page 38) and 1.8 (page 39) for details of starfish anatomy. 
In the digestive system, ArPPLNP1 mRNA expression was detected in the 
peristomial membrane (Figure 3.7a), esophagus (Figure 3.7b), cardiac stomach (Figure 
3.7c, d), pyloric stomach (Figure 3.7e, f), pyloric ducts (Figure 3.8a, b) and pyloric 
caeca (Figure 3.8c, d). In the peristomial membrane and esophagus, stained cells are 
present in the coelomic epithelium and in the external epithelium (Figure 3.7a, b). In the 
cardiac stomach, ArPPLNP1 is widely expressed. Stained cells are present in the 
mucosa of the floor (Figure 3.7c), pouches and roof (Figure 3.7c, d) of the cardiac 
stomach. The floor of the pyloric stomach has a similar pattern of expression as the roof 
of the cardiac stomach (Figure 3.7e, f). 
The pyloric ducts, which link the pyloric stomach with the paired pyloric caeca 
in each arm contain stained cells, which are concentrated in the mucosal epithelium on 
the oral side of the ducts (Figure 3.8a, b). Similarly, stained cells are concentrated in the 
mucosal epithelium on the oral side of the central canal of the pyloric caeca (Figure 3.8c, 
d), which is directly connected to the pyloric ducts (Anderson, 1953). 
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Figure 3.7 Localization of ArPPLNP1 mRNA in the digestive system of A. rubens 
using in situ hybridization. 
(a) Transverse section of the peristomial membrane showing stained cells (arrowheads) 
in the coelomic epithelium. (b) Longitudinal section of the esophagus showing stained 
cells in the coelomic epithelium. (c, d) Transverse section of central disk showing 
stained cells in the cardiac stomach. The boxed region in (c) is shown at higher 
magnification in panel (d), where stained cells can be seen in mucosal layer. (e, f) 
Transverse section of central disk showing stained cells in the cardiac stomach and 
pyloric stomach. The boxed region of the pyloric stomach in (e) is shown at higher 
magnification in panel (f), where stained cells can be seen in mucosal layer. CE, 
coelomic epithelium; CS, cardiac stomach; CT, collagenous tissue; Es, esophagus; Mu, 
mucosa; PM, peristomial membrane; PS, pyloric stomach; VM, visceral muscle. Scale 
bars: 20 µm in (a), (b), (d), (f); 100 µm in (c), (e). Refer to Figure 1.7 (page 38) and 1.8 
(page 39) for details of starfish anatomy. 
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Figure 3.8 Localization of ArPPLNP1 mRNA in the pyloric duct and pyloric caeca of A. 
rubens using in situ hybridization. 
(a, b) Transverse section of a pyloric duct showing stained cells (arrowheads) that are 
concentrated in the oral (lower) domain of the duct. The boxed region in (a) is shown at 
higher magnification in panel (b), where stained cells can be seen in the mucosal layer. 
(c, d) Transverse section of a pyloric caecum showing stained cells (arrowheads) that 
are concentrated in the oral (lower) domain of a pyloric caecum diverticulum. The 
boxed region in (c) is shown at higher magnification in panel (d), where stained cells 
can be seen in the mucosal layer.  Lu, lumen; PC, pyloric caeca; PD, pyloric duct. Scale 
bars: 50 µm in (a); 10 µm in (b), (d); 100 µm in (c). Refer to Figure 1.7 (page 38) and 
1.8 (page 39) for details of starfish anatomy. 
ArPPLNP1-expressing cells are present within the aboral coelomic epithelium. 
Stained cells can be seen associated with the longitudinally orientated apical muscle, 
which is shown here in both transverse (Figure 3.9a, b) and longitudinal (Figure 3.9c, d) 
sections of the starfish arm. Stained cells can also be seen in the coelomic epithelium 
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located at the base of the finger-like papulae, which project through the body wall to the 
external aboral surface of the arms (Figure 3.9e, f).   
 
Figure 3.9 Localization of ArPPLNP1 mRNA in the apical muscle and coelomic lining 
of the body wall in A. rubens using in situ hybridization.  
(a, b) Transverse section of apical muscle showing stained cells (arrowheads) in the 
coelomic epithelium. The boxed region in (a) is shown at higher magnification in panel 
(b). (c, d) Longitudinal section of apical muscle showing stained cells (arrowheads) in 
the coelomic epithelium. The boxed region in (c) is shown at higher magnification in 
panel (d). (e, f) Transverse section of an arm showing stained cells (arrowheads) in the 
coelomic epithelium at the base of a papula. The boxed region in (e) is shown at higher 
magnification in panel (f). AM, apical muscle; CE, coelomic epithelium; Pa, papulae. 
Scale bars: 50 µm in (a), (c), (e); 10 µm in (b), (d), (f). Refer to Figure 1.7 (page 38) and 
1.8 (page 39) for details of starfish anatomy. 
3.3.4 Localization of neuropeptides derived from ArPPLNP1 using 
immunohistochemistry 
3.3.4.1 Characterisation of a rabbit antiserum to ArPPLN1b using ELISA 
To assess the presence and titre of antibodies to the ArPPLN1-ag peptide in 
rabbit sera, antiserum and pre-immune serum were incubated at a range of dilutions (10-
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3 - 10-8) with a fixed amount of the antigen peptide added to each well of the microtitre 
plate (10-10 moles). As expected, no ArPPLN1-ag immunoreactivity was detected with 
pre-immune serum but ArPPLN1-ag immunoreactivity was detected with antiserum at 
dilutions ranging from 10-3 to 10-5 (Figure 3.10a). To assess the sensitivity of the 
antiserum for detection of the ArPPLN1-ag peptide, the antiserum (diluted to10-4) was 
incubated with different amounts of peptide ranging from 10-10 to 10-15 moles. At this 
antiserum dilution, the peptide was detected in the range from 10-10 moles to 10-12 moles 
(Figure 3.10b). Collectively, these data indicate that the antiserum contains a high titre 
of antibodies to the ArPPLN1-ag peptide. 
 
Figure 3.10 Characterization of rabbit antiserum to ArPPLN1b using an enzyme-linked 
immunosorbent assay (ELISA). 
(a) Incubation of antiserum (red) and pre-immune serum (blue) at dilutions between 10-3 
and 10-8 with 0.1 nmol of antigen peptide (ArPPLN1-ag) per well reveals no 
immunoreaction with pre-immune serum, whereas with the antiserum the antigen is 
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detected at well above the background optical density (OD) with dilutions from 10-3 to 
10-5. (b) Incubation of antiserum (red) and pre-immune serum (blue) at 10-4 dilution 
with between 10-15 and 10-10 moles of antigen peptide (ArPPLN1-ag) per well reveals no 
immunoreaction with pre-immune serum, whereas with the antiserum the antigen is 
detected at well above the background OD with 10-12 to 10-10 moles per well. All data 
points are mean values from two separate experiments performed in duplicate. 
3.3.4.2 Immunohistochemical localization of neuropeptides derived from 
ArPPLNP1 in A. rubens 
Antiserum to the C-terminal region of ArPPLN1b (KGAFDPLSAGFTD; see 
above) was used to investigate the distribution of this peptide in A. rubens using 
immunohistochemistry. It should be noted, however, that two of the other peptides 
derived from ArPPLNP1 (ArPPLN1a and ArPPLN1c) have the same C-terminal 
DPLSAGFTD sequence as ArPPLN1b and so it is likely that these are also 
immunoreactive with the antiserum. Having demonstrated using ELISA that the 
antiserum contains a high titre of antibodies to the antigen peptide (Figure 3.10), the 
antiserum was used for immunohistochemistry at a dilution of 10-5. 
3.3.4.2.1 Radial nerve cords, circumoral nerve ring, marginal nerve cords 
and lateral motor nerves 
An extensive and intense pattern of ArPPLN1b-immunoreactivity (ir) was 
revealed in radial nerve cord of A. rubens (Figure 3.11a). The specificity of this 
immunostaining was confirmed in control experiments testing antiserum that had been 
pre-absorbed with the antigen peptide. Thus, in tests with pre-absorbed antiserum no 
immunostaining was observed in the radial nerve cords (Figure 3.11a inset) or in other 
parts of the starfish body (data not shown). 
ArPPLN1b-ir was revealed in bipolar cell bodies located in the epithelium of the 
ectoneural region of the radial nerve cord and in a dense meshwork of fibers in the 
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underlying neuropile (Figure 3.11a, b). Interestingly, the intensity of immunostaining in 
the ectoneural neuropile is not homogeneous; for example, in the region that forms the 
tip of the V-shaped nerve cord there is zone of neuropile with a lower density of stained 
fibers that is bounded above (aboral) and below (oral) by zones with a higher density of 
stained fibers (Figure 3.11a, c). ArPPLN1b-ir was also revealed in monopolar cell 
bodies in the hyponeural region of the radial nerve cord and the axonal processes of 
these neurons (Figure 3.11a, d), which can be seen projecting to the base of the adjacent 
tube foot stem and to the transverse infra-ambulacral muscle (Figure 3.11e). 
Immunostained processes in the neuropile of the ectoneural region of the radial nerve 




Figure 3.11 Localization of ArPPLN1b-immunoreactivity (ArPPLN1b-ir) in the radial 
nerve cord of A. rubens.  
(a) Tranvserse section of a radial nerve cord showing ArPPLN1b-ir in both the 
ectoneural and hyponeural regions. The inset of (a) shows absence of immunostaining 
in a radial nerve cord section incubated with ArPPLN1b antiserum pre-absorbed with 
the antigen peptide (ArPPLN1b-ag), demonstrating the specificity of immunostaining 
observed with the ArPPLN1b antiserum. (b) High magnification image of the 
ectoneural region of the radial nerve cord showing immunostained bipolar shaped cells 
in the sub-cuticular epithelium (arrowheads) and densely packed immunostained 
processes in the underlying neuropile region. (c) High magnification image of the 
ectoneural region at the tip of the V-shaped radial nerve cord showing layer-specific 
variation in the density of immunostained processes. (d) High magnification image 
showing immunostained monopolar shaped cells (arrowheads) and their stained 
processes (arrow) in hyponeural region of the radial nerve cord. The unstained 
collagenous tissue layer (white arrowhead) that separates the hyponeural region from 
the densely stained ectoneural neuropile can also be seen here. (e, f) High magnification 
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images showing immunostaining at the junction between the radial nerve cord and an 
adjacent tube foot. The continuity of immunostaining in the ectoneural region of the 
radial nerve and in the basiepithelial nerve plexus of the tube foot (asterisks) can be 
seen here. In (e) the stained process(es) (arrowhead) of a hyponeural neuron(s) can be 
seen projecting over the roof of the perihemal canal in close association with the 
transverse infra-ambulacral muscle. In (f) the stained processes (arrowhead) of 
hyponeural neurons can be seen projecting to the base of the adjacent tube foot. CuL, 
cuticle layer; Ec, ectoneural region; Hy, hyponeural region; RHS, radial hemal strand; 
TF, tube foot. Scale bars: 50 µm in (a); 200 µm in (a) inset; 10 µm in (b), (d), (e); 20 µm 
in (c), (f). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
The pattern of immunostaining in the circumoral nerve ring (Figure 3.12a, b) is 
consistent with that in the radial nerve cords, with bipolar cell bodies in the ectoneural 
epithelium projecting into the densely stained underlying neuropile and with the 
processes of stained monopolar cells in the hyponeural region projecting into underlying 
nerve tract that is separated from the ectoneural neuropile by a thin layer of unstained 
collagenous tissue (Figure 3.12b, c). As in the radial nerve cord, there was regional 
variability in the density of immunostained fibers in the ectoneural neuropile. Thus, in 
the region of the circumoral nerve ring proximal to the peristomial membrane there is a 
layer of neuropile with a lower density of immunostained fibers that are bounded on 
either side by layers of neuropile with a higher density of immunostained fibers (Figure 
3.12c). This pattern of staining seen in the circumoral nerve ring is anatomically 
equivalent to the “banded” pattern of staining seen in the tip region of the radial nerve 
cord (see above). Stained fibers in the ectoneural neuropile are continuous with the 
basiepithelial plexus of the adjacent peristomial membrane (Figure 3.12a). 
Located lateral to the outer row of tube feet on each side of the arm is the 
marginal nerve, which is a thickening of the basiepithelial nerve plexus (Smith, 1937; 
1950). Cells exhibiting ArPPLN1b-ir are present in the epithelial layer of the marginal 
nerve and ArPPLN1b-ir is present in the underlying neuropile (Figure 3.12d). Closely 
associated with the marginal nerve are the lateral motor nerves, which contain the axons 
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of hyponeural motor neurons that innervate the body wall musculature and the coelomic 
lining of the aboral body wall (Smith, 1950). ArPPLN1b-ir is present in the lateral 
motor nerve and stained processes emerging from a lateral motor nerve can be seen 
innervating the muscle that links the ambulacral and adambulacral ossicles (Figure 
3.12d). 
 
Figure 3.12 Localization of ArPPLN1b-immunoreactivity in the circumoral nerve ring 
and marginal nerve of A. rubens. 
(a) ArPPLN1b-ir in a transverse section of the circumoral nerve ring; here 
immunostained processes can also be seen in the peristomial membrane, an adjacent 
oral tube foot and in a Tiedemann’s body. (b) A high-magnification image of 
circumoral nerve ring showing immunostained bipolar shaped cells in the sub-cuticular 
epithelium (arrowheads) of the ectoneural region and densely packed immunostained 
processes in the underlying neuropile. In the hyponeural region immunostained 
monopolar shaped cells (white arrowhead) can be seen with their stained processes 
(arrow) adjacent to the unstained collagenous tissue layer (white arrow). (c) High 
magnification image of the ectoneural region of the circumoral nerve ring showing 
layer-specific variation in the density of immunostained processes. (d) Immunostaining 
in a sub-epithelial thickening of the basiepithelial plexus known as the marginal nerve 
(arrow), which is located at the junction between the outer row of tube feet and the 
adjacent body wall. Internal to the marginal nerve, separated by a thin layer of 
collagenous tissue, can be seen stained axonal processes that coalesce to form the lateral 
motor nerve (arrowhead). Individual stained axonal processes derived from the lateral 
motor nerve can be seen here innervating an adjacent inter-ossicular muscle (white 
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arrowhead). CONR, circumoral nerve ring; Ec, ectoneural region; Hy, hyponeural 
region; PM, peristomial membrane; TB, Tiedemann's body; TF, tube foot. Scale bars: 
100 µm in (a); 20 µm in (b), (c); 50 µm in (d). Refer to Figure 1.7 (page 38) and 1.8 
(page 39) for details of starfish anatomy. 
3.3.4.2.2 Hemal system and Tiedemann’s bodies 
Anatomically associated with the radial nerve cords and circumoral nerve ring 
are the radial hemal strands and the oral hemal ring, respectively, which constitute, at 
least in part, the circulatory system of starfish (Ferguson, 1984). ArPPLN1b-ir is 
present in fibers located in the walls of the radial hemal strands and the oral hemal ring 
(Figure 3.13a, b). Forming a completely separate system of fluid-filled canals in starfish 
are the radial water canals and ring canal, components of the water vascular system that 
are in continuity with the fluid-filled lumen of the tube feet and ampullae (Smith, 1950). 
Closely associated with the ring canal are five pairs of organs known as Tiedemann’s 
bodies, which also contain fibers that exhibit ArPPLN1b-ir (Figure 3.13c, d). 
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Figure 3.13 Localization ArPPLN1b immunoreactivity in the hemal system and 
Tiedemann’s bodies of A. rubens.  
(a) Immunostained processes (arrowheads) are present in the radial hemal strand, which 
is anatomically connected with the intensely stained radial nerve cord. (b) 
Immunostained processes (white arrowheads) are present in the oral hemal ring, which 
is anatomically connected to the circumoral nerve ring (out of focus at bottom left). 
Immunostained processes can also be seen here in the coelomic epithelium (arrows). (c, 
d) Immunostained processes can be seen here in one of the ten Tiedemann’s bodies, 
which are located aboral to the circumoral nerve ring in the central disk. Immunostained 
processes can also be seen on the right side of the image, where they are associated with 
inter-ossicular muscles of the body wall (see figure 3.19). The boxed region in (c) is 
shown at higher magnification in panel (d), where immunostained processes can be seen 
in the Tiedemann’s body (black arrowheads), the coelomic epithelium (arrow) and the 
oral hemal ring (white arrowheads). CE, coelomic epithelium; CONR, circumoral nerve 
ring; Ec, ectoneural region; Hy, hyponeural region; OHR, oral hemal ring; Os, ossicle; 
RHS, radial hemal strand; TB, Tiedemann's body. Scale bars: 20 µm in (a), (b), (d); 100 
µm in (c). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
3.3.4.2.3 Tube feet and terminal tentacle 
Strong immunostaining is present throughout the basiepithelial nerve plexus of 
the tube foot stem (Figure 3.14a, b) and in the basal nerve ring located in the tube foot 
sucker (Figure 3.14c, d). Immunostained processes can be seen extending from the 
basiepithelial nerve plexus into each fold of the contracted tube foot stem (Figure 3.14b). 
Likewise, immunostained processes extend from the basal nerve ring into the sucker 
(Figure 3.14c). Immunostained processes are also present beneath the coelomic 
epithelium of the tube foot ampulla (Figure 3.14e, f). 
In the terminal tentacle, immunostained bipolar-shaped cells are present in the 
epithelial wall of this organ and in the underlying basiepithelial nerve plexus. Stained 
cells and underlying processes are also present in the optic cushion, the lateral lappets of 
the terminal tentacle and in the body wall epithelium that surrounds the cavity 
containing the terminal tentacle (Figure 3.15a-d). 
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Figure 3.14 Localization of ArPPLN1b immunoreactivity in tube feet and ampullae of 
A. rubens. 
(a) Longitudinal section of a tube foot showing immunostaining in the sub-epithelial 
nerve plexus, basal nerve ring and sucker. The boxed regions are shown at higher 
magnification in panels (b) and (c). (b) High magnification image showing 
immunostaining in the sub-epithelial nerve plexus and in processes projecting into 
epithelial folds of the contracted tube foot (arrowheads). (c) High magnification image 
showing immunostaining in the basal nerve ring and in processes projecting into the 
tube foot sucker (arrowheads). (d) Immunostaining in a transverse section of a tube foot 
showing immunostaining in the sub-epithelial nerve plexus and basal nerve ring. (e, f) 
Immunostaining in the sub-epithelial nerve plexus of an ampulla (arrowheads). The 
boxed region in panel (e) is shown at higher magnification in panel (f). BNR, basal 
nerve ring; CT, collagenous tissue; Ep, epithelium; ML, muscle layer; SNP, sub-
epithelial nerve plexus; Su, sucker. Scale bars: 100 µm in (a), (e); 20 µm in (b), (c), (d); 
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10 µm in (f). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
 
Figure 3.15 Localization of ArPPLN1b immunoreactivity in the terminal tentacle and 
associated structures in the arm tip of A. rubens.  
(a) Immunostaining in a transverse section of a terminal tentacle and in the surrounding 
body wall epithelium. The boxed regions are shown at higher magnification in panel (b) 
and (c). (b) A high magnification image of arm tip body wall epithelium showing 
immunostained bipolar shaped cells (arrowhead) and in a dense meshwork of fibers in 
the underlying basiepithelial plexus (asterisks). (c) High magnification image of the 
terminal tentacle showing immunostained bipolar shaped cells in the epithelium 
(arrowheads) and in a dense meshwork of fibers in the underlying basiepithelial plexus 
(asterisks). (d) Immunostaining in a transverse section at the base of the terminal 
tentacle. Immunostained cells and processes can be seen here in the body wall 
epithelium, the terminal tentacle and associated lateral lappets and the optic cushion. 
CuL, cuticle layer; Ep, epithelium; LL, lateral lappet; OC, optic cushion; TT, terminal 
tentacle. Scale bars: 50 µm in (a); 10 µm in (b), (c); 100 µm in (d). Refer to Figure 1.7 
(page 38) and 1.8 (page 39) for details of starfish anatomy. 
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3.3.4.2.4 Digestive system 
Immunostained cells are present in the coelomic epithelium of the peristomial 
membrane and esophagus and in the underlying nerve plexus (Figure 3.16). The 
basiepithelial nerve plexus underlying the external epithelial layer of the peristomial 
membrane and esophagus also contains immunostained processes. Thus, the peristomial 
membrane and esophagus have two distinct layers of immunostained processes. 
Immunostaining is present throughout the cardiac stomach (Figure 3.17a), 
including the floor of the cardiac stomach, the highly-folded pouches of the cardiac 
stomach and the roof of the cardiac stomach. This immunostaining is localized in 
bipolar shaped cells present in the mucosal layer of the cardiac stomach and in their 
underlying processes which project into the intensely stained basiepithelial nerve plexus 
(Figure 3.17a, b). A similar pattern of immunostaining is present in the pyloric stomach 
(Figure 3.17a, c) and in the pyloric ducts (Figure 3.17d, e) that connect the pyloric 
stomach with the paired digestive glands (pyloric caeca) located in each arm (Figure 
3.17d, f). Immunostained mucosal cells and processes in the underlying basiepithelial 
nerve plexus are also present in the pyloric caeca (Figure 3.17d, f). 
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Figure 3.16 Localization of ArPPLN1b immunoreactivity in the peristomial membrane 
and esophagus of A. rubens.  
(a) An immunostained bipolar shaped cell can be seen here in the external epithelial 
layer of the peristomial membrane (arrowhead) and in processes located in the 
underlying basiepithelial nerve plexus. Immunostaining is also present in cells and 
processes located beneath the coelomic epithelium, which is separated from the 
basiepithelial nerve plexus by a layer of collagenous tissue. (b) Transverse section of 
the central disk showing immunostaining in the peristomial membrane, the esophagus 
and the cardiac stomach. The boxed region is shown at higher magnification in panel (c). 
(c) High magnification image of a longitudinal section of the esophagus (in a transverse 
section of the central disk) showing immunostained cells (arrowheads) and processes 
(asterisks) beneath the coelomic epithelium and stained processes (arrows) in the 
basiepithelial nerve plexus beneath the epithelial layer that forms the external lining of 
the esophagus. (d) Horizontal section of the central disk at the level of the junction 
between the esophagus and the peristomial membrane showing immunostained cells 
(arrowheads) and processes (arrows). (e) High magnification transverse section of the 
esophagus (in a horizontal section of the central disk) showing immunostained cells and 
processes beneath the folded coelomic epithelium and dense immunostaining in the 
basiepithelial plexus beneath the epithelial lining of the eosophagus lumen. BNP, 
basiepithelial nerve plexus; CE, coelomic epithelium; CS, cardiac stomach; CT, 
collagenous tissue; Es, esophagus; Mo, mouth; PM, peristomial membrane. Scale bars: 
20 µm in (a), (c), (e); 100 µm in (b); 50 µm in (d). Refer to Figure 1.7 (page 38) and 1.8 
(page 39) for details of starfish anatomy. 
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Figure 3.17 Localization of ArPPLN1b immunoreactivity in the cardiac stomach, 
pyloric stomach, pyloric duct and pyloric caeca of A. rubens.  
(a) Transverse section of the central disk region showing immunostaining in the cardiac 
stomach and pyloric stomach. (b) High magnification image of the cardiac stomach 
showing immunostaining in bipolar-shaped cells in the mucosa and in the underlying 
basiepithelial nerve plexus. (c) High magnification image of the pyloric stomach 
showing immunostaining in bipolar-shaped cells in the mucosa and in the underlying 
basiepithelial nerve plexus. (d) Horizontal section of the arm of a juvenile starfish 
showing immunostaing in the pyloric duct and pyloric caeca. (e) High magnification 
image of a transverse section of pyloric duct showing immunostaining in bipolar shaped 
mucosal cells and in the underlying basiepithelial nerve plexus. (f) High magnification 
image of a transverse section through a lobe of a pyloric caecum showing 
immunostaining in bipolar shaped mucosal cells and in the underlying basiepithelial 
nerve plexus (arrowheads). BNP, basiepithelial nerve plexus; CE, coelomic epithelium; 
CS, cardiac stomach; CT, collagenous tissue; Lu, lumen; Mu, mucosa; PC, pyloric 
caeca; PD, pyloric duct; PS, pyloric stomach. Scale bars: 200 µm in (a); 20 µm in (b), 
 144 
(c), (d); 100 µm in (e); 50 µm in (f). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for 
details of starfish anatomy. 
3.3.4.2.5 Coelomic epithelium, apical muscle, papulae and spines 
Immunostained cells are present in the coelomic epithelium that forms the aboral 
lining of the coelom in each arm (Figure 3.18a, b). The processes of these cells form a 
sub-epithelial plexus that is closely associated with an underlying thin layer of 
longitudinally orientated muscle (Figure 3.18c). Separated from the longitudinal muscle 
by a layer of collagenous tissue, immunostained processes are also present in close 
association with a layer of circularly orientated muscle. Thus, the coelomic lining is 
characterized by two separate layers of immunostained fibers. The apical muscle is a 
thickening of the longitudinal muscle layer of the coelomic lining, which runs in sagittal 
position along the length of the arm into the central disk region. Immunostained cells 
are present in the coelomic epithelial lining of the apical muscle and the cross-sectional 
profiles of immunostained processes can be seen within the apical muscle. As in other 
regions of the aboral coelomic lining, stained processes are also present in the thin 
circular muscle layer underneath the apical muscle. The pattern of immunostaining 
observed in the coelomic epithelium also extends into the lining of the papulae (Figure 
3.18a, d), thin-walled finger-like structures that project externally through the body wall. 
Furthermore, immunostained processes are present in the sub-epithelial plexus of the 
outer epithelium of the body wall (Figure 3.18a, e). 
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Figure 3.18 Localization of ArPPLN1b immunoreactivity in the body wall, apical 
muscle and body wall appendages of A. rubens.  
(a) Transverse section of aboral body wall showing immunostaining in the coelomic 
lining of the body wall (arrowheads), the coelomic lining of papulae and in the sub-
epithelial plexus (arrow) of the external body wall epithelium. (b) High magnification 
image of the coelomic lining of the body wall showing stained cells in the coelomic 
epithelium (arrowheads) and in the underlying basiepithelial plexus. Immunostaining is 
also present in a nerve plexus (arrow) that is closely associated with a layer of circularly 
orientated muscle. (c) Immunostained axon profiles (arrowheads) in a transverse section 
of the apical muscle. Longitudinally orientated immunostained processes (arrow) can 
also be seen associated with a layer of circularly orientated muscle. (d) High 
magnification view of a longitudinal section of a papula showing immunostaining in the 
coelomic lining (arrowheads). (e) High magnification of the body wall external 
epithelium showing immunostaining in the sub-epithelial nerve plexus. CBNP, 
coelomic basiepithelial nerve plexus; CMLNP, circular muscle layer nerve plexus; CT, 
collagenous tissue; CuL, cuticle layer; Os, ossicle; Pa, papulae; SNP, sub-epithelial 
nerve plexus; Sp, spine. Scale bars: 100 µm in (a); 20 µm in (b), (d), (e); 50 µm in (c). 
Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
3.3.4.2.6 Interossicular muscles 
Immunostained nerve processes can be seen ramifying amongst the muscle 
fibers of inter-ossicular muscles throughout the body wall (Figure 3.19a-e, g). 
Comparison of the immunostained sections with adjacent sections stained using 
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Masson’s trichrome method confirmed that the immunostaining fibers are clearly 
associated with muscles linking adjacent skeletal osscicles and do not appear to be 
present in the adjacent interossicular collagenous ligaments (Figure 3.19f, g). 
Furthermore, the immunostained processes extend along the length of muscle fibers into 
the ossicles (Figure 3.19e, g). 
 
Figure 3.19 Localization of ArPPLN1b immunoreactivity in the innervation of inter-
ossicular muscles in A. rubens.  
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(a) Transverse section of the ambulacrum showing immunostaining associated with 
muscles linking the ambulacral ossicles, which include the TSM, TIM and LSM. The 
intensely stained radial nerve cord (arrowhead) can also be seen in this image. The 
boxed regions are shown at higher magnification in panels (b) and (c). (b) A high 
magnification image showing immunostained nerve fibers (arrowheads) in a 
longitudinal section through the TSM. (c) A high magnification image showing the 
immunostained profiles of nerve fibers in a transverse section through the LSM. (d, e) 
Immunostaining in the body wall at the junction between two arms in a juvenile starfish. 
Immunostained fibers can be seen associated with muscles that link adambulacral 
ossicles (arrowheads). Stained fibers are also evident in thickenings of the sub-epithelial 
nerve plexus of the body wall (arrows) and in the tube feet.  (e) High magnification 
image of the boxed region in (d). (f) Trichrome stained section of the body wall 
showing an interossicular muscle (white asterisks) and collagenous tissue (area bounded 
by black dots) linking adjacent ossicles. (g) Immunostained section adjacent to the 
section shown in panel (f). By comparing the immunstaining with the trichrome staining 
it can be seen that the immunostained fibers are associated with the inter-ossicular 
muscle but not with the collagenous tissue (area bounded by black dots). LSM, 
longitudinal supra-ambulacral muscle; TF, tube foot; TIM, transverse infra-ambulacral 
muscle; TSM, transverse supra-ambulacral muscle. Scale bars: 200 µm in (a); 20 µm in 
(b), (c), (e), (f), (g); 100 µm in (d). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for 
details of starfish anatomy. 
3.3.5 Bioactivity of ArPPLN1b in A. rubens 
3.3.5.1 ArPPLN1b causes dose-dependent relaxation of in vitro preparations of 
apical muscle, tube feet and cardiac stomach from A. rubens 
ArPPLN1b (FGGKGAFDPLSAGFTD) caused dose-dependent relaxation of 
apical muscle when tested at in vitro concentrations ranging from 10-8 to 10-6 M and was 
more effective than S2 (SGPYSFNSGLTF-NH2) as a relaxant of this preparation 
(Figure 3.20b). Thus, the relative relaxing effect of ArPPLN1b at 10-6 M was 16.29
2.09% (n = 13), whereas the relative relaxing effect of S2 at 10-6 M was only 7.53
1.70% (n = 11), which is only marginally higher than the relative relaxing effect 
ArPPLN1b at 10-7 M (4.900.70%; n = 11). 
ArPPLN1b caused dose-dependent relaxation of tube feet when tested at in vitro 
concentrations ranging from 10-8 to 10-5 M and was more effective than S2 as a relaxant 
of this preparation (Figure 3.20d). Thus, the relative relaxing effect of ArPPLN1b at 10-
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5 M was 22.171.59% (n = 6), whereas the relative relaxing effect of S2 at 10-5 M was 
only 11.671.75% (n = 7), which is the same as the relative relaxing effect ArPPLN1b 
at 10-6 M (11.641.24%; n = 6). 
ArPPLN1b caused dose-dependent relaxation of cardiac stomach when tested at 
in vitro concentrations ranging from 10-10 to 10-6 M but was much less effective than S2 
as a relaxant of this preparation (Figure 3.20f). Thus, the relative relaxing effect of 
ArPPLN1b at 10-6 M was only 10.431.60%  (n = 11), whereas the relative relaxing 
effect of S2 at 10-6 M was 48.038.17% (n = 5). 
Control tests in which 20 µl of the vehicle (water) were added to the organ bath 
did not cause relaxation or contraction of any of the three preparations used here. 
3.3.5.2 ArPPLN1b does not induce cardiac stomach eversion in A. rubens 
Cardiac stomach eversion was observed within 5 min after injection of S2 
(SGPYSFNSGLTF-NH2) in seven out of ten starfish. By comparison, stomach eversion 
was not observed in any of the ten starfish injected with ArPPLN1b, even after a 15-min 
period of observation. 
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Figure 3.20 Graphs comparing the concentration-dependent relaxing effects of 
ArPPLN1b (FGGKGAFDPLSAGFTD) and the SALMFamide neuropeptide S2 
(SGPYSFNSGLTF-NH2) on in vitro apical muscle, tube foot and cardiac stomach 
preparations from A. rubens.  
(a) Representative recording showing the dose-dependent relaxing effect of ArPPLN1b 
(10-8 - 10-6 M) on an apical muscle preparation pre-contracted with artificial seawater 
containing 10-6 M added Ach (leftward arrow). (b) Apical muscle, where ArPPLN1b is 
more effective as a relaxant than S2 when tested at 10-6 M (p = 0.004; t-test). (c) 
Representative recording showing the dose-dependent relaxing effect of ArPPLN1b (10-
8 - 10-5 M) on a tube foot preparation pre-contracted with artificial seawater containing 
10-6 M added Ach (leftward arrow). (d) Tube foot, where where ArPPLN1b is more 
effective as a relaxant than S2 when tested at 10-6 M (p = 0.007; t-test) and 10-5 M (p = 
0.001; t-test). (e) Representative recording showing the dose-dependent relaxing effect 
of ArPPLN1b (10-10 - 10-6 M) on a cardiac stomach preparation pre-contracted with 
artificial seawater containing 10 mM added KCL (leftward arrow). (f) Cardiac stomach, 
where ArPPLN1b is less effective as a relaxant than S2 when tested at 10-7 M (p = 
0.0002; t-test) and 10-6 M (p = 0.00002; t-test). Following each test with ArPPLN1b, the 
preparation was washed with artificial seawater (downward arrow). Each point 
represents the mean ± SEM from at least four separate experiments, with the effect 
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calculated as the percentage reversal of contraction induced by application of 10 µM 
acetylcholine (apical muscle and tube foot) or 30 mM KCl (stomach). Ach, acetyl 
choline; ASW, artificial seawater.  
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3.4 Discussion 
The anatomical distribution and pharmacological actions of PP/OK-type 
neuropeptides have been characterized in protostomian invertebrates, including 
mollusks and arthropods (Pearson and Lloyd, 1989; Hall and Lloyd, 1990; Lloyd et al., 
1996; De Lange et al., 1997; Beck et al., 2000; Dircksen et al., 2000; Jiang et al., 2015; 
Wulff et al., 2017). Here the first detailed anatomical analysis of PP/OK-type 
neuropeptide expression in a deuterostomian invertebrate, the starfish A. rubens is 
reported. Use of both mRNA in situ hybridization and immunohistochemistry revealed 
a widespread pattern of expression of ArPPLNP1 and neuropeptides derived from this 
precursor, including cells and/or fibers in the radial nerve cords and circumoral nerve 
ring, tube feet, terminal tentacle, digestive system, coelomic lining, papulae and inter-
ossicular muscles. Consistent with previous studies on the starfish P. pectinifera (Kim 
et al., 2016) in vitro pharmacological tests revealed that the most abundant of the 
neuropeptides derived from ArPPLNP1 (ArPPLN1b or ArSMP) causes relaxation of 
apical muscle, tube foot and cardiac stomach preparations from A. rubens. Importantly, 
these findings indicate that PP/OK-type neuropeptides may act as inhibitory 
neuromuscular transmitters in starfish. This is interesting because, as discussed in more 
detail below, it provides new insights into the mechanisms of neuromuscular signaling 
in echinoderms and the evolution of PP/OK-type neuropeptide function in the animal 
kingdom. However, it would be simplistic to conclude that the sole function of PP/OK-
type neuropeptides derived from the ArPPLNP1 precursor is to act as inhibitory 
neuromuscular transmitters because the patterns of ArPPLN1b-ir in A. rubens indicate 
signaling roles that extend beyond neuromuscular systems, as also discussed in more 
detail below. 
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3.4.1 Physiological interpretation of the anatomy and pharmacological actions of 
ArPPLNP1-derived neuropeptides in A. rubens 
3.4.1.1 Radial nerve cords, circumoral nerve ring, tube feet and terminal tentacle 
Localization of ArPPLNP1 expression in the radial nerve cords and circumoral 
nerve ring is consistent with the detection of ArPPLNP1 transcripts in the radial nerve 
cords of A. rubens and P. pectinifera using PCR (Kim et al., 2016). More specifically, 
the visualization of ArPPLNP1 transcripts in cells of both the ectoneural and 
hyponeural regions of the radial nerve cords and circumoral nerve ring can be 
interpreted from a physiological perspective. Our knowledge of the functional 
architecture of the nervous system of starfish and other echinoderms is clearly rather 
limited by comparison with other invertebrate species that are used as model systems in 
neurobiology (e.g. Drosophila, C. elegans, Aplysia). Nevertheless, anatomical and 
electrophysiological studies indicate that the hyponeural region has a purely motor 
function, whereas the ectoneural region comprises a mixed population of sensory 
neurons, interneurons and motor neurons (Smith, 1937; 1950; Cobb, 1970; Mashanov et 
al., 2016). The primary function of the radial nerve cords and circumoral nerve ring is to 
co-ordinate the activity of tube feet to enable whole-animal locomotor activity (Smith, 
1950). Therefore, the expression of ArPPLNP1 and neuropeptides derived from it in 
ectoneural cell bodies and their processes is indicative of roles in mediating intercellular 
signaling associated with neural control of tube foot-mediated locomotor activity in 
starfish. The neuropile of the ectoneural region of the radial nerve cords and circumoral 
nerve ring is continuous with the basi-epithelial nerve plexus of the tube feet. Therefore, 
ectoneural neurons in the radial nerve cord and circumoral nerve ring can, in principle, 
directly control tube foot activity. However, cells expressing ArPPLNP1 are also 
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located along the length of the tube foot stem in A. rubens in close association with the 
basi-epithelial nerve plexus, which is strongly immunoreactive with antibodies to 
ArPPLN1b. Accordingly, it has been shown that synthetic ArPPLN1b causes relaxation 
of A. rubens tube foot preparations in vitro here. Thus, combining anatomical and 
pharmacological findings, neuropeptides derived from ArPPLNP1 may act 
physiologically to cause relaxation of the longitudinally orientated muscle layer in tube 
feet. This action could be functionally relevant for tube foot extension associated with 
the cyclical patterns of tube foot activity during starfish locomotor activity (Smith, 1950; 
Hennebert et al., 2013). Interestingly, ArPPLNP1 is also expressed by cells closely 
associated with the basal nerve ring in the tube foot sucker, which attaches to and 
detaches from the substratum during locomotor activity (Smith, 1950; Hennebert et al., 
2013), and one possibility is that ArPPLNP1-derived peptides involved in regulation of 
the secretion of adhesive proteins (Hennebert et al., 2012). 
The expression of ArPPLNP1 by cells in the hyponeural region of the radial 
nerve cords and circumoral nerve ring is consistent with the notion that neuropeptides 
derived from this precursor act as neuromuscular transmitters in starfish (Smith, 1950; 
Cobb, 1970; Mashanov et al., 2016). Thus, hyponeural neurons directly innervate the 
muscle layer of the ampullae, bulb-shaped and fluid-filled contractile organs that 
control the entry or withdrawal of fluid from the lumen of the tube feet during 
locomotor activity (Smith, 1950; Hennebert et al., 2013). In accordance with hyponeural 
expression of ArPPLNP1, ArPPLN1b-ir nerve fibres are present in the ampulla (Figure 
3.14). If ArPPLNP1-derived neuropeptides cause relaxation of muscle in the ampulla, 
then this action could be physiologically relevant in enabling accommodation of fluid in 
the ampulla during tube foot retraction. Furthermore, the axons of hyponeural neurons 
project to the lateral motor nerves (Smith, 1950), which also exhibit strong ArPPLN1b-
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ir. This is the first study to demonstrate the presence of a neuropeptide in the lateral 
motor nerves, which is important because the presence of immunostained fibers in the 
lateral motor nerves is consistent with notion that ArPPLN1-type neuropeptides act as 
neuromuscular transmitters that control the activity of body wall interossicular muscles, 
as discussed in more detail below. 
The terminal tentacle is a specialized tube foot-like sensory organ located at the 
tips of each arm in starfish, which can be extended and retracted (Hennebert et al., 
2013). Consistent with the expression of ArPPLNP1 by cells along the length of tube 
foot stems, this precursor and neuropeptides derived from it are also expressed by cells 
in the wall of the terminal tentacle. Accordingly, by analogy with tube feet, 
neuropeptides derived from ArPPLNP1 could act as muscle relaxants to enable 
extension of the terminal tentacle. Interestingly, ArPPLNP1 expressing cells and 
ArPPLN1b-ir cells and fibres are also present in flaps of tissue known as lateral lappets 
(Smith, 1937), which are located on both sides of the terminal tentacle. To the best of 
our knowledge, the functions of these structures has not been investigated. One 
possibility is that the lateral lappets have a chemosensory function, providing an 
expanded surface area for detection of environmental chemical cues from, for example, 
conspecifics or prey. It is noteworthy that ArPPLN1b-ir is also present in the optic 
cushion, a photo sensory organ located at the base of each terminal tentacle, and further 
studies are required to investigate the functional significance this. 
3.4.1.2 Digestive system 
ArPPLNP1 transcripts and ArPPLN1b-ir are present in many regions of the 
digestive system, including the peristomial membrane that surrounds the oral opening, 
the esophagus, cardiac stomach, pyloric stomach and the pyloric caeca. In vitro 
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pharmacological tests with ArPPLN1b revealed that this peptide causes relaxation of 
cardiac stomach preparations. However, ArPPLN1b was less effective as a relaxant of 
the cardiac stomach than the A. rubens neuropeptide SALMFamide-2 (S2). This 
contrasts with a previous study on the starfish P. pectinifera, where P. pectinifera SMP 
(a homolog of ArPPLN1b) was found to be equally as effective as A. rubens S2 in 
causing in vitro relaxation of the cardiac stomach (Kim et al., 2016). A likely 
explanation for this is that S2 is not a naturally occurring neuropeptide in this species, 
based on analysis of genome/transcriptome sequence data from the closely related 
species P. miniata (Elphick et al., 2015). In P. miniata there is an S2-like peptide but its 
sequence is different to that of S2 from A. rubens and therefore S2 may be less effective 
as a cardiac stomach relaxant in P. pectinifera than the naturally occurring S2-like 
peptide in this species. 
S2 belongs to a family of neuropeptides known as SALMFamides, which were 
the first echinoderm neuropeptides to be sequenced (Elphick et al., 2015). 
Immunocytochemical analysis of the expression of S2 in A. rubens reveals that, like 
ArPPLNP1-derived neuropeptides, it is widely expressed, including the cardiac stomach 
and other regions of the digestive system (Newman et al., 1995a). Injection of A. rubens 
with S2 can induce cardiac stomach eversion, indicating a physiological role in the 
regulation of the extraoral feeding behaviour of starfish (Melarange et al., 1999). Here it 
has been compared that the effects of injecting equimolar amounts of S2 and ArPPLN1b 
in A. rubens and found that S2 induced stomach eversion in seven out ten animals but 
stomach eversion was not observed in any of the animals injected with ArPPLN1b. 
These findings are consistent with in vitro pharmacological experiments, where 
ArPPLN1b was found to be less effective as a cardiac stomach relaxant than S2. 
Collectively, these observations lead us to conclude that the physiological roles of 
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ArPPLNP1-derived neuropeptides in the digestive system A. rubens may not be limited 
to acting as muscle relaxants. If this is the case, then what other roles might ArPPLNP1-
derived neuropeptides have in the digestive system of A. rubens? 
Previous studies have revealed that molluscan pedal peptides stimulate ciliary 
activity on the surface of the foot in Aplysia and in the salivary ducts of Tritonia 
(Willows et al., 1997; Gaston, 1998). It is noteworthy, therefore, that cells expressing 
ArPPLNP1 and associated ArPPLN1b-ir are located in regions of the digestive system 
in A. rubens that enable ciliary-mediated movement of food material. For example, the 
pyloric ducts transfer food material from the pyloric stomach to the pyloric caeca. 
Experimental observation of ciliary-generated currents has revealed that cells on the 
oral side of the pyloric duct generate centrifuge currents that move material from the 
pyloric stomach to pyloric caeca, whereas cells on the aboral side of the pyloric duct 
generate centripete currents that move material from the pyloric caeca to the pyloric 
stomach (Irving, 1924; Jangoux, 1982). Interestingly, ArPPLNP1-expressing cells 
(Figure 3.8a) and ArPPLN1b-ir are more abundant on the oral side of the pyloric duct in 
A. rubens. Furthermore, ciliary-mediated movement of food material occurs throughout 
the starfish digestive system (Anderson, 1953; 1954) and a potential role for 
ArPPLNP1-derived neuropeptides would be in regulation of ciliary-mediated movement 
of food material through the digestive system of A. rubens. 
3.4.1.3 Coelomic lining, apical muscle, papulae and body wall sub-epithelial plexus 
The most prominent components of the nervous system in starfish are the 
ectoneural and hyponeural systems that form the radial nerve cords and circumoral 
nerve ring, as highlighted above. However, in crinoid echinoderms (e.g. feather stars) 
there is a third component to the nervous system that is more prominent than the 
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ectoneural and hyponeural systems - this is the entoneural or aboral system (Smith, 
1937). In starfish, the entoneural system is also present but is relatively inconspicuous 
when compared to that in crinoids. It comprises neurons located within the coelomic 
lining of the aboral body wall in close association with an underlying layer of 
longitudinally orientated muscle and another population of neurons associated with a 
deeper layer of circularly orientated muscle. A prominent feature associated with the 
aboral nervous system in starfish is the apical muscle, a thickening of the longitudinally 
orientated muscle layer that is located along the midline of each arm. Furthermore, from 
a functional perspective, contraction of the apical muscle facilitates flexion of the arms 
during behaviors that require changes in arm posture (e.g. feeding and righting behavior) 
(Smith, 1950). 
It was the use of the apical muscle as a bioassay system for myoactive 
neuropeptides that enabled the purification of starfish myorelaxant peptide (SMP) from 
P. pectinifera (Kim et al., 2016). ArPPLN1b is a homolog of SMP from P. pectinifera 
and accordingly here ArPPLN1b was found to cause relaxation of in vitro preparations 
of the apical muscle from A. rubens (Figure 3.20b). 
Previous studies have reported that the SALMFamide neuropeptide S2 also 
causes relaxation of the apical muscle in A. rubens, although only at relatively high 
concentrations (Melarange and Elphick, 2003). Consistent with previously reported 
findings from P. pectinifera, here it is shown that ArPPLN1b is more potent/effective 
than the SALMFamide neuropeptide S2 in causing relaxation of the apical muscle. This 
contrasts with converse findings from cardiac stomach preparations, where S2 is more 
potent/effective than ArPPLN1b (see above and Figure 3.20f). 
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Consistent with the in vitro pharmacological effects of ArPPLN1b on apical 
muscle preparations, cells expressing ArPPLNP1 transcripts are located in the coelomic 
epithelium overlying the apical muscle (Figure 3.9a-d) and the immunostained axonal 
processes of these cells can be seen in transverse sections of the apical muscle (Figure 
3.18c). Expression of ArPPLNP1 also extends beyond the apical muscle to cells in the 
coelomic epithelium located throughout the lining of the aboral body wall and 
accordingly ArPPLNP1-ir is present in throughout the longitudinally orientated muscle 
layer of the coelomic lining aborally. Immunostained processes are also present in the 
underlying circularly orientated muscle layer of the coelomic lining (Figure 3.18a, b), 
which may be derived from the lateral motor nerves (Smith, 1950). 
The coelomic lining of the aboral body wall extends into papulae, thin-walled 
and retractable dermal appendages that penetrate through the body wall to enable gas 
exchange between the external seawater and the coelomic fluid (Cobb, 1978). 
ArPPLN1b-ir is present in fibres located within the coelomic lining of the papulae and 
these fibres are continuous with the innervation of the longitudinally and circularly 
orientated muscle layers of the coelomic lining of the aboral body wall (Figure 3.18a, d). 
Given that ArPPLN1b (ArSMP) acts as relaxant of the apical muscle, it seems likely 
that ArPPLNP1-derived neuropeptides also cause relaxation of muscle associated with 
the dermal papulae. Therefore, PP/OK-type neuropeptides may participate in neural 
mechanisms controlling the protraction of papulae from the aboral body surface of 
starfish. 
ArPPLN1b-ir is also present within the sub-epithelial nerve plexus below the 
external epithelium of the body wall and associated with appendages, such as spines and 
pedicellariae. These two types of appendages are mainly involved in passive and active 
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defense in starfish (Dubois and Ameye, 2001) and ArPPLNP1-drived peptides may be 
involved in regulation of the activity of these appendages. 
3.4.1.4 Interossicular muscles 
One of the most striking features of ArPPLN1b-ir in A. rubens is the presence of 
immunoreactive nerve fibres associated with interossicular muscles. The starfish 
endoskeleton comprises calcite ossicles that are interlinked by both collagenous 
ligaments and interossicular muscles (Blowes et al., 2017) and changes in body posture 
are mediated by changes in the contractile state of the muscles that connect adjacent 
ossicles. Importantly, this is the first study to report the presence of neuropeptide-
expressing nerve fibres in the inter-ossicular muscles of starfish. Consistent with the 
presence of ArPPLN1b-ir in nerve processes in the inter-ossicular muscles, ArPPLN1b-
ir is also present in the lateral motor nerves (see above). 
As ArPPLN1b (ArSMP) causes relaxation of muscle associated with the apical 
muscle, tube feet and cardiac stomach, it seems likely that ArPPLNP1-derived 
neuropeptides also act to cause relaxation of the inter-ossicular muscles. Experimental 
studies specifically designed to investigate the effect of ArPPLNP1-derived 
neuropeptides on inter-ossicular muscles are now required to address this hypothesis.  
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4 Identification, localization and functional characterization of 
neuropeptides derived from pedal peptide-like neuropeptide precursor 
2 in the starfish Asterias rubens 
4.1 Introduction 
In chapter 3, a detailed analysis of the anatomy of ArPPLNP1 expression in A. 
rubens using mRNA in situ hybridization and immunohistochemistry was reported. 
Consistent with qPCR data from P. pectinifera (Kim et al., 2016), a widespread pattern 
of expression of ArPPLNP1 and the neuropeptides derived from this precursor was 
revealed in A. rubens. Thus, cells expressing ArPPLNP1 transcripts were detected, for 
example, in the radial nerve cords, circumoral nerve ring, esophagus, cardiac stomach, 
pyloric stomach, pyloric caeca, tube feet and body wall. Immunohistochemical analysis 
using antibodies to one of the neuropeptides derived from ArPPLNP1 (ArPPLN1b) 
revealed a pattern of immunostained cells consistent with data obtained using mRNA in 
situ hybridization. Furthermore, immunohistochemistry revealed extensive networks of 
immunostained processes in the radial nerve cords, circumoral nerve ring, digestive 
system, tube feet, coelomic lining, apical muscle and body wall. One of the most 
striking features of the immunostaining was the presence of labeled processes in close 
association with interossicular muscles that link the calcite ossicles of the endoskeleton. 
Consistent with this pattern of expression, intense immunostaining was also observed in 
the lateral motor nerves, components of the starfish nervous system that were first 
described based on analysis of histochemical staining (Smith, 1937). Investigation of 
the in vitro pharmacological effects of ArPPLN1b (ArSMP) revealed that it causes 
dose-dependent relaxation of three preparations from A. rubens - apical muscle, tube 
feet and cardiac stomach, consistent with previous findings from P. pectinifera (Kim et 
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al., 2016). Thus, collectively the data obtained from experimental studies on 
SMP/PPLN1-type neuropeptides in P. pectinifera and A. rubens indicate that a 
physiological role of these peptides is to act as inhibitory neuromuscular transmitters in 
starfish. 
A partial sequence of a second A. rubens PP/OK-type precursor, now referred to 
as ArPPLNP2, has been reported, which comprises a 31-residue N-terminal signal 
peptide and seven putative neuropeptides bounded by dibasic cleavage sites ((Semmens 
et al., 2016; GenBank: KT601720). A putative peptide (SAFSGSRGLTNLASGFN) 
derived from this partial ArPPLNP2 shares sequence similarity with other PP/OK-type 
peptide representatives in lophotrochozoans (e.g. Capitella, Lottia) and orcokinin-type 
peptides in arthropods (e.g. Drosophila). 
4.1.1 Aims and objectives 
Nothing is known about the expression pattern or actions of neuropeptides 
derived from the second PP/OK-type neuropeptide precursor in A. rubens - ArPPLNP2. 
Therefore, the objective of the experimental work reported in this chapter was to 
address this issue. Firstly, a cDNA encoding the full length amino acid sequence of 
ArPPLNP2 was cloned and sequenced. Secondly, mass spectrometry was used to 
determine the structures of neuropeptides derived from ArPPLN2 by analyzing A. 
rubens radial nerve cord extracts. Thirdly, mRNA in situ hybridization was used to map 
the expression of ArPPLNP2 transcripts in A. rubens. Fourthly, an antiserum to one of 
the peptides derived from ArPPLNP2 (ArPPLN2h) was generated and characterized 
using an enzyme-linked immunosorbent assay (ELISA). Fifthly, immunohistochemistry 
was used to map the expression of ArPPLN2h in A. rubens. Lastly, in vitro 
pharmacology was used to investigate the effects of ArPPLN2h on the three 
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preparations from A. rubens – apical muscle, tube foot and cardiac stomach. The 
findings of this study provide new insights into the physiology of PP/OK-type 
neuropeptide signaling in the phylum Echinodermata.  
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4.2 Methods  
4.2.1 Animals 
Starfish (A. rubens) with a diameter > 4 cm were collected at low tide from the 
Thanet coast (Kent, UK) or were obtained from a fisherman based at Whitstable (Kent, 
UK). These animals were maintained in a circulating seawater aquarium at ~12 oC in 
the School of Biological and Chemical Sciences at Queen Mary University of London 
and were fed on mussels (Mytilus edulis). Smaller juvenile specimens of A. rubens 
(diameter 0.5 - 1.5 cm) were collected at the University of Gothenberg Sven Lovén 
Centre for Marine Infrastructure (Kristenberg, Sweden) and fixed in Bouin’s solution. 
4.2.2 cDNA cloning and sequence analysis 
Analysis of A. rubens radial nerve cord transcriptome sequence data has enabled 
identification of a contig encoding the partial sequence (325 residues) of pedal peptide-
like neuropeptide precursor 2 (ArPPLNP2), which comprises a 31-residue N-terminal 
signal peptide and seven putative neuropeptides bounded by dibasic cleavage sites 
(Semmens et al., 2016; GenBank Accession number KT601720). To facilitate cloning 
and sequencing of the complete open reading frame of ArPPLNP2, ovarian 
transcriptome sequence data obtained from other starfish species was analysed [(Reich 
et al., 2015); http://www.echinobase.org/Echinobase/Blasts] and a contig 
(GAUS01023767.1) comprising the 3’ region of PPLNP2 was identified in Asterias 
forbesi. Combining the partial PPLNP2 transcript sequences from A. rubens and A. 
forbesi, forward and reverse primers (5’-GAGACATCGAGGGTGGTTTTG-3’, 5’-
GGCCCGGCCTAAGAATCAT-3’) were designed to enable PCR amplification of a 
full-length ArPPLNP2 cDNA from A. rubens. 
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The methods used for RNA extraction, cloning and sequencing were as 
described previously in chapter 2, but with minor modifications. Zero Blunt TOPO PCR 
cloning kit (Invitrogen, Carlsbad, CA, USA) was used to ligate the PCR product into 
the pCR-Blunt II with TOPO vector for sequencing of a ArPPLNP2 cDNA comprising 
the entire ORF. T-easy vector (Promega) was employed for cloning a cDNA comprising 
a partial ORF of ArPPLNP2, using the following primers: 5’-
CTATTCTGTCTGGCTCTT-3’ (forward) and 5’- GACAGCTTCTTCTCTCTTA-3’ 
(reverse). 
4.2.3 Mass spectrometry 
The structures of neuropeptides derived from ArPPLNP2 were determined by 
MS/MS analysis of A. rubens radial nerve cords extracted in 90% methanol/9% acetic 
acid, as described previously in chapter 2. The pH of the extracts was adjusted using 
ammonium bicarbonate and then the extracts were reduced with dithiothreitol (DTT) 
and alkylated using iodoacetamide, but the extracts were not treated with trypsin or any 
other proteolytic enzyme. Samples of the extract were analysed using nanoLC-ESI-
MS/MS using an Orbitrap Fusion (ThermoScientific) and data analysis was performed 
as described in chapter 2, except that more recent versions of Mascot (Matrix Science, 
London, UK; version 2.5.0) and Scaffold (version Scaffold_4.5.3, Proteome Software 
Inc., Portland, OR) were used to annotate the spectra presented in the results section. 
Mascot was searched with a fragment ion mass tolerance of 0.050 Da and a parent ion 
tolerance of 10.0 PPM. Conversion of Gln- to pyro-Glu at the N-terminus, amidation of 
the C-terminus, oxidation of methionine and carbamidomethyl of cysteine were 
specified in Mascot as variable modifications. 
4.2.4 Localization of ArPPLNP2 using mRNA in situ hybridization 
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A cDNA comprising a partial ORF of ArPPLNP2 was used as a template for 
synthesis of probes for mRNA in situ hybridization. The methods employed for i) 
production of anti-sense and sense DIG-labeled RNA probes, ii) preparation of sections 
of fixed specimens (diameter 4 - 6 cm) of A. rubens and iii) visualization of ArPPLNP2 
transcripts in sections of A. rubens were the same as reported in chapter 2. 
4.2.5 Localization of ArPPLNP2-derived neuropeptides using 
immunohistochemistry 
4.2.5.1 Production and characterization of rabbit antisera to ArPPLNP2-derived 
neuropeptides 
The peptide ArPPLN2h (GRTSLSGSSGLTHLSSGFH) was selected as 
representative target antigen for production of rabbit antibodies to ArPPLN2-derived 
neuropeptides. A peptide comprising the C-terminal octapeptide of ArPPLN2h but with 
the addition of N-terminal lysine and tyrosine residues (KYTHLSSGFH) was designed 
as an antigen (ag) peptide (ArPPLN2h-ag) and synthesized by Peptide Protein Research 
Ltd. (Hampshire, UK). The inclusion of a lysine residue was to enable glutaraldehyde-
mediated coupling to a carrier protein (thyroglobulin) and the inclusion of a tyrosine 
was to enable production of a 125-iodine-labelled peptide so that the antibodies could 
be used for radioimmunoassay, if required. Rabbit immunization with the ArPPLN2h-
ag - thyroglobulin conjugate and serum collection was performed by Charles River Labs 
(Margate, UK), as described previously for ArPPLN1b (chapter 3). 
To assess production of antibodies during the immunization protocol and 
following collection of a terminal bleed, antisera were tested for antibodies to 
ArPPLN2h-ag using Enzyme-Linked ImmunoSorbent Assays (ELISA), employing the 
same methods as described previously for ArPPLN1b (chapter 3). 
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4.2.5.2 Tissue fixation, sectioning and immunostaining 
The methods employed for i) preparation of sections of fixed specimens 
(diameter 4 - 6 cm) of A. rubens, ii) visualization of ArPPLN2h expression in sections 
of A. rubens using immunohistochemistry (including pre-absorption tests) and iii) 
photography of immunostained sections and preparation of montages were the same as 
those reported for ArPPLN1b in chapter 3. 
4.2.6 In vitro and in vivo bioassay and pharmacology 
Consistent with the selection of ArPPLN2h (GRTSLSGSSGLTHLSSGFH) as a 
representative neuropeptide for generation of antibodies (see above), ArPPLN2h was 
also selected as a representative ArPPLNP2-derived peptide for in vitro and in vivo 
pharmacological experiments. ArPPLN2h was synthesized by Peptide Protein Research 
Ltd. (Hampshire, UK) and was tested on in vitro preparations of the cardiac stomach, 
apical muscle and tube foot from A. rubens, using the same methods reported previously 
for ArPPLNP1b (chapter 3). The SALMFamide neuropeptide S2 (SGPYSFNSGLTF-
NH2), which is a known relaxant of the cardiac stomach, apical muscle and tube feet in 
A. rubens (Melarange et al., 1999; Melarange and Elphick, 2003), was tested in parallel 
with ArPPLN2h both as a positive control and to enable comparative analysis of 
potency/efficacy. A previous study demonstrated that S2 causes eversion of the cardiac 
stomach in A. rubens when injected in vivo (Melarange et al., 1999). Therefore, here the 
effect of in vivo injection of ArPPLN2h in A. rubens was investigated by intracoelomic 
injection of starfish (n = 10) with 100 µl of 1 mM ArPPLN2h.  
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4.3 Results 
4.3.1 Cloning and sequencing of a cDNA encoding ArPPLNP2 
A cDNA encoding ArPPLNP2 was cloned and sequenced (GenBank accession 
number KT601720), as illustrated in Figure 4.1. The ArPPLNP2 transcript is a 1761-
base cDNA comprising an opening reading frame of 1692-bases and a 69-base 5’ 
untranslated region (Figure 4.1). The ArPPLNP2 ORF encodes a 563 amino acid 
residue protein comprising a 31-residue signal peptide and 13 copies of predicted 
PP/OK-type peptides, which are named ArPPLN2a-k according to their position in the 
precursor protein. Thus, there are three copies of ArPPLN2h 
(GRTSLSGSSGLTHLSSGFH) and one copy of each of the following: 
GRTNMYGSSQLSRLSSGFN (ArPPLN2a), GRSSFAGSSRLTNLGSGFT 
(ArPPLN2b), GRSSFTGSSRLTNLASGFN (ArPPLN2c), 
GRSAFSGSRGLTNLASGFN (ArPPLN2d), GRSSFAGVSGLTHLGSGFN 
(ArPPLN2e), GRSAFSGSKGLTNLASGFN (ArPPLN2f), 
GRTSLSGSGGLTNLSSGFH (ArPPLN2g), GRSSFSGSNGLTNLGSGFH (ArPPLN2i) 
GRTSLSGSSGLTHLGSGFH (ArPPLN2j), GRSHFTGSSRLTNLNSGFN (ArPPLN2k) 
(Figure 4.1, 4.2a). As illustrated in Figure 4.2a, all the peptides have the conserved 
motifs GRT/S and LTH/NLxSGFH/N located N-terminally and C-terminally, 
respectively. Furthermore, comparison of ArPPLN2h, as a representative peptide, with 
other PP/OK-type peptides revealed sequence conservation at several positions, but 
most notably three hydrophobic residues: Leu5 located in the N-terminal region and 
Leu14 and Phe18 located in the C-terminal region. 
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Figure 4.1 A. rubens pedal peptide-like neuropeptide precursor 2 (ArPPLNP2).  
The nucleotide sequence (lowercase, 1761 bases) of a cloned cDNA encoding 
ArPPLNP2 (uppercase, 563 amino acid residues) is shown. The predicted signal peptide 
is shown in blue, thirteen putative neuropeptides derived from the precursor protein are 
shown in red and putative dibasic cleavage sites are shown in green. The asterisk shows 
the position of the stop codon. The nucleotide sequences used for primer design are 
highlighted in red within red boxes. Nucleotides and amino acids that differ from the 
previously reported partial contig assembled from transcriptome sequence data 
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(Semmens et al., 2016) are highlighted in grey. The ArPPLNP2 cDNA sequence has 
been deposited under GenBank accession number KT601720. 
 
Figure 4.2 Alignment of predicted neuropeptides derived from ArPPLNP2 (a) and 
alignment of ArPPLN2h as a representative ArPPLNP2-derived peptide with PP/OK-
type peptides in other species (b). 
(a) Three copies of ArPPLN2h occur in ArPPLNP2, whereas all the other peptides 
occur singly (see Figure 4.1). Therefore, the alignment compares the sequences of the 
single-copy peptides with the sequence of ArPPLN2h. All of the predicted peptides 
derived from ArPPLNP2 comprise nineteen residues. Residues that are identical to the 
corresponding residue in ArPPLN2h are shown with a black dot. Eight of the residues 
in ArPPLN2h are conserved in the ten other peptides (highlighted in yellow). (b) 
Manual alignment of ArPPLN2h with ArPPLN1b and with PP/OK-type peptides from 
other species. Hydrophobic residues (Phe, Leu or Met) are conserved at three positions 
(highlighted in yellow), one located in the N-terminal region and two located in the C-
terminal region. Other residues that are conserved between peptides from at least one 
deuterostome (echinoderm) species and at least one protostome species are highlighted 
in grey. Citations and/or accession numbers for the peptide sequences included here are 
as follows: ArPPLN2h (this paper; KT601720); ArPPLN1b (Kim et al., 2016; Chapter 3; 
KT870153); PpeSMPa (Kim et al. 2016; KT870152); SpPPLN1d (Rowe and Elphick, 
2012; XP_785647); SpPPLN2h (Rowe and Elphick, 2012; XP_003727926); AjPPLN2a 
(Rowe et al., 2014; Isotig 17873); PP1-peptide (Lloyd and Connolly, 1989; Moroz et al., 
2006; NP_001191585); PP3-peptide (Moroz et al., 2006; NP_001191625); NLP14-
peptide (NP_001257067); NLP15-peptide (T20275); orcokinin (Stangier et al., 1992; 
P37086). 
4.3.2 Mass spectrometric detection of ArPPLNP2-drived neuropeptides in A. 
rubens radial nerve cords extract 
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Ten of the eleven predicted peptides derived from ArPPLNP2 (Figure 4.3, 4.4) 
were detected by MS/MS in an acidified methanol extract of radial nerve cord that was 
subject to reduction and alkylation but without additional protease (trypsin) treatment. 
ArPPLN2a (GRTNMYGSSQLSRLSSGFN, 688.00 m/z, 3+ ions, Figure 4.3b), 
ArPPLN2b (GRSSFAGSSRLTNLGSGFT, 634.65 m/z, 3+ ion, Figure 4.3c), 
ArPPLN2d (GRSAFSGSRGLTNLASGFN, 633.65 m/z, 3+ ion, Figure 4.3d), 
ArPPLN2e (GRSSFAGVSGLTHLGSGFN, 617.64 m/z, 3+ ions, Figure 4.3e), 
ArPPLN2f (GRSAFSGSKGLTNLASGFN, 624.32 m/z, 3+ ions, Figure 4.3f), 
ArPPLN2g-partial (GRTSLSGSGGLT, observed at 546.78 m/z, 2+ ion, Figure 4.4a), 
ArPPLN2h (GRTSLSGSSGLTHLSSGFH, 629.98 m/z, 3+ ions, Figure 4.4b), 
ArPPLN2i (GRSSFSGSNGLTNLGSGFH, 627.97 m/z, 3+ ions, Figure 4.4c), 
ArPPLN2j (GRTSLSGSSGLTHLGSGFH, 619.98 m/z, 3+ ions, Figure 4.4d), 
ArPPLN2k (GRSHFTGSSRLTNLNSGFN, observed at 513.76 m/z, 4+ ion, Figure 4.4e) 
were detected in the radial nerve extract. ArPPLN2a, e, f, h, i, j were detected with high 




Figure 4.3 Mass spectrometric identification of ArPPLN2 peptides in an extract of A. 
rubens radial nerve cords.  
(a) Sequence of ArPPLNP2 with the predicted signal peptide marked in blue, predicted 
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cleavage sites marked in green, and peptides ArPPLN2 a to k marked in red. (b - f) 
annotated MS/MS spectra for ArPPLN2a, b, d, e, f, respectively. The b series of peptide 
fragment ions are shown in red, the y series in blue and additional identified peptide 
fragment ions in green. The amino acid sequence identified in the mass spectrum is 
highlighted at the top of the figures. (b) MS/MS spectrum for the ArPPLN2a peptide, 
GRTNMYGSSQLSRLSSGFN, observed at 688.00 m/z, 3+ ion, with precursor mass 
error 1.1 ppm (Mascot score 31.30). (c) MS/MS spectrum for the ArPPLN2b peptide, 
GRSSFAGSSRLTNLGSGFT, observed at 634.65 m/z, 3+ ion, with precursor mass 
error -0.065 ppm (Mascot score 24.54). (d) MS/MS spectrum for the ArPPLN2d peptide, 
GRSAFSGSRGLTNLASGFN, observed at 633.65 m/z, 3+ ion, with precursor mass 
error 0.94 ppm (Mascot score 31.76). (e) MS/MS spectrum for the ArPPLN2e peptide, 
GRSSFAGVSGLTHLGSGFN, observed at 617.64 m/z, 3+ ion, with precursor mass 
error 0.0092 ppm (Mascot score 38.01). (f) MS/MS spectrum for the ArPPLN2f peptide, 
GRSAFSGSKGLTNLASGFN, observed at 624.32 m/z, 3+ ion, with precursor mass 
error 0.13 ppm (Mascot score 64.86). 
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Figure 4.4 Mass spectrometric identification of ArPPLN2 peptides in an extract of A. 
rubens radial nerve cords.  
(a - e) annotated MS/MS spectra for ArPPLN2g-partial, h, i, j, k, respectively. The b 
series of peptide fragment ions are shown in red, the y series in blue and additional 
identified peptide fragment ions in green. The amino acid sequence identified in the 
mass spectrum is highlighted at the top of the figures. (a) MS/MS spectrum for the 
ArPPLN2g-partial peptide, GRTSLSGSGGLT, observed at 546.78 m/z, 2+ ion, with 
 174 
precursor mass error -2.1 ppm (Mascot score 31.77). (b) MS/MS spectrum for the 
ArPPLN2h peptide, GRTSLSGSSGLTHLSSGFH, observed at 629.98 m/z, 3+ ion, with 
precursor mass error 0.41 ppm (Mascot score 67.8). (c) MS/MS spectrum for the 
ArPPLN2i peptide, GRSSFSGSNGLTNLGSGFH, observed at 627.97 m/z, 3+ ion, with 
precursor mass error 1.1 ppm (Mascot score 65.62). (d) MS/MS spectrum for the 
ArPPLN2j peptide, GRTSLSGSSGLTHLGSGFH, observed at 619.98 m/z, 3+ ion, with 
precursor mass error 0.55 ppm (Mascot score 67.47). (e) MS/MS spectrum for the 
ArPPLN2k peptide, GRSHFTGSSRLTNLNSGFN, observed at 513.76 m/z, 4+ ion, 
with precursor mass error 0.28 ppm (Mascot score 11.74). 
4.3.3 Localization of ArPPLNP2 transcripts in A. rubens using mRNA in situ 
hybridization 
Analysis of the distribution of ArPPLNP2 transcripts in A. rubens revealed a 
widespread pattern of expression, including stained cells in the radial nerve cords and 
circumoral nerve ring (Figure 4.5, 4.6), tube feet (Figure 4.7), terminal tentacle (Figure 
4.8) and digestive system (Figure 4.9, 4.10). 
 In longitudinal sections of the radial nerve cords, stained cells can be seen as 
clusters in the hyponeural region (Figure 4.5a, b), whilst in the ectoneural region stained 
cells were observed quite sparsely along the length of the epithelial layer (Figure 4.5a, 
c). The specificity of the staining observed with anti-sense probes (Figure 4.5a) was 
demonstrated by control experiments where no staining was observed with sense probes 
(Figure 4.5a inset). Transverse sections of the radial nerve also revealed the clustered 
arrangement of hyponeural cell bodies expressing ArPPLNP2, with more stained cells 
present in some sections (Figure 4.5d, e) than others (Figure 4.5f). Transverse sections 
of radial nerve cords also revealed that stained cells in the ectoneural epithelium are 
more concentrated in the lateral regions of the radial nerve cords (Figure 4.5d, f), and 
extend into the epithelium of adjacent tube feet (Figure 4.5f, g). 
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Figure 4.5 Localization of ArPPLNP2 mRNA in the radial nerve cord of A. rubens 
using in situ hybridization.  
(a) Longitudinal parasagittal section of the radial nerve cords incubated with antisense 
probes showing groups of cells interspersed along the length of the nerve cord in the 
hyponeural (rectangle and arrows) and ectoneural regions (rectangle and arrowheads). 
Higher magnification images of the boxed regions are shown in (b) and (c). The inset of 
panel (a) shows the absence of staining in a longitudinal parasagittal section of radial 
nerve cord incubated with sense probes, demonstrating the specificity of staining 
observed with antisense probes. (b) High magnification image showing stained cells in 
the hyponeural region of the radial nerve cord. (c) High magnification image showing 
stained cells in the ectoneural region of the radial nerve cord. (d) Transverse section of 
radial nerve cord incubated with antisense probes showing groups of cells in the 
hyponeural (rectangle and arrow) and ectoneural regions (arrowheads). (e) High 
magnification view of hyponeural region highlighted by rectangle in panel (d). (f) 
Transverse section of radial nerve cord incubated with antisense probes showing groups 
of cells in the ectoneural regions (rectangle and arrowheads). (g) High magnification 
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view of ectoneural region highlighted by rectangle in panel (f). Ec, ectoneural region of 
radial nerve cord; Hy, hyponeural region of radial nerve cord; RHS, radial hemal strand; 
RNC, radial nerve cord; TF, tube foot. Scale bars: 50 µm in (a), (a) inset, (d), (f); 10 µm 
in (b), (c), (e), (g). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
Transverse sections of the circumoral nerve ring revealed that stained cells are 
largely concentrated in the outer and inner regions of the ectoneural epithelium, 
proximal to peri-oral tube feet and the peristomial membrane, respectively (Figure 4.6a, 
b, c). Stained cells are also present in the hyponeural region of the circumoral nerve ring 
(Figure 4.6c), but because this tissue is sometimes damaged or lost during tissue 
processing the stained hyponeural cells are not always seen (Figure 4.6a). 
 
Figure 4.6 Localization of ArPPLNP2 mRNA in the circumoral nerve ring of A. rubens 
using in situ hybridization.  
(a) Transverse section of circumoral nerve ring showing stained cells in the epithelium 
of ectoneural region (arrowheads). A higher magnification image of the boxed region is 
shown in (b). Note that in this section no hyponeural staining is evident because the 
hyponeural tissue is damaged (arrow). (b) High magnification image of stained cells in 
the epithelial layer of the ectoneural region of the circumoral nerve ring. (c) Transverse 
section of circumoral nerve ring incubated with antisense probes showing stained cells 
in the ectoneural region and in the hyponeural region, which has become detached from 
the larger during tissue processing (arrowheads). A higher magnification image of the 
boxed region is shown in (d).  (d) High magnification image of stained cells in a 
detached hyponeural region of the cirumoral nerve ring. CONR, circumoral nerve ring; 
Ec, ectoneural region of radial nerve cord; Hy, hyponeural region of radial nerve cord; 
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Os, ossicle; TF, tube foot. Scale bars: 50 µm in (a), (c); 10 µm in (b), (d). Refer to 
Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
In tube feet, stained cells were observed in a sub-epithelial position at the base 
of tube feet proximal to radial nerve cord (Figure 4.5g, 4.7a, 4.7b) or circumoral nerve 
ring (Figure 4.6a, c) or between adjacent tube feet (Figure 4.7a). Stained cells are also in 
the tube foot sucker, closely associated with the basal nerve ring (Figure 4.7d). In the 
tube foot-like terminal tentacles stained cells were observed in or below the external 
epithelial layer of the terminal tentacles (Figure 4.8a, c, d, f) and in the body wall 
epithelium that surrounds the terminal tentacle (Figure 4.8a, b, d, e). Stained cells were 
also observed in the photoreceptor cell layer of the optic cushion, which is located at the 
base of each terminal tentacle. 
 
Figure 4.7 Localization of ArPPLNP2 mRNA in tube feet of A. rubens using in situ 
hybridization. 
(a, b) Longitudinal section of a tube foot showing stained cells (rectangle) in the sub-
epithelial layer of the tube foot stem near to the junction with the adjacent radial nerve 
cord. The boxed region in panel (a) is shown at higher magnification in (b). (c) Stained 
cells located in the sub-epithelial layer at the junction between adjacent tube feet.  (d) 
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Stained cells located near to the tube foot basal nerve ring. The inset of shows the 
location of the stained cells (rectangle) in a lower magnification image that shows the 
part of the tube foot stem and the sucker. BNR, basal nerve ring; CT, collagenous tissue 
tissue; Ep, epithelium; ML, muscle layer; RNC, radial nerve cord; Su, sucker; TF, tube 
foot. Scale bars: 100 µm in (a), (d) inset; 10 µm in (b), (d); 20 µm in (c). Refer to Figure 
1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
 
Figure 4.8 Localization of ArPPLNP2 mRNA in the arm tip region of A. rubens using 
in situ hybridization.  
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(a) Transverse section of a paraffin wax embedded arm tip showing the terminal 
tentacle cut obliquely. Stained cells can be seen in the external epithelial layer of the 
terminal tentacle (arrowheads) and in the body wall epithelium (arrow) that surrounds 
the terminal tentacle. The boxed regions are shown at higher magnification in panels (b) 
and (c). (d) Transverse cryostat section of an arm tip showing the pigmented optic 
cushion and terminal tentacle. Stained cells can be seen in the terminal tentacle external 
epithelium (rectangle with arrowhead) and in the body wall epithelium (rectangle with 
arrow). The boxed areas in (d) are shown at higher magnification in (e) and (f). (g) High 
magnification image of in the photoreceptor cell layer of an optic cushion showing a 
stained cell (white arrowhead) between pigmented cells. CuL, cuticle layer; Ep, 
epithelium; OC, optic cushion; Sp, spine; TT, terminal tentacle. Scale bars: 50 µm in (a), 
(d); 10 µm in (b), (c), (e), (f), (g). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for 
details of starfish anatomy. 
In the digestive system, ArPPLNP2 mRNA expression was detected in cardiac 
stomach (Figure 4.9a), pyloric stomach (Figure 4.9b), pyloric duct (Figure 4.9c, d), 
pyloric caeca (Figure 4.9e, f). In all of these regions of the digestive system the stained 
cells appear to be largely located in the the coelomic epithelium (Figure 4.9a-d), which 
is closely associated with an underlying visceral muscle layer. In the pyloric ducts and 
in diverticula of the pyloric caeca the stained cells are concentrated on the oral 
(lowermost) side (Figure 4.9e, f). 
 180 
 
Figure 4.9 Localization of ArPPLNP2 mRNA in the digestive system of A. rubens 
using in situ hybridization. 
(a) Section of a cardiac stomach showing stained cells (arrowheads) in the coelomic 
epithelium. (b) Section of pyloric stomach showing stained cells in the coelomic 
epithelium. (c, d) Transverse section of a pyloric duct showing stained cells (rectangle 
and arrowheads) in the coelomic epithelium. The boxed region in (c) is shown at higher 
magnification in panel (d). (e, f) Transverse section of a pyloric caecum diverticulum 
showing stained cells (rectangle and arrowheads) in the coelomic epithelium layer. The 
boxed region in (e) is shown at higher magnification in panel (f). CE, coelomic 
 181 
epithelium; CT, collagenous tissue; Lu, lumen; Mu, mucosa. Scale bars: 20 µm in (a), 
(b); 50 µm in (c); 10 µm in (d), (f); 100 µm in (e). Refer to Figure 1.7 (page 38) and 1.8 
(page 39) for details of starfish anatomy. 
The cardiac stomach is attached to the ambulacrum in each of the five arms of A. 
rubens by extrinsic retractor strands. The paired extrinsic retractor strands coalesce to 
form a nodule that connects the extrinsic retractor strands with the intrinsic retractor 
strands located within the wall of the cardiac stomach (Anderson, 1954). Large numbers 
of ArPPLNP2-expressing cells were observed in the coelomic lining of the nodule and 
in mesenteries that link the extrinsic retractor strands with ambulacral ossicles (Figure 
4.10a, b, c). 
 
Figure 4.10 Localization of ArPPLNP2 mRNA in cardiac stomach extrinsic retractor 
strand nodule of A. rubens using in situ hybridization. 
(a) Transverse section of an arm showing stained cells (rectangles and arrowheads) in 
the coelomic epithelium of a cardiac stomach extrinsic retractor strand nodule and in 
mesenteries that attach the extrinsic retractor strands to the ambulacral ossicles. The 
boxed regions in (a) are shown at higher magnification in (b) and (c). In (b) stained cells 
can be seen in the coelomic epithelium of a mesentery (arrowheads) and in the coelomic 
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epithelium of a nodule. AMO, ambulacral ossicle; Me, mesentery; No, nodule. Scale 
bars: 100 µm in (a); 20 µm in (b), (c). Refer to Figure 1.7 (page 38) and 1.8 (page 39) 
for details of starfish anatomy. 
4.3.4 Localization of ArPPLN2h using immunohistochemistry 
4.3.4.1 Characterisation of a rabbit antiserum to ArPPLN2h using ELISA 
To assess the presence and titre of antibodies to the ArPPLN2h-ag peptide in 
rabbit sera, antiserum and pre-immune serum were incubated at a range of dilutions (10-
3 - 10-8) with a fixed amount of the antigen peptide added to each well of the microtitre 
plate (10-10 moles). As expected, no ArPPLN2h-ag immunoreactivity was detected with 
pre-immune serum but ArPPLN2h-ag immunoreactivity was detected with antiserum at 
dilutions ranging from 10-3 to 10-6. Furthermore, to assess the specificity of the 
antiserum it was also tested in the same way with a peptide (ArPPLN1b) derived from 
ArPPLNP1 and, importantly, no immunoreactivity was observed (Figure 4.11a). 
To assess the sensitivity of the antiserum for detection of the ArPPLN2h-ag 
peptide, the antiserum (diluted to10-4) was incubated with different amounts of peptide 
ranging from 10-10 to 10-15 moles. At this antiserum dilution, the ArPPLN2h-ag peptide 
was detected in the range from 10-10 to 10-12 moles, whereas the pre-immune serum 
exhibited no reactivity with ArPPLN2h and the antiserum exhibited no reactivity with 
ArPPLN1b antigen peptide (Figure 4.11b). Collectively, these data indicate that the 
antiserum contains a high titre of specific antibodies to the ArPPLN2h-ag peptide. 
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Figure 4.11 Characterization of rabbit antiserum to ArPPLN2h using an enzyme-linked 
immunosorbent assay (ELISA).  
(a) Incubation of antiserum at dilutions between 10-3 and 10-8 with 0.1 nmol of the 
antigen peptide ArPPLN2-ag (green) reveals antigen detection at well above the 
background optical density (OD) with dilutions from 10-3 to 10-5, whereas no 
immunoreaction is observed with pre-immune serum (blue). When the ArPPLLN2h-
antiserum was tested with a ArPPLN1-ag peptide (also 0.1 nmol per well) there was no 
immunoreaction (red), demonstrating that ArPPLLN2h-antiserum does not cross-react 
with ArPPLN1-type peptides. (b) Incubation of antiserum (green) and pre-immune 
serum (blue) at 10-4 dilution with between 10-15 and 10-10 moles of the ArPPLN2-ag 
peptide per well reveals no immunoreaction with pre-immune serum, whereas with the 
antiserum the antigen is detected at well above the background OD with 10-12 to 10-10 
moles per well. When the antiserum is tested in the same way with a ArPPLN1-ag 
peptide there is no immunoreaction, again demonstrating the specificity of the 
antiserum for ArPPLN-type neuropeptides. All data points are mean values from two 
separate experiments performed in duplicate. 
4.3.4.2 Immunohistochemical localization of neuropeptides derived from 
ArPPLNP2 in A. rubens 
Antiserum to the C-terminal region of ArPPLN2h (KYTHLSSGFH) was used 
for immunohistochemical analysis of ArPPLN2-type neuropeptide expression in A. 
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rubens.  It is noteworthy, however, that the ArPPLN2h antigen peptide used for 
antibody production shares a high level of sequence similarity with other peptides 
derived from ArPPLNP2, in particular ArPPLN2g, ArPPLN2i and ArPPLN2j (Figure 
4.2a). Therefore, it is likely that when the antiserum is used for immunohistochemistry 
it labels not only ArPPLN2h, as demonstrated by ELISA (Figure 4.11), but also other 
peptides derived from ArPPLNP2. 
4.3.4.2.1 Radial nerve cords, circumoral nerve ring, marginal nerve cords 
and lateral motor nerves 
The ArPPLN2h antiserum revealed extensive immunostaining in the radial nerve 
cords, in both the ectoneural and hyponeural regions (Figure 4.12a). Importantly, the 
specificity of this immunostaining was demonstrated in pre-absorption experiments, 
where pre-incubation of the antiserum with the ArPPLN2h antigen peptide resulted in a 
complete loss of immunostaining in the radial nerve cords (Figure 4.12a inset). 
Immunostained bipolar shaped cells were observed throughout the ectoneural 
epithelium of the radial nerve cords, with the cells having a process projecting toward 
the cuticular surface and another process projecting into the underlying densely stained 
neuropile (Figure 4.12b). In the hyponeural region monopolar shaped cells were 
observed with a single process projecting into an underlying fiber plexus. (Figure 4.12c). 
Nerve processes derived from the hyponeural region of the radial nerve cords could also 
be seen to project around the wall of the peri-hemal coelom to innervate the transverse 
infra-ambulacral muscle (Figure 4.12d), whilst immunostained fibers in the ectoneural 




Figure 4.12 Localization of ArPPLN2h-immunoreactivity (ArPPLN2h-ir) in the radial 
nerve cord of A. rubens.  
(a) Transverse section of a radial nerve cord showing ArPPLN2h-ir in both the 
ectoneural and hyponeural regions. The inset of (a) shows absence of immunostaining 
in a radial nerve cord section incubated with ArPPLN1b antiserum pre-absorbed with 
the antigen peptide (ArPPLN2h-ag), demonstrating the specificity of immunostaining 
observed with the ArPPLN2 antiserum. (b) High magnification image of the ectoneural 
region of the radial nerve cord showing immunostained bipolar shaped cells in the sub-
cuticular epithelium (arrowheads) and densely packed immunostained processes 
(asterisks) in the underlying neuropile region. (c) High magnification image showing 
immunostained monopolar shaped cells (arrowhead) and their stained processes (arrow) 
in hyponeural region of the radial nerve cord. Densely packed immunostained processes 
(asterisks) in the ectoneural region. The unstained collagenous tissue layer (white 
arrowhead) that separates the hyponeural region from the densely stained ectoneural 
neuropile can also be seen here. (d) High magnification images showing 
immunostaining at the junction between the radial nerve cord and an adjacent tube foot. 
The continuity of immunostaining in the ectoneural region of the radial nerve and in the 
basiepithelial nerve plexus of the tube foot (asterisks) can be seen here. The stained 
process(es) (arrowhead) of a hyponeural neuron(s) can be seen projecting over the roof 
of the perihemal canal in close association with the transverse infra-ambulacral muscle. 
CuL, cuticle layer; Ec, ectoneural region; Hy, hyponeural region; RHS, radial hemal 
strand; TF, tube foot. Scale bars: 50 µm in (a); 200 µm in (a) inset; 10 µm in (b), (c); 20 
µm in (d). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
The pattern of immunostaining in the circumoral nerve ring (Figure 4.13a) was 
consistent with that in the radial nerve cords, with bipolar shaped immunostained cells 
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located throughout the ectoneural epithelium (Figure 4.13a, b), intense immunostaining 
in the ectoneural neuropile (Figure 4.13 a, b, c) and monopolar shaped immunostained 
cells in the hyponeural region projecting into an underlying nerve plexus (Figure 4.13a, 
c). Lateral to the outer rows of tube feet in each arm are thickenings of the sub-
epidermal nerve plexus known as the marginal nerves, which have immunostained cells 
in an external epithelium and immunostained processes in an underlying neuropile 
(Figure 4.13d). Internal to the marginal nerve immunostaining was observed in the 
lateral motor nerve (Figure 4.13d). 
 
Figure 4.13 Localization of ArPPLN2h-immunoreactivity in the circumoral nerve ring 
and marginal nerve of A. rubens.  
(a) Immunostaining in a transverse section of the circumoral nerve ring; here 
immunostained processes can also be seen here in the peristomial membrane, an 
adjacent oral tube foot and in a Tiedemann’s body. High magnification images of the 
boxed regions can be seen in (b) and (c). (b) A high-magnification image of a 
circumoral nerve ring showing immunostained bipolar-shaped cells (arrowhead) in the 
sub-cuticular epithelium of the ectoneural region and intense staining (asterisks) in the 
underlying neuropile. Stained processes projecting from bipolar cells into the neuropile 
can also be seen here (white arrowhead). (c) A high-magnification image of a 
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circumoral nerve ring showing immunostained monopolar shaped cells (black 
arrowheads) in the hyponeural region with stained processes (white arrowhead) 
projecting into a fiber layer that is adjacent to the unstained collagenous tissue layer 
(arrow). The intensely stained ectoneural neuropile is labeled here with an asterisk. (d) 
Immunostaining in a sub-epithelial thickening of the basi-epithelial nerve plexus known 
as the marginal nerve (arrow), which is located at the junction between the outer row of 
tube feet and the adjacent body wall. Internal to the marginal nerve, separated by a thin 
layer of collagenous tissue, can be seen stained axonal processes in the lateral motor 
nerve (arrowheads). CONR, circumoral nerve ring; CuL, cuticle layer; Ec, ectoneural 
region; Hy, hyponeural region; PM, peristomial membrane; TB, Tiedemann's body; TF, 
tube foot. Scale bars: 100 µm in (a); 10 µm in (b), (c); 50 µm in (d). Refer to Figure 1.7 
(page 38) and 1.8 (page 39) for details of starfish anatomy. 
4.3.4.2.2 Hemal system and Tiedemann’s bodies 
Closely associated with the radial nerve cords and the circumoral nerve ring, is 
the hemal system comprising the radial hemal strand and the oral hemal ring. 
Immunostained processes were observed in both the radial hemal strand (Figure 4.14a) 
and the oral hemal ring (Fig 4.14b). Immunostaining was also observed in Tiedemann’s 




Figure 4.14 Localization of ArPPLN2h immunoreactivity in the hemal system and 
Tiedemann’s bodies of A. rubens.  
(a) Immunostaining (arrowheads) in the radial hemal strand, which is anatomically 
connected to the hyponeural region of the adjacent radial nerve cord. (b) Immunostained 
processes (white arrowheads) in the oral hemal ring, which is anatomically connected to 
the circumoral nerve ring (at bottom right). Immunostaining can also be seen here in the 
coelomic epithelium (white arrow). (c, d) Immunostained processs can be seen here in 
one of the ten Tiedemann’s bodies (black arrowheads), which are located aboral to the 
circumoral nerve ring in the central disk, the coelomic epithelium (white arrow) and the 
peristomial membrane (white arrowhead). The boxed region in (c) is shown at higher 
magnification in panel (d). CE, coelomic epithelium; CONR, circumoral nerve ring; Ec, 
ectoneural region; Hy, hyponeural region; OHR, oral hemal ring; Os, ossicle; RHS, 
radial hemal strand; TB, Tiedemann's body; TF, tube foot. Scale bars: 20 µm in (a), (b), 
(d); 100 µm in (c). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
4.3.4.2.3 Tube feet and terminal tentacle 
Immunostaining is present throughout the basiepithelial nerve plexus of tube 
feet stems (Figure 4.15a, b) and in the basal nerve ring located in the tube foot sucker 
(Figure 4.15a, c, d). Immunostained processes can be seen extending from the 
basiepithelial nerve plexus into epidermal folds of the tube foot stem when it is in a 
contracted state (Figure 4.15b). Immunostained processes also extend from the basal 
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nerve ring into the tube foot sucker (Figure 4.15c). Immunostained processes are also 
present beneath the coelomic epithelium of the tube foot ampulla (Figure 4.15e, f). 
 
Figure 4.15 Localization of ArPPLN2h immunoreactivity in tube feet and ampullae of 
A. rubens.  
(a) Longitudinal section of a tube foot showing immunostaining in the sub-epithelial 
nerve plexus, basal nerve ring and sucker. The boxed regions are shown at higher 
magnification in panels (b) and (c). (b) High magnification image showing 
immunostaining in the sub-epithelial nerve plexus and in processes projecting into 
epithelial folds of the contracted tube foot (arrowheads). (c) High magnification image 
showing immunostaining in the basal nerve ring and in processes projecting into the 
tube foot sucker (arrowheads). (d) Transverse section of a tube foot showing 
immunostaining in the sub-epithelial nerve plexus and basal nerve ring. (e, f) 
Immunostaining in the sub-epithelial nerve plexus of an ampulla (arrowheads). (f). High 
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magnification image showing immunostained processes (arrowhead) in the coelomic 
lining of an ampulla. Am, ampulla; BNR, basal nerve ring; CT, collagenous tissue; Ep, 
epithelium; ML, muscle layer; SNP, sub-epithelial nerve plexus; Su, sucker. Scale bars: 
100 µm in (a), (e); 20 µm in (b), (c), (d); 10 µm in (f). Refer to Figure 1.7 (page 38) and 
1.8 (page 39) for details of starfish anatomy. 
Stained cells and processes are present in the body wall epithelium and its 
underlying basiepithelial nerve plexus surrounding the terminal tentacle (Figure 4.16a, 
b). In the terminal tentacle, immunostained bipolar shaped cells are present in the 
external epithelial layer and in the underlying nerve plexus (Figure 4.16a, c). 
Immunostaining is also present in the lateral lappets of the terminal tentacle (Figure 




Figure 4.16 Localization of ArPPLN2h immunoreactivity in the terminal tentacle and 
associated structures in the arm tip of A. rubens.  
(a) Immunostaining in a transverse section of a terminal tentacle and in the surrounding 
body wall epithelium. The boxed regions are shown at higher magnification in panel (b) 
and (c). (b) A high magnification image of arm tip epithelium showing immunostained 
bipolar shaped cells in the epithelium (arrowhead) and in a dense meshwork of fibers in 
the underlying basiepithelial plexus (asterisks). (c) High magnification image of the 
terminal tentacle showing immunostained bipolar shaped cells in the epithelium 
(arrowheads) with stained processes projecting into a dense meshwork of fibers in the 
underlying basiepithelial plexus (asterisks). (d) Immunostaining in a transverse section 
at the base of the terminal tentacle. Immunostained cells and processes can be seen here 
in the body wall epithelium, the terminal tentacle and associated lateral lappets and the 
optic cushion. CuL, cuticle layer; Ep, epithelium; LL, lateral lappet; TT, terminal 
tentacle; OC, optic cushion. Scale bars: 50 µm in (a); 10 µm in (b), (c); 100 µm in (d). 
Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
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4.3.4.2.4 Digestive system 
The external epithelial layer of the peristomial membrane that surrounds the 
mouth contains immunostained cells and immunostained processes are present in the 
underlying basiepithelial nerve plexus (Figure 4.17a, b). A similar pattern of 
immunostaining is observed in the short esophagus that is located between the 
peristomial membrane and the cardiac stomach (Figure 4.17b, c, d). 
 
Figure 4.17 Localization of ArPPLN2h immunoreactivity in the peristomial membrane 
and esophagus of A. rubens.  
(a) Immunostained bipolar shaped cells can be seen here in the external epithelial layer 
of the peristomial membrane (arrowheads) and in processes located in the underlying 
basiepithelial nerve plexus. Immunostaining is also present in the coelomic epithelium, 
which is separated from the basiepithelial nerve plexus by a layer of collagenous tissue. 
(b) Transverse section of the central disk showing immunostaining in the peristomial 
membrane, the esophagus and the cardiac stomach. The intensely stained circumoral 
nerve ring can also be seen here. The boxed region is shown at higher magnification in 
panel (c). (c) High magnification image of a longitudinal section of the esophagus 
showing immunostained processes beneath the coelomic epithelium (arrowheads) in the 
basiepithelial nerve plexus beneath the epithelial layer that lines the lumen of the 
esophagus. (d) High magnification transverse section of the esophagus showing 
immunostained cells and processes in the coelomic lining (arrowheads) and dense 
immunostaining in the basiepithelial plexus beneath the lumenal epithelial lining of the 
esophagus. BNP, basiepithelial nerve plexus; CE, coelomic epithelium; CONR, 
circumoral nerve ring; CS, cardiac stomach; CT, collagenous tissue; Es, esophagus; Lu, 
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lumen; PM, peristome membrane. Scale bars: 20 µm in (a), (c), (e); 200 µm in (b); 50 
µm in (d). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
A widespread pattern of immunostaining was observed in the cardiac stomach 
(Figure 4.18a) and in the extrinsic extractor strands that link the cardiac stomach to the 
ambulacrum in each of the five arms. The paired extrinsic retractor strands coalesce to 
form a nodule that is located close to a site of insertion on the wall of the cardiac 
stomach and a dense meshwork of immunolabelled fibers can be seen in the nodule 
(Figure 4.18b). Immunostained bipolar shaped cells are present in the mucosa of the 
cardiac stomach and in the underlying basiepithelial nerve plexus (Figure 4.18c). 
Immunostained processes are also present in the visceral nerve plexus located beneath 
the coelomic epithelium of the cardiac stomach. A similar pattern of immunostaining to 
that seen in the cardiac stomach is also observed in the pyloric stomach (Figure 4.18d). 
The pyloric duct and pyloric caeca also exhibit immunostaining (Figure 4.18e), with 
stained processes in the visceral nerve plexus and immunolabelled bipolar shaped cells 
in the mucosal layer giving rise to immunoreactive fiber networks in the basiepithelial 
nerve plexus (Figure 4.18e, f). 
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Figure 4.18 Localization of ArPPLN2h immunoreactivity in the cardiac stomach, 
pyloric stomach, pyloric ducts and pyloric caeca of A. rubens.  
(a) Immunostaining in the cardiac stomach and in the nodule that links the cardiac 
stomach to extrinsic retractor strands; a high-magnification image of the boxed area is 
shown in (b). (b) Immunostained processes can be seen in the basiepithelial plexus 
beneath the coelomic lining of the nodule (arrowhead) and in the core of the nodule 
(asterisk). (c) High magnification image of a cardiac stomach showing immunostained 
cells in the mucosa (arrowhead) and immunostained processes in the basiepithelial 
nerve plexus beneath the mucosa and in the visceral nerve plexus beneath the coelomic 
epithelium. (d) High magnification image of the pyloric stomach showing 
immunostained cells in the mucosa (arrowheads) and immunostained processes in the 
basiepithelial nerve plexus (black arrow) and visceral nerve plexus (white arrow). (e) 
Immunostaining in a horizontal section of a pyloric duct and pyloric caecum. (f) High 
magnification image of a pyloric caecum showing immunostaining in mucosal cell 
bodies (arrowhead), in the basiepithelial nerve plexus (black arrow) and in the visceral 
nerve plexus (white arrow). BNP, basiepithelial nerve plexus; CE, coelomic epithelium; 
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CS, cardiac stomach; Lu, lumen; Mu, mucosa; No, nodule; PC, pyloric caeca; PD, 
pyloric duct; VNP, visceral nerve plexus. Scale bars: 100 µm in (a), (e); 20 µm in (b), 
(c), (d), (f). Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish 
anatomy. 
4.3.4.2.5 Body wall and body wall-associated appendages 
ArPPLNP2h-immunoreactive fibers were observed in the coelomic lining of the 
body wall (Figure 4.19a). Thus, stained fibers are present in the coelomic basiepithelial 
nerve plexus that is located beneath the coelomic epithelium and which is closely 
associated with a longitudinally orientated muscle layer (Figure 4.19a, b). Furthermore, 
immunostained fibers were also observed within the circularly orientated muscle layer 
of the coelomic lining (Figure 4.19a, b). Immunostaining of nerve fibers was also 
observed in the sub-epidermal plexus of the body wall (Figure 4.19a, c, d, e). This 
staining also extends into papulae, hollow finger-shaped organs located above voids in 
the calcite skeleton that enable gas exchange between the external seawater and the 
coelomic fluid. Another type of body wall appendage in starfish are pedicellariae, 
pincer-like organs that keep the body surface clear of encrusting material.  In 
pedicellariae immunostaining was observed in processes associated with the adductor 
muscles (Figure 4.19f). 
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Figure 4.19 Localization of ArPPLN2h immunoreactivity in the body wall and body 
wall appendages of A. rubens.  
(a) Transverse section of aboral body wall showing immunostaining in the sub-
epidermal nerve plexus, the coelomic basiepithelial nerve plexus and circular muscle 
layer nerve plexus. The boxed area is shown at high magnification in (b). (b) High 
magnification image of the coelomic lining of the body wall showing stained processes 
in the coelomic basiepithelial nerve plexus (white arrowhead) in the nerve plexus 
associated with the circular muscle layer (black arrowheads). (c) Immunostaining in the 
sub-epidermal nerve plexus of the body wall and in papulae. The boxed area is shown at 
higher magnification in (d). (d) High magnification image showing immunostaining in 
the sup-epidermal nerve plexus of a papula and adjacent body wall. (e) High 
magnification of the body wall external epithelium showing immunostaining in the sub-
epidermal nerve plexus. (f) High magnification image showing immunostained 
processes in a pedicellaria. BW, body wall; CBNP, coelomic basiepithelial nerve plexus; 
CMLNP, circular muscle layer nerve plexus; CT, collagenous tissue; CuL, cuticle layer; 
Os, ossicle; Pa, papulae; Pe, pedicellaria; SNP, sub-epidermal nerve plexus. Scale bars: 
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100 µm in (a), (c); 20 µm in (b), (d), (e), (f). Refer to Figure 1.7 (page 38) and 1.8 (page 
39) for details of starfish anatomy. 
4.3.4.2.6 Interossicular muscles 
Immunostained fibers were revealed in association with interossicular muscles 
that link adjacent ossicles of the body wall endoskeleton. In Figure 4.20a these stained 
fibers can be seen at low magnification in a transverse section through the ambulacral 
region of the body wall. High magnification images show the profiles of immunostained 
fibers in the longitudinal supra-ambulabral muscle (Figure 4.20b) and in beaded 
immunostained fibers running along the length of muscle fibers in the transverse infra-
ambulacral muscle (Figure 4.20c) and in the transverse supra-ambulacral muscle 
(Figure 4.20d). The immunostained processes can also be seen to extend into the 
ossicles (Figure 4.20c, d), where muscle fibers form loop-shaped straps around struts of 
the ossicular stereom. A similar pattern of immunostained fibers in association with 
interadambulacral muscles is shown in Figure 4.20 e and f. 
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Figure 4.20 Localization of ArPPLN2h immunoreactivity in the innervation of 
interossicular muscles in A. rubens.  
(a) Transverse section of the ambulacrum showing immunostaining associated with 
muscles linking the ambulacral ossicles, which include the TSM, TIM and LSM. The 
intensely stained radial nerve cord can also be seen in this image. The boxed regions are 
shown at higher magnification in panels (b) and (c). (b) High magnification image 
immunostained profiles of processes (arrowheads) in the LSM. (c) High magnification 
image of showing immunostained processes (arrowheads) in the TIM and at the TIM-
AMO interface (d) High magnification image showing immunostained processes in the 
TSM and at the TIM-AMO interface. (e, f) Immunostaining in the body wall at the 
junction between two arms in a juvenile starfish. Immunostained fibers can be seen 
associated with muscles that link adambulacral ossicles (arrowheads). Stained fibers are 
also evident in thickenings of the sub-epithelial nerve plexus of the body wall (arrows) 
and in the tube feet. A high magnification image of the boxed region is shown in (f). (f) 
Immunostained processes (arrowheads) in muscles that link adambulacral ossicles. 
AMO, ambulacral ossicle; LSM, longitudinal supra-ambulacral muscle; RNC, radial 
nerve cord; TIM, transverse infra-ambulacral muscle; TSM, transverse supra-
ambulacral muscle. Scale bars: 200 µm in (a); 20 µm in (b), (c), (d), (f); 100 µm in (e). 
Refer to Figure 1.7 (page 38) and 1.8 (page 39) for details of starfish anatomy. 
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4.3.5 Bioactivity of ArPPLN2h in A. rubens 
4.3.5.1 ArPPLN2h has no effect on in vitro preparations of apical muscle and tube 
feet from A. rubens but is a potent relaxant of cardiac stomach preparations 
ArPPLN2h (GRTSLSGSSGLTHLSSGFH) was tested at a high concentration 
(10-6 M) on three in vitro preparations from A. rubens: apical muscle, tube feet and 
cardiac stomach. No effects on the contractile state of apical muscle and tube foot 
preparations were observed, whereas ArPPLN2h caused relaxation of cardiac stomach 
preparations. ArPPLN2h caused dose-dependent relaxation of cardiac stomach 
preparations and comparison of the effects of ArPPLN2h with the SALMFamide 
neuropeptide S2 (SGPYSFNSGLTF-NH2) revealed that the potency and efficacy of 
ArPPLN2h was very similar to that of S2 (Figure 4.21). Thus, relaxing effects were 
observed with ArPPLN2h and S2 in the concentration range 10-8 and 10-6 M and the 
maximum effect (Emax) observed at 10-6 M was 40.055.07% and 48.038.17% 
reversal of KCl-induced contraction for ArPPLN2h and S2, respectively. 
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Figure 4.21 ArPPLN2h (GRTSLSGSSGLTHLSSGFH) causes dose-dependent 
relaxation of in vitro preparations of the cardiac stomach from A. rubens. 
(a) Representative recording showing the dose-dependent relaxing effect of ArPPLN2h 
(10-10 - 10-6 M) on a cardiac stomach preparation pre-contracted with artificial seawater 
containing 30 mM added KCl (leftward arrow). Following tests with ArPPLN2h, the 
preparation was washed with artificial seawater (downward arrow). (b) Graph showing 
concentration-dependent relaxing effect of ArPPLN2h (green) on cardiac stomach 
preparations. Each point represents the mean ± SEM from at least four separate 
experiments, with the effect calculated as the percentage reversal of contraction induced 
by KCl. The effectiveness of ArPPLN2h as a cardiac stomach relaxant is much greater 
than that of the ArPPLN1b (red) but similar to the SALMFamide neuropeptide S2 
(SGPYSFNSGLTF-NH2) (blue). 
4.3.5.2 ArPPLN2h does not induce cardiac stomach eversion 
Previous studies revealed that the SALMFamide S2 causes cardiac stomach in 
vitro and induces cardiac stomach eversion when injected in vivo (Melarange et al., 
1999). Here ArPPLN2h and S2 were found to cause cardiac stomach relaxation in vitro 
with similar potency and efficiency. Therefore, the effects of ArPPLN2h and S2 in vivo 
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were compared, with 100 µl of peptide at a concentration of 1 mM injected at two or 
three sites in the aboral body wall of the arms proximal to the junctions with the central 
disk region. Cardiac stomach eversion was observed within 5 min of injection in seven 
out of ten starfish injected with S2 but stomach eversion was not observed in any of ten 
animals injected with ArPPLN2h.  
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4.4 Discussion 
In chapter 3 the structural, anatomical and functional characterization of 
neuropeptides derived from pedal peptide-like neuropeptide precursor 1 in the starfish A. 
rubens was reported. Here the structural, anatomical and functional characterization of 
neuropeptides derived from A. rubens pedal peptide-like neuropeptide precursor 2 
(ArPPLNP2) has been reported. 
A partial sequence of ArPPLNP2 was determined previously by analysis of 
transcriptome sequence data (Semmens et al., 2016), whilst here a cDNA comprising 
the entire open reading frame has been sequenced. ArPPLNP2 comprises thirteen copies 
of eleven PP/OK-type peptides (ArPPLN2a-k), with three copies of ArPPLN2h 
(GRTSLSGSSGLTHLSSGFH) and one copy each of the other ten peptides. The 
predicted structures of ArPPLN2a-k were confirmed here by mass spectroscopic 
analysis of A. rubens radial nerve cord extracts. All of the PP/OK-type peptides derived 
from ArPPLNP2 comprise nineteen residues and share a high level of sequence 
similarity with each other (Figure 4.2a). Furthermore, alignment of ArPPLNP2-derived 
peptides with other PP/OK-type neuropeptides in starfish (ArPPLNP1-derived peptides), 
other echinoderms and other invertebrates reveals conserved structural characteristics 
(Figure 4.2b). Thus, the hydrophobic residues (Phe, Leu, Met) at positions 5, 14 and 18 
in ArPPLNP2-derived peptides appear to be characteristic of PP/OK-type neuropeptides, 
although the number of intervening residues is variable. Other residues in ArPPLNP2-
derived peptides that also occur in at least some PP/OK-type peptides in other 
echinoderms and in protostomes include the glycine residues at positions 10 and 17. 
The functional significance of the conserved residues remains to be determined for 
starfish PP/OK-type peptides. However, it is noteworthy that a structure-activity study 
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on the prototypical crustacean orcokinin peptide revealed that N-terminal truncation to 
the position where residue 2 in orcokinin (phenylalanine) removed results in a complete 
loss of bioactivity. Furthermore, C-terminal truncation to the point where residue 12 in 
orcokinin (phenylalanine) is removed results in a 50% loss of bioactivity, whilst C-
terminal truncation to the point where residue 10 in orcokinin (phenylalanine) is 
removed results in a complete loss of bioactivity (Bungart et al., 1995). Thus, these N- 
and C-terminal phenylalanine residues appear to be critically important for the 
bioactivity of orcokinin, consistent with the evolutionary conservation of hydrophobic 
residues at these positions in PP/OK-type peptides from other protostomian 
invertebrates and from echinoderms (e.g. starfish) (Figure 4.2b). 
4.4.1 Functional interpretation of the expression patterns and actions ArPPLN2-
type peptides in A. rubens 
The main aim of this study was to obtain the first insights into the physiological 
roles of PPLN2-type peptides in A. rubens. To accomplish this, the objectives were to 
investigate the expression of ArPPLNP2 and neuropeptides derived from this precursor 
using mRNA in situ hybridization and immunohistochemistry and to investigate the in 
vitro/in vivo pharmacological actions of ArPPLN2h in A. rubens as a representative 
neuropeptide derived from ArPPLNP2. In the text below, the findings are discussed by 
focusing one-by-one on groups of anatomically and/or functionally related systems in A. 
rubens. 
4.4.1.1 Radial nerve cords, circumoral nerve ring, marginal nerves, lateral motor 
nerves and innervation of interossicular muscles 
Cells expressing ArPPLNP2 transcripts were detected in both the ectoneural and 
hyponeural regions of the radial nerve cords and circumoral nerve ring in A. rubens. 
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The distribution of cells in the radial nerve cords and circumoral nerve ring that were 
immunolabeled by antibodies to ArPPLN2h was consistent with the pattern of 
ArPPLNP2 mRNA expression. Furthermore, immunohistochemistry revealed dense 
networks of immunolabelled fibers in the ectoneural neuropile of the radial nerve cords 
and circumoral nerve ring. ArPPLN2h-expressing cells and fibers are also present in the 
marginal nerves, which are ectoneural thickenings of the basiepithelial nerve plexus 
located lateral to the outer row of tube feet in each arm. Collectively, these findings 
indicate that neuropeptides derived from ArPPLNP2 have a widespread role in 
mediating neuronal signaling in the ectoneural division of the starfish nervous system. 
However, little is known about the functional organization of the ectoneural nervous 
system in starfish (or echinoderms), although it is thought to comprise sensory neurons, 
interneurons and motor neurons (Cobb, 1970; Cobb, 1987; Mashanov et al., 2016). On 
the other hand, the hyponeural division of the nervous system is recognized as having a 
purely motor function, based on both anatomical and functional studies (Cobb, 1970; 
Cobb, 1987; Mashanov et al., 2016). Therefore, the presence of ArPPLNP2 transcripts 
and ArPPLN2h immunoreactivity in hyponeural cell bodies can be interpreted as 
evidence of a role for ArPPLNP2-derived neuropeptides in motoneuronal function in 
starfish. The processes of the ArPPLN2h-immunoreactive monopolar hyponeural cells 
are also immunoreactive and in some instances these can be traced beyond the 
hyponeural region of the radial nerve cords or circumoral nerve ring. For example, in 
sections of the arms stained processes can be seen projecting towards the transverse 
infra-ambulacral muscle, which is located just above the hyponeural system, indicating 
a potential role in neuromuscular signaling in starfish. Consistent with this notion, 
ArPPLN2h-immunoreactive processes are also present in the lateral motor nerve, which 
innervates interossicular muscles in the starfish body wall (Smith, 1937; 1950). 
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Accordingly, the widespread occurrence of ArPPLN2h-immunoreactive processes in 
interossicular muscles and other muscles in A. rubens is indicative of a general role for 
ArPPLNP2-derived neuropeptides in neuromuscular signaling. 
4.4.1.2 Tube feet, terminal tentacle and associated structures 
The presence of ArPPLNP2-expressing cells and ArPPLN2h-immunoreactive 
processes in the basiepithelial nerve plexus of tube feet in A. rubens suggested a 
potential role for ArPPLN2-derived neuropeptides in regulation of the contractility of 
these motile and muscular organs and therefore ArPPLN2h was tested for myoactivity 
on in vitro preparations of tube feet. Interestingly, ArPPLN2h had no effect on tube foot 
preparations. This contrasts with previous findings with the ArPPLNP1-derived 
neuropeptide ArPPLN1b, which has a pattern of expression in tube feet that is very 
similar to that of ArPPLN2h but which causes dose-dependent relaxation of tube foot 
preparations (Chapter 3). These findings are indicative of differences in the 
physiological roles of ArPPLNP1-derived and ArPPLNP2-derived neuropeptides in A. 
rubens, which may be explained by differences in the expression patterns of the as yet 
uncharacterized receptors that mediate effects of ArPPLN1b and ArPPLN2h. Both 
ArPPLN1b and ArPPLN2h are also present in the tube foot basal nerve ring and in 
processes that innervate the adhesive tube foot sucker and, as discussed previously in 
chapter 3, this could be indicative of roles in regulation of the secretion of proteins that 
mediate tube adhesion or detachment (Santos et al., 2005; Hennebert et al., 2012; 
Hennebert et al., 2013).  
Each tube foot stem is linked via a tubular canal that extends through the body 
wall to a bulb-shaped muscular ampulla, which is located in the perivisceral coelom. 
Contraction of the ampulla facilitates tube foot extension, whereas relaxation of the 
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ampulla enables accommodation of fluid from the lumen of the stem when a tube foot 
contracts (Santos et al., 2005; Hennebert et al., 2012; Hennebert et al., 2013). Both 
ArPPLN1b-immunoreactive (Chapter 3) and ArPPLN2h-immunoreactive (this study) 
fibers are present in ampullae and are located in close proximity to the muscle layer. 
Previous studies have reported that the ampullae are innervated by hyponeural neurons 
(Smith, 1950) and therefore it is likely that ArPPLN1b- and ArPPLN2h-
immunoreactive fibers in the ampulla originate from ArPPLNP1- and ArPPLNP2-
expressing hyponeural motoneurons. 
The terminal tentacle is a tube foot-like sensory organ located at the tip of each 
arm in A. rubens and in other starfish. ArPPLN2h-immunoreactive cells and fibers are 
present in the wall of the fluid-filled terminal tentacles, consistent with the pattern of 
expression seen in tube feet (see above). ArPPLN2h-immunoreactive cells and fibers 
are also present in the body wall epithelium and in lateral lappets that surround the 
terminal tentacle. The physiological roles of the lateral lappets (Smith, 1937) are not 
known, although a possible function would be to act as chemosensory organs, with 
detection of chemicals facilitated by their large surface area to volume ratio. Turning to 
a different sensory modality, located at the base of the terminal tentacle is a pigmented 
photosensory organ known as the optic cushion and here ArPPLNP2-expressing cells 
are present in the photoreceptor cell layer, located in-between pigmented cells. 
Interestingly, orcokinin appears to have a physiological role in mediating light 
entrainment of circadian activity in insects (Hofer and Homberg, 2006) and therefore it 
is possible that PP/OK-type peptides may have a similar role in starfish and other 
echinoderms. 
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4.4.1.3 Digestive system 
Cells expressing ArPPLNP2 transcripts were detected in the coelomic epithelial 
layer in many regions of the digestive system, including the cardiac stomach, the 
extrinsic retractor strands of the cardiac stomach, the pyloric stomach, the pyloric ducts 
and the pyloric caeca. In accordance with this pattern of precursor expression, 
antibodies to ArPPLN2h labeled processes located in the visceral nerve plexus 
underlying the coelomic epithelium in all of these regions of the digestive system and in 
the peristomial membrane and esophagus. An abundance of immunoreactive fibers in 
the extrinsic retractor strand nodule of the cardiac stomach was particularly striking and 
consistent with the abundance of coelomic epithelial cells lining the nodule that express 
ArPPLNP2 transcripts. Furthermore, immunostained cells and processes were also 
revealed in the mucosal layer and the basiepithelial nerve plexus of the cardiac stomach, 
respectively. Consistent with the extensive expression of ArPPLN2-type neuropeptides 
in the cardiac stomach and other regions of the digestive system, it has been found that 
ArPPLN2h caused dose-dependent relaxation of in vitro cardiac stomach preparations 
here. The expression of ArPPLNP1 and neuropeptides derived from this precursor in the 
cardiac stomach of A. rubens has been reported and found that ArPPLN1b, like 
ArPPLN2h, causes relaxation of in vitro preparations of the cardiac stomach (Chapter 3). 
Here the bioactivity of ArPPLN1b and ArPPLN2h as cardiac stomach relaxants has 
been compared and found that ArPPLN2h is much more effective than ArPPLN1b. This 
difference in the bioactivity of the two peptides may be associated with differences in 
the patterns of expression of ArPPLNP1- and ArPPLNP2-derived peptides in the 
cardiac stomach. Both types of peptides are expressed by mucosal cells and their 
processes in the basiepithelial plexus, but only ArPPLNP2-derived peptide (ArPPLN2h) 
expression was detected in the visceral nerve plexus that underlies the coelomic 
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epithelium of the cardiac stomach. This is significant because the visceral nerve plexus 
is closely associated with the visceral muscle layer of the cardiac stomach, whereas the 
basiepithelial nerve plexus is separated from the visceral muscle layer by a layer of 
collagenous tissue. It is speculated that, therefore, ArPPLN2-type peptides derived from 
processes in the visceral nerve plexus act directly on the muscle layer to cause 
relaxation, whereas ArPPLN1-type and ArPPLN2-type peptides derived from processes 
in the basiepithelial nerve plexus may act indirectly by triggering local release of 
diffusible signaling molecules that act as muscle relaxants (e.g. nitric oxide; (Melarange 
and Elphick, 2003)). 
Previous studies have revealed that the SALMFamide neuropeptides S1 and S2 
cause relaxation of in vitro cardiac stomach preparations from A. rubens, but with S2 
ten times more potent than S1 (Melarange et al., 1999). Therefore, here the bioactivity 
of ArPPLN2h with S2 has been compared and found that the potency/efficacy of 
ArPPLN2h is very similar to that of S2 in vitro. In vivo pharmacological tests with S2 
have revealed that injection of this peptide into the perivisceral coelom of A. rubens 
triggers eversion of the cardiac stomach, indicating that S2 may be involved in 
physiological mechanisms that mediate control of stomach eversion when starfish feed 
extraorally on prey (e.g. mussels) (Melarange et al., 1999). Therefore, it was of interest 
to investigate if ArPPLN2h also triggers cardiac stomach eversion in A. rubens. 
Interestingly, it was found that whilst cardiac stomach eversion was observed within 
five minutes of injection in seven out of ten animals injected with S2, cardiac stomach 
eversion was not observed in any of ten animals injected with ArPPLN2h. Thus, whilst 
S2 and ArPPLN2h exhibit similar cardiac stomach relaxing activity in vitro, this does 
not necessary translate into the same bioactivity in vivo.  This difference in in vivo 
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bioactivity may reflect differences in regions of the cardiac stomach musculature that 
are regulated by S2 and ArPPLN2h as muscle relaxants. 
4.4.1.4 Hemal system and Tiedemann’s bodies 
The functional significance of ArPPLN2-type neuropeptide expression in the 
hemal system and the water vascular system associated Tiedemann’s bodies of A. 
rubens is unknown. It is noteworthy, however, that ArPPLN1-type neuropeptide 
expression was also detected in these structures in A. rubens (Chapter 3). A common 
functional characteristic of the hemal system and Tiedemann’s bodies are roles in the 
transport around the starfish body of fluids and circulating cells (Ferguson, 1984).  It is 
noteworthy that previous studies on mollusks have revealed that PP/OK-type peptides 
regulate ciliary activity (Gaston, 1998) and therefore PPLN1-type and PPLN2-type 
peptides may have a similar role in the starfish hemal system and water vascular system. 
Furthermore, such a role could extend to other systems; for example, in ciliary-mediated 
movement of food materials through the digestive system, as discussed previously for 
ArPPLNP1-derived peptides in chapter 3. 
4.4.2 Comparison of the expression and bioactivity of ArPPLN1-type and 
ArPPLN2-type peptides in A. rubens 
Comparison of the expression patterns of ArPPLN1-type and ArPPLN2-type 
precursors/neuropeptides reveals some general similarities. Both neuropeptide types are 
widely expressed in A. rubens with, for example, prominent expression in the ectoneural 
and hyponeural regions of the radial nerve cords and circumoral nerve ring, tube feet, 
digestive system and innervation of interossicular muscles. By way of comparison, the 
precursor of relaxin-like gonad stimulating peptide in A. rubens (AruRGPP) has a much 
more restricted pattern of expression, including a small and sparsely distributed 
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population of cells in the ectoneural region of the radial nerve cords and circumoral 
nerve ring and in the tube feet. In fact, only region where AruRGPP expression is 
prominent in A. rubens is in the arm tip epithelium surrounding the terminal tentacle 
(chapter 2). 
The similarities in the expression patterns of ArPPLN1-type and ArPPLN2-type 
precursors/neuropeptides presumably reflect a common evolutionary origin as PP/OK-
type precursors/neuropeptides, as discussed in more detail below. However, there are 
also distinct differences in the expression patterns and bioactivity of ArPPLN1-type and 
ArPPLN2-type precursors/neuropeptides. Some of these differences have already been 
discussed above and here others have been highlighted. The prototype of PPLN1-type 
peptides in starfish is starfish myorelaxant peptide (SMP), which was discovered on 
account of its relaxing effect on the apical muscle of P. pectinifera (Kim et al., 2016) 
and accordingly ArPPLN1b causes dose-dependent relaxation of apical muscle 
preparations from A. rubens (Chapter 3). Furthermore, consistent with the bioactivity of 
ArPPLN1b, antibodies to ArPPLN1b reveal that this peptide is present in axonal 
processes that ramify amongst the muscle fibers of the apical muscle (Chapter 3). It is 
interesting, therefore, that in this study no ArPPLN2h-immunoreactivity was detected in 
the apical muscle of A. rubens and in accordance with this finding ArPPLN2h does not 
affect the contractile state of the apical muscle in vitro. Thus, whilst both PPLN1-type 
and PPLN2-type peptides act as muscle relaxants in starfish, it appears that they are 
specialized with respect to the muscle systems that they regulate. Thus, PPLN1-type 
peptides act as relaxants of the apical muscle and tube feet, whereas PPLN2-type 
peptides do not cause relaxation of these muscle preparations in vitro. Conversely, 
PPLN2-type peptides cause relaxation of cardiac stomach preparations with an efficacy 
and potency comparable to that of the SALMFamide neuropeptide S2, whilst PPLN1-
 211 
type peptides are much less efficacious as cardiac stomach relaxants. Indeed, it is 
possible that the relaxing effect of ArPPLN1b on the cardiac stomach in vitro (Chapter 
3) reflects agonist cross-reactivity with receptors that are naturally activated by 
ArPPLN2-type peptides. Addressing this issue will require molecular identification of 
the receptors that mediate the effects of PP/OK-type peptides in starfish, although this is 
an objective that has yet to be accomplished for any animal species. 
  
 212 
5 General discussion 
Neuropeptides are signaling molecules that modulate neural circuits to regulate 
behavior and physiological processes throughout the animal kingdom. Research on 
neuropeptides in echinoderms, which occupy an “intermediate” position in animal 
phylogeny between the protostomes and the vertebrates, can provide new insights into 
the evolution of neuropeptide signaling systems. In the experimental work reported in 
this thesis, neuropeptides belonging to two different neuropeptide families, relaxin-type 
and pedal peptide/orcokinin-type, have been characterised in the starfish A. rubens. 
5.1 General summary 
Investigation of the expression of AruRGPP in A. rubens using mRNA in situ 
hybridization revealed expression by cells in the radial nerve cords, circumoral nerve 
ring and tube feet. Furthermore, a band of AruRGPP-expressing cells was also 
identified in the body wall epithelium lining the cavity that surrounds the sensory 
terminal tentacle and optic cushion at the tips of the arms, where AruRLPP2 is also 
expressed. In vitro tests revealed that AruRGP induces spawning of ovarian fragments 
from A. rubens. Collectively, these findings suggest that AruRGP may be released by 
cells in the arm tips to trigger spawning in starfish in response to environmental cues. 
Analysis of the expression of ArPPLNP1, ArPPLNP2 and peptides derived from 
these precursors in A. rubens using mRNA in situ hybridization and 
immunohistochemistry revealed a widespread distribution, including expression in 
radial nerve cords, circumoral nerve ring, digestive system, tube feet and innervation of 
interossicular muscles. Consistent with this pattern of expression, peptides derived from 
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ArPPLNP1 and ArPPLNP2 act as muscle relaxants in starfish. A summary of the results 
obtained in this project can be found at the end of this section in Table 5.1.  
5.2 Relaxin-type neuropeptides in starfish 
5.2.1 An evolutionary perspective on relaxin-type neuropeptides in starfish 
Two relaxin-type neuropeptide precursors from the starfish A. rubens have been 
cloned and analyzed. Based on sequence analysis and phylogenetic relationships in the 
relaxin/insulin/IGF neuropeptide family, AruRGPP and AruRLPP2 are closer to 
relaxin/insulin-like peptide precursors than insulin/IGF-type peptide precursors (Figure 
2.4). Protostome insulin-like peptide precursors are more likely to belong to the 
insulin/IGF subfamily and there are no reports of relaxin-type neuropeptide 
identification in protostomes. This suggests that relaxin-type neuropeptides may be 
unique to deuterostomes. 
RGPs from different types of starfish share more similarities with each other 
than with AruRLPP2 (Figure 2.3). Thus, AruRLP2 is a relaxin-type peptide but not an 
RGP-type neuropeptide. Analysis of genome and transcriptome sequences of other 
starfish species may enable discovery of orthologues of AruRLPP2. When it comes to 
the RGPs, AruRGP is identical (100%) to AamRGP from A. amurensis but shares less 
sequence identity with AjaRGP from Aphelasterias japonica (Order Forcipulatida; 
Family Asteriidae) (87%) and with PpeRGP from P. pectinifera (Figure 2.2C) (Order 
Valvatida; Family Asterinidae) (65%), which is consistent with the different genera they 
belong to. In this study, the gene structure of some members of the relaxin/insulin/IGF 
neuropeptide family were compared (Figure 2.5), which provided further evidence that 
the two starfish relaxin-like neuropeptides belong to the relaxin/insulin-like peptide 
subfamily. 
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It can be concluded that the RGPs and RLP2 are members of the relaxin/insulin-
like peptide family. Furthermore, the A chains of starfish RGPs and RLP2 all harbour 
the cysteine motif (CCxxxCxxxxxxxxC), but none of the B chains possess the distinct 
and well-conserved vertebrate relaxin-specific receptor-binding motif RxxxRxx(I/V) 
(Bathgate et al., 2002). Receptors that mediate effects of relaxin-type peptides in 
starfish are not known. 
5.2.2 Future directions for research on relaxin-type neuropeptides in starfish 
The receptors of the relaxin-type subfamily of peptides in vertebrates have been 
identified and the structures and properties of the four vertebrate relaxin-type receptors 
(RXFP1 - 4, four highly conserved family A GPCRs) have been characterized (Bathgate 
et al., 2013). Therefore, these receptors may provide a basis for identification of relaxin-
type receptors in starfish. Potential starfish relaxin-type peptide receptors could be 
identified by BLAST analysis of genome and transcriptome data and/or by analyzing 
the location of related genes on chromosomes/scaffolds. Paralogous genes that emerged 
through local duplication of an ancestral gene prior to and during the emergence of 
vertebrates tend to be located in the same vicinity on vertebrate ancestral chromosomes 
linkage groups (Kim et al., 2014). By comparing the vertebrate rhodopsin-like 
neuropeptide GPCRs with nonvertebrate chordate and protostomian GPCRs, it has been 
suggested that local duplication prior to the emergence of vertebrates produced the 
current diversity of neuropeptide and GPCR superfamilies (Yun et al., 2015). The 
localization of neuropeptide precursor and receptor genes on starfish genomic scaffolds 
or chromosomes could be helpful to predict potential receptors for relaxin-type peptides 
in starfish. Then candidate receptors could be tested by pharmacological 
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characterization when heterologously expressed in cells, as demonstrated previously for 
starfish GnRH-type receptors (Tian et al., 2016). 
For the two starfish relaxin-type neuropeptides, only the localization of cells 
expressing AruRGPP/AruRLPP2 mRNA has been investigated (chapter 2). To gain 
further insights into the expression of the neuropeptides derived from these precursors, 
immunohistochemical methods need to be employed. Currently, antibodies to AruRGP 
and AruRLP2 have not been produced. However, Masatoshi Mita and colleagues have 
successfully generated antibodies to PpeRGP (Katayama and Mita, 2016; Yamamoto et 
al., 2016). A novel method for conjugate preparation was developed to produce specific 
antibodies against disulfide-rich heterodimeric peptide-KLH conjugates. However, the 
antibodies to PpeRGP are so specific that AamRGP, which is identical AruRGP, is not 
detected. Nevertheless, the strategy used to generate PpeRGP antibodies could be 
applied to AruRGP in the future. By producing antibodies to AruRGP it may be 
possible to determine the release sites of AruRGPP-expressing cells, which would 
provide new insights into how the levels of RGP in the coelom are elevated in starfish 
prior to spawning. 
Previous reports showed that RGP/GSS is expressed in the radial nerve cords 
(Mita et al., 2009a; Mita et al., 2009b), while in this study a cluster of RGP-expressing 
cells in the arm tips of starfish have been discovered. Further investigation of RGP 
expression patterns in other starfish species would determine if arm tip expression of 
RGP is a general characteristic of starfish and would provide further insights into 
whether arm tip RGP-expressing cells could be the physiological source of RGP that 
triggers spawning. Furthermore, several experiments could be performed to test this 
hypothesis. There is evidence that at least in some starfish species spawning of one 
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starfish can induce spawning of other starfish nearby with a concentration of about 2 
eggs ml-1 or 1 x 104 sperm ml-1 (Beach et al., 1975; Caballes and Pratchett, 2017). 
Spawning incidence of males are higher than that of females. Particularly, sperm seems 
more likely to increase the spawning rates (more incidence and less response time) of 
males compared to eggs (Caballes and Pratchett, 2017). Therefore, it would be 
interesting to perform experiments where cells expressing RGP in the arm tips are 
removed by cutting off the arm tips and then investigating if this prevents spawning-
induced spawning. Also the effect of arm tip ablation on the concentration of RGP in 
the coelomic fluid could be investigated in starfish during the spawning season.  
Another approach for analysis of the physiological roles of relaxin-type peptides 
in starfish would be to use gene knockdown/deletion methods; for example, using zinc-
finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) or 
clustered regularly interspaced short palindromic repeats (CRISPR). If RGPP gene 
expression in the radial nerve cords or the arm tips could be manipulated separately, 
then the source of RGP as a regulator of starfish reproduction could be determined. 
If the arm tips are the actual source of RGP responsible for triggering spawning 
in starfish, then RGP synthesized in the radial nerve cord and tube feet may have other 
roles. Pharmacological tests similar to those used for PP/OK-type neuropeptides 
(chapter 3, 4) could be used to check whether RGP causes relaxation or contraction of 
the tube feet, the effects that would be indicative of roles in regulation of the locomotor 
activity and/or feeding behavior of starfish. Before the purification of RGP, the 
shedding substance obtained from the radial nerve extracts of starfish was reported to 
cause considerable contraction of the intact ovaries (Chaet, 1964b). A similar effect has 
been reported for NGIWYamide purified from sea cucumber, Apostichopus japonicus. 
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This neuropeptide can induce oocyte maturation and gamete spawning (Kato et al., 
2009), but it can also cause contraction of radial longitudinal muscle, intestine and 
tentacle of sea cucumber and lead to stiffness of collagenous tissue in the body wall 
dermis of sea cucumber (Iwakoshi, 1995; Birenheide et al., 1998; Inoue et al., 1999; 
Ohtani et al., 1999). Likewise, because AruRGP mRNA is also transcribed in tube feet 
of A. rubens it would be of interest to test the effects of AruRGP on other parts of A. 
rubens besides the gonad, including tube feet. It was not possible to do these 
experiments in this study because only very limited amounts of AruRGP were available 
for the in vitro tests reported in chapter 2.  
The in vitro and in vivo effects of RGP on spawning have been investigated 
extensively (Mita, 2016), whereas RLP2 is a new discovery and nothing is known about 
its physiological roles. Because AruRLPP2 expression was only detected in the starfish 
arm tips using mRNA in situ hybridization, this may explain why AruRLP2 was not 
detected in the radial nerve cord extracts using mass spectrometry. If AruRLP2 could be 
synthesized it would be interesting to investigate if it also triggers spawning, like 
AruRGP, or it has other physiological roles in starfish. 
The expression of ArRGPP and ArRLP2 during starfish larval development has 
not been investigated. A previous study has investigated the expression of other 
neuropeptide precursors in A. rubens larvae (Mayorova et al., 2016) and therefore it 
would be interesting to extend this to AruRGPP and AruRLP2 to obtain insights into 
potential roles of relaxin-type peptides in larval starfish. 
5.3 PP/OK-type neuropeptides 
5.3.1 Evolution and comparative physiology of PP/OK-type neuropeptide 
signaling in the Bilateria 
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PP/OK-type neuropeptides were first discovered in protostomian invertebrates 
(mollusks, arthropods) and the identification PP/OK-type neuropeptide precursors in 
echinoderms established that the evolution of PP/OK-type neuropeptides can be traced 
back to the common ancestor of protostomes and deuterostomes (Rowe and Elphick, 
2012). The functional characterization of PP/OK-type neuropeptides in starfish has 
provided the first opportunity to compare the physiological roles of PP/OK-type 
neuropeptides in protostomian and deuterostomian invertebrates, thereby gaining 
insights into the evolution of PP/OK-type signaling. 
The discovery of a PP/OK-type neuropeptide (SMP) that acts as a muscle 
relaxant in the starfish P. pectinifera provided the first insight into the physiological 
roles of PP/OK-type neuropeptides in a deuterostome (Kim et al., 2016). Here 
characterisation ArPPLNP1, ArPPLNP2 and peptides derived from these precursors in 
A. rubens has provided the first insights into the anatomy of PP/OK-type neuropeptide 
signaling in a deuterostome. Collectively, the data obtained from P. pectinifera and A. 
rubens indicate that SMP/PPLN-type neuropeptides have a general and widespread role 
as inhibitory neuromuscular transmitters in starfish. 
This study is the first detailed analysis of the anatomical expression patterns and 
actions of PP/OK-type neuropeptides in an echinoderm. In the future, it would be 
interesting to perform similar investigations in other echinoderms. For example, do 
PP/OK-type neuropeptides act as muscle relaxants in all echinoderms? Addressing this 
issue is feasible because precursors of PP/OK-type neuropeptides have been identified 
in other echinoderms, including two precursors in the sea urchin S. purpuratus 
(SpPPLNP1 and SpPPLNP2; (Rowe and Elphick, 2012)), one precursor in the sea 
cucumber A. japonicus (Rowe et al., 2014) and one or more precursors in several brittle 
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star species (Zandawala et al., 2017). The existence of multiple PP/OK-type 
neuropeptide precursors in echinoderm species must be a consequence of one or more 
duplications of a gene or genes encoding a common ancestral precursor protein(s), but 
the timing of these gene duplications is not known. Thus, it is not clear whether the 
existence of two PP/OK-type precursors in sea urchins and in starfish is a consequence 
of duplication of an ancestral precursor in a common ancestor of both sea urchins and 
starfish or whether it reflects independent duplication events in the echinoid (sea urchin) 
and asteroid (starfish) lineages. Further insights into this issue may emerge when 
complete genome sequences are available for species belonging to each of the five 
extant echinoderm classes. 
As discussed in detail in chapter 3, comparative analysis of the physiological 
roles of PP/OK-type neuropeptides in the Bilateria is limited in as much as the 
echinoderms are the only deuterostomian phylum in which PP/OK-type neuropeptides 
have been identified. Thus, the functional characterization of PP/OK-type neuropeptides 
in starfish reported here and in previous paper (Kim et al., 2016) represents the totality 
of our knowledge of physiological roles of PP/OK-type neuropeptides in deuterostomes. 
This contrasts with a much more extensive series of studies on PP-type neuropeptides in 
mollusks and OK-type neuropeptides in arthropods. It is clear from these studies that 
PP/OK-type neuropeptides have a wide variety of physiological roles in protostomes, 
including regulation of muscle and ciliary activity associated with locomotor activity in 
mollusks (Hall and Lloyd, 1990) and regulation of both frequency and amplitude of 
hindgut contraction in arthropods (Stangier et al., 1992). A unifying theme amongst the 
pharmacological actions of PP/OK-type neuropeptides in protostomes are stimulatory 
effects, with the effector tissues often being muscular in nature. Thus, this contrasts 
with the relaxing effects of PP/OK-type neuropeptides on starfish muscle reported here 
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(Chapter 3, 4) and previously ((Kim et al., 2016). This may reflect an excitatory-
inhibitory transition in the roles of PP/OK-type neuropeptides as regulators of muscle 
activity that accompanied the divergence of protostomes and deuterostomes. To address 
this issue, investigation of the occurrence and physiological roles of PP/OK-type 
neuropeptides in a variety of deuterostomian and protostomian taxa is now needed. 
Furthermore, discovery of the receptors that mediate the effects of PP/OK-type 
neuropeptides will be necessary to gain a deeper understanding of the evolution PP/OK-
type neuropeptide signaling in the Bilateria. 
One of the challenges associated with investigation of the evolution of PP/OK-
type neuropeptide signaling is that receptors for this family of neuropeptides have as yet 
not been identified in any species. Investigation of the evolution of other neuropeptide 
signaling systems has revealed that in some cases the ligands for orthologous 
neuropeptide receptors can diverge to such an extent over large evolutionary timescales 
that they are not recognizable as orthologous neuropeptides based on sequence 
similarity. A good example of this would be neuropeptide-S (NPS) in vertebrates and 
crustacean-cardioactive peptide (CCAP)-type neuropeptides in protostomes, which 
exhibit very little sequence similarity in spite of being ligands for orthologous receptors 
(Mirabeau and Joly, 2013; Semmens et al., 2015). Likewise, the possibility remains that 
orthologs of the protostome/echinoderm PP/OK-type neuropeptides exist in 
hemichordates and/or chordates, but have not been identified thus far due to sequence 
divergence. For this reason, discovery of receptors for PP/OK-type neuropeptides are 
essential for reconstruction of the evolution of this signaling system in the animal 
kingdom. Intriguingly, there is some evidence that the evolutionary origin of PP/OK-
type neuropeptide signaling may extend beyond the Bilateria to other metazoans 
because the SITFamide precursor in the placozoan Trichoplax adhaerens comprises 
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multiple copies of peptides that share some sequence similarity with PP/OK-type 
neuropeptides (Nikitin, 2015). This similarity may, of course, simply reflect 
convergence. Nevertheless, it highlights the need for further characterization of PP/OK-
type neuropeptide signaling in a range of phyla and discovery of the receptors that 
mediate the effects of these neuropeptides. 
5.3.2 Future directions for research on PP/OK-type peptides in starfish and other 
echinoderms 
It is currently difficult to identify PP/OK-type peptide receptors in starfish 
because PP/OK-type receptors have yet to be identified in any animal species. However, 
there are co-evolutionary relationships between the peptides and receptors (Mirabeau 
and Joly, 2013) and the genomic locations of genes encoding neuropeptide precursors or 
receptors can provide insights into evolutionary relationships. The genome of A. rubens 
has yet to be sequenced but the genome sequences of other starfish species have been 
obtained, including the crown-of-thorns starfish A. planci (Hall et al., 2017) and P. 
miniata (http://www.echinobase.org/Echinobase/pm). Identification of other genes that 
are located near to the PP/OK-type precursor genes in these species may provide 
insights into relationships of PP/OK-type peptides with other neuropeptides. In this way, 
candidate receptors could be identified. 
Discovery of the effects of ArPPLN1-type and ArPPLN2-type peptides in 
causing muscle relaxation in starfish has provided the first insight into the physiological 
roles of PP/OK-type neuropeptides in echinoderms, but it would be simplistic to 
conclude that the sole function of these neuropeptides in starfish is to act as inhibitory 
neuromuscular transmitters. For example, the abundance of ArPPLN1-type and 
ArPPLN2-type peptide expression in the radial nerve cords and circumoral nerve ring 
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may be indicative of roles in communication between neurons within these major 
components of the starfish nervous system. Furthermore, as discussed in chapter 3, the 
presence of ArPPLN1 and ArPPLN2 type peptides in regions of the digestive system 
involved in ciliary-mediated transit of food material may be indicative of roles in neural 
control of ciliary activity, which would be consistent with the effects that PP-type 
peptides have in causing an increase in ciliary beating frequency in mollusks (Hall and 
Lloyd, 1990). Software such as ciliaFA has been reported to allow automated, high 
throughput measurement of respiratory and ependymal ciliary beat frequency (ranging 
from 3 to 52 Hz) (Smith et al., 2012) and therefore this could be useful to investigate the 
effects of ArPPLNs on ciliary activity in the starfish digestive system. 
From a developmental perspective, localization of the expression several 
neuropeptide precursors in the larvae of A. rubens was reported recently using mRNA 
in situ hybridization (Mayorova et al., 2016). However, at the time when this study was 
completed in the Elphick group, probes/antibodies for localization of the expression of 
ArPPLN1/2-type neuropeptides were not available. With the generation of the 
ArPPLN1/2-specific probes/antibodies reported here, there now exists an opportunity to 
extend analysis of expression of ArPPLN1/2-type neuropeptides to the larval stages of 
A. rubens. 
Another interesting avenue for future research on PP/OK-type neuropeptides 
would be to compare the neuroanatomy of these signaling systems in different types of 
starfish, sampling species based on phylogenetic relationships. Such comparisons could 
reveal whether or not PPLN-type neuropeptides act as mediators of inhibitory 
neuromuscular transmission in all extant starfish species. Furthermore, comparison of 
species according to differences in ecological adaptations (e.g. burrowing versus non-
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burrowing species; (Santos et al., 2005)) might reveal how the physiology and anatomy 
of a neuropeptide signaling system in starfish has been adapted for life in different 
niches. 
Extending the comparative approach further, precursors of PP/OK-type 
neuropeptides have been identified in three of the four other extant echinoderm classes: 
echinoids (e.g. the sea urchin S. purpuratus; (Rowe and Elphick, 2012)), holothurians 
(e.g. the sea cucumber A. japonicus; (Rowe et al., 2014)) and ophiuroids (e.g. the brittle 
star Ophionotus victoriae; (Zandawala et al., 2017)). However, nothing is known about 
the physiological roles of PP/OK-type neuropeptides in other echinoderms. For example, 
it would be interesting to determine if PP/OK-type neuropeptides act as inhibitory 
neuromuscular transmitters in all echinoderms. 
5.4 Importance of this study 
The expression pattern of four neuropeptide precursors (AruRGPP, AruRLPP2, 
ArPPLNP1 and ArPPLNP2) have been systematically investigated in the starfish A. 
rubens. This is the first comprehensive analysis of the expression of these neuropeptide 
precursor types in an echinoderm. AruRGPP and AruRLPP2 are highly expressed in the 
starfish arm tips, where the sensory organs of starfish (terminal tentacle and optic 
cushion) are located. This novel finding provides new insights into the physiological 
source of AruRGP and AruRLP2 to regulate starfish reproduction affected by 
environmental cues. 
The wide expression of ArPPLNP1, ArPPLNP2 and corresponding peptides 
detected via in situ hybridization and immunohistochemistry imply multiple functions 
of the pedal peptide/orcokinin-type neuropeptides in starfish besides acting as muscle 
relaxants, which was demonstrated by in vitro tests on apical muscle, tube feet and 
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stomach preparations in this study. With the development of other bioassays, other 
functions of these neuropeptides may be revealed; for example, analysis of effects on 
ciliary beat frequency in the pyloric duct and analysis of effects on body wall stiffness. 
In summary, this study has enriched the limited knowledge of starfish neuroanatomy.
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Supplementary figure 8.1 relaxin-like gonad-stimulating peptide precursor (RGPP) 
and relaxin-like peptide precursor 2 RLPP2) identified from other starfish species. A: 
The PmiRGPP cDNA sequence (lowercase, 351 bases; AKZP01031377.1) encoding the 
PmiRGP precursor protein (uppercase, 116 amino acid residues) is shown. B: The 
AplRGPP cDNA sequence (lowercase, 354 bases; gbr_scaffold8) encoding the AplRGP 
precursor protein (uppercase, 117 amino acid residues) is shown. C: The PmiRLPP2 
cDNA sequence (lowercase, 348 bases; AKZP01053386.1) encoding the PmiRLP2 
precursor protein (uppercase, 115 amino acid residues) is shown. D: The AplRLPP2 
cDNA sequence (lowercase, 342 bases; gbr_scaffold3) encoding the AplRLP2 
precursor protein (uppercase, 113 amino acid residues) is shown. The predicted signal 
peptide is shown in blue and predicted dibasic cleavage sites are shown in green. 
Relaxin-type peptides (with cysteine [C] residues underlined) are shown in red, with the 
A and B chains highlighted in green and blue, respectively. The asterisk shows the 




9.1 Preparation of extracts of A. rubens radial nerve cords for mass 
spectrometry  
(1) Radial nerve cords were dissected from the arms of A. rubens using the method 
described by Chaet (1964); 
(2) The radial nerve cords were transferred into 90% methanol/9% acetic acid with or 
without the addition of protease inhibitors (pepstatin A (0.01 mM); 
phenylmethylsulfonyl fluoride (PMSF; 0.1 mM));  
(3) Tissue was lysed and homogenized by sonication (two 2 minutes pulses with 15 s 
intervals);  
(4) The extract was centrifuged at 13,000 rpm in a benchtop microcentrifuge for 5 
minutes at 4°C and the supernatant was transferred to a glass vial;  
(5) The solvent was bubbled off using nitrogen gas and the remaining extract was then 
stored at -20°C; 
(6) 10 µl of the extract obtained in step (5) was diluted with 50 µl of 1 mM ammonium 
bicarbonate (Sigma Aldrich) to neutralize the high concentration of acetic acid used for 
extraction; 
(7) To break disuphide bridges and then chemically modify (alkylate) cysteine residues, 
5 µl 100 mM dithiothreritol (Sigma Aldrich) was added to the extract at 60°C for 15 
minutes and then 5 µl of 200 mM iodoacetamide (Sigma Aldrich) was added in the dark 
at room temperature for 30 minutes; 
(8) Samples of both the reduced/alkylated and non-reduced/non-alkylated material were 
treated with trypsin (Promega) solution (0.5 µg) incubating overnight at 37oC; 
(9) The trypsin digestion was arrested by adding 10 µl of 10% formic acid (J T Baker). 
9.2 Mass spectrometry procedure 
NanoLC-ESI-MS/MS was used to analyze samples of radial nerve extracts. A 3 
µl aliquot of each sample separated by reversed phase chromatography prior to mass 
spectrometric analysis was used. The procedures are shown below: 
(1) Prepare two columns, an Acclaim PepMap µ-pre-column cartridge (300 µm i.d. x 5 
mm 5 µm 100 Å) and an Acclaim PepMap RSLC (75 µm x 25 cm 2 µm 100 Å) 
 246 
(Thermo Scientific), installed on an Ultimate 3000 RSLCnano system (Dionex, 
Sunnyvale, CA); 
(2) Make mobile phase buffer A (0.1% formic acid in water) and B (0.1 % formic acid 
in acetonitrile); 
(3) Load the samples onto the µ-pre-column equilibrated in 2% aqueous acetonitrile 
containing 0.1% trifluoroacetic acid for 8 minutes at 10 µl min-1; 
(4) Elute the peptides onto the analytical column at 300 nl min-1 by increasing the 
mobile phase B concentration from 4% to 25% for 90 minutes then to 35% for 10 
minutes and 90% for 5 minutes followed by 15 minutes’ re-equilibration at 4% buffer B; 
(5) Inject the peptides into a Thermo Orbitrap Fusion (Q-OT-qIT, Thermo Scientific) 
mass spectrometer directly (300 µl min-1) via a Triversa Nanomate nanospray source 
(Advion Biosciences, NY); 
(6) Perform the survey scans of peptide precursors from 400 to 1600 m/z at 120K 
resolution (at 200 m/z) with automatic gain control (AGC) 5 x 105; 
(7) Isolate the precursor ions with charge states 2-6 at 1.2Th in the quadrupole and HCD 
fragments with standardized collision energy of 35; 
(8) Analyze the Tandem Mass Spectrometry (MS / MS) data using Orbitrap 30K 
Resolution with AGC set to 5.4 x 104 and the maximum injection time of 200 ms;  
(9) The dynamic rejection duration is set to 60 seconds, with a tolerance of 10 ppm 
around the selected precursor and its isotopes; 
(10) Turn on the Monoisotopic precursor selection running in the highest speed mode 
with a 2-second cycle. 
9.3 Preparation of RNA probes 
The RNA probes were synthesized by using a PCR method: 
(1) Linearised plasmids containing the right cDNAs were used in combination with 
M13 primers (Forward: 5’-GTAAAACGACGGCCAGTG-3’; Reverse: 5’-
GGAAACAGCTATGACCATG-3’). Taq DNA polymerase (Taq DNA Polymerase 
with Thermopol Buffer, New England Biolabs) was used as recommended in the 
manufacturer’s instructions under conditions for a routine PCR (initial denaturation at 
95 oC for 30 seconds; 30 cycles of 95 oC for 30 seconds, annealing at 50 oC for 30 
seconds, elongation at 68 oC for 1-2 minute; final extension at 68 oC for 5 minutes; hold 
at 4 oC) with two reaction volume of 50 µl including 5 µl 10x Thermo-pol buffer, 5 µL 2 
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mM dNTPs (Sigma-Aldrich); 2.5 µl 10 mM forward primer (Sigma-Aldrich), 2.5 µl 10 
mM reverse primer (Sigma-Aldrich), 1 µl plasmid DNA,  0.5 µl 2.5 units Taq-
polymerase (New England Biolabs) and 33.5 µl ddH2O; 
(2) 5 µl PCR product and 1.5% gel electrophoresis was performed to check the size of 
the fragment after finishing the reactions; 
(3) Purify the remaining PCR product using PCR Product Purification Kit (High Pure 
PCR Product Purification Kit, Roche), when a PCR product of right size is obtained; 
(4) Prepare a mixture of the labeling reaction including 10µl linearized plasmid DNA 
(~1µg), 2µl 10 x DIG RNA labeling mixture (Roche), 2µl 10x transcription buffer 
(Roche), 2µl T3 or T7 RNA polymerase (Roche) for antisense or sense probe, 
respectively, and 4µl sterile DEPC treated water; 
(5) After mixing and centrifuging the mixture briefly, incubate the reaction for 2.5 hours 
at 37 oC; 
(6) Add RNase-free DNase (Roche) to the labelling mixture and digest the template 
DNA for 30 minutes at 37 oC; 
(7) Stop the reaction by adding 2µl 0.2M EDTA (pH 8.0) and add 2µl 4M LiCl and 
50µl pre-chilled (-20 oC) ethanol to the reaction; 
(8) Mix mixture well and leave for at least 30 minutes at -80 oC; 
(9) Centrifuge the reaction at 13000 rpm for 15 minutes at 4 oC, and then decant the 
ethanol; 
(10) Wash the pellet with pre-chilled 70% ethanol and centrifuge again at 13000 rpm 
for 5 minutes at 4 oC; 
(11) Decant the ethanol and dry the pellet on a hot plate at 45 oC for approximately 15 
minutes; 
(12) Dissolve the pellet in 50µl sterile DEPC-treated water and add 1µl RNase inhibitor 
(Roche); 
(13) Check the quality of the probes using 1% gel electrophoresis and measure the 
concentration; 
(14) Adjust the probe concentration to about 100 ng/µl with 25% formaldehyde (FA) / 
2x saline-sodium citrate (SSC) for long-term storage at -20 oC. 
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9.4 Tissue fixation for in situ hybridization 
Small-sized adult A. rubens (diameter 4 - 6 cm) were fixed in 4% 
paraformaldehyde (PFA) in phosphate-buffered saline (PBS, pH 7.4) overnight at 4 oC. 
Then different protocols were followed to make paraffin-embedded and frozen sections.  
For paraffin-embedded sections:  
(1) 4% PFA/PBS fixed starfish were dissected into arms and central disk and washed in 
autoclaved PBS for 10 minutes; 
(2) to decalcify the tissue, arms and central disk were placed in Morse’s solution (10 % 
sodium citrate; 20 % formic acid in autoclaved water) for approximately 3 or 8 hours, 
respectively, changing the solution every hour; 
(3) the tissues were washed in dH2O 10 minutes; 
(4) place arm or central disk in 50% ethanol, 70% ethanol, 90% ethanol and 3 x 100% 
ethanol sequentially for 30 minutes each; 
(5) place arms or central disk in xylene solution for 1 x 5 minutes, and then 1 x 8 
minutes; 
(6) the tissues were washed in melted filtered wax for 3 x 1 hours in oven; 
(7) finally, add filtered wax into a rectangle formed by two L-shape metal, and place the 
tissues into the wax. 
To enable visualization of the pigmented eye spot located at the tips of the 
starfish arms, frozen sections of arm tips were also prepared because the pigment is lost 
with the wax embedding method. 
For frozen sections (mainly used for the arm tips): 
(1) arm tips were dissected and washed in PBS for 3 x 5 minutes; 
(2) place the tips in 10% sucrose/PBS and 20% sucrose/PBS, 30% sucrose/PBS 
sequentially for 3 hours each at room temperature; 
(3) dry the tips by using paper tissue and place the tips into RA Lamb OCT embedding 
cryoembedding Matrix (Fischer Scientific) for 5 minutes; 
(4) add embedding matrix into a rectangle formed by two L-shape metal molds;  
(5) place the tips into the embedding matrix and freeze it immediately with dry ice for 
dissection. 
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9.5 Probe hybridization and immunodetection 
For probe hybridisation and immunodetection of in situ hybridization, there is 
only slight difference in the tissue rehydration at the beginning and slide mounting at 
the end for paraffin-embedded and frozen sections. Paraffin-embedded slides were 
placed in an oven at 65 oC for 45 minutes followed by 15 minutes to cool down at room 
temperature. Then slides were processed according to the procedure below: 
(1) Place slides into xylene for 3 x 7 minutes to get rid of the wax;  
(2) Rehydrate the tissue through a graded series of ethanol (2 x 7 minutes 100% ethanol, 
1 x 7 minutes 90% ethanol, 1 x 7 minutes 70% ethanol, 1 x 7 minutes 50% ethanol, 1 x 
7 minutes 30% ethanol, 2 x 7 minutes PBS); 
(3) Post-fix the slides in 4% PFA/PBS for 20 minutes at room temperature; 
(4) Wash slides with PBS/Tween 0.1% for 3 x 5 minutes; 
(5) Digest the tissue with Proteinase K (final concentration 10µg/mL) (QIAgen)/Protein 
K buffer (50 mM Tris-HCl [pH 7.5]; 6.25 mM EDTA in dH2O) at 37 oC for 12 minutes; 
(6) Post-fix slides again with 4% PFA/PBS used in step (3) for 5 minutes at room 
temperature; 
(7) Wash slides with PBS/Tween 0.1% for 3 x 5 minutes; 
(8) Acetylate slides with 1.325 % triethanolamine (pH 7-8), 0.25% acetic anhydride and 
0.175% acetic acid in dH2O with stirring for 10 minutes; 
(9) Wash slides with PBS/Tween 0.1% for 2 x 5 minutes and 5 x SSC for 5 minutes at 
RT; 
(10) Dry and pre-hybridise slides with hybridisation buffer (50% formamide; 5 x SSC; 
500 µg/ml yeast; 50 µg/ml heparin; 0.1 % Tween-20 in dH2O) in humidified chamber 
made by 5 x SSC for approximately 2 hours; 
(11) Denature DIG-labeled mRNA probes (800 ng/ml) at 85 oC for 2 minutes and add 
the probe-hybridization buffer mixture to the prehybridised slides; 
(12) Seal the slides with parafilm and keep them in humidified chamber at 65 oC 
overnight for hybridisation; 
(13) Remove the parafilm by using 5x SSC with slight shaking and wash slides with 
0.2x SSC 2 x 40 minutes at 65 oC to get rid of the excess probes; 
(14) Wash slides with 0.2x SSC 10 minutes and equilibrated in buffer B1 (10 mM Tris-
HCl [pH 7.5]; 150 mM NaCl in autoclaved water) for 10 minutes at room temperature; 
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(15) Dry slides on blotting paper and incubate slides with 5% goat serum/B1 in 
humidified chamber for approximately 2 hours; 
(16) Add alkaline phosphatase (AP)-conjugated anti-DIG antibody (Roche) at 1:3000 
dilution in 2.5% goat serum/B1 and incubate slides in humidified chamber overnight at 
4 oC; 
(17) Wash slides with buffer B1 (3 x 5 minutes) and equilibrate slides with buffer B3 
(100 mM Tris-HCl [pH 9.5]; 100 mM NaCl; 50 mM MgCl2 in dH2O) for 10 minutes at 
room temperature; 
(18) Dry slides on blotting paper and add staining buffer (nitro-blue tetrazolium 
chloride [NBT, 75 mg/ml in dimethylformamide] and 5-bromo-4-chloro-3'-
indolyphosphate p-toluidine salt substrate solution [BCIP, 50 mg/ml BCIP in dH2O]) to 
slides in humidified chamber until desired signal was achieved; 
(19) Stop the reaction when the desired staining intensity is achieved by rinsing the 
slides in dH2O for 3 x 5 minutes; 
(20) Dry slides on hotplate for about 45 minutes until totally dry; 
(21) Wash slides with 100% ethanol for 2 x 10 seconds and histoclear (Natural 
Diagnostics) for 2 x 7 minutes; 
(22) Add histomount (Natural Diagnostics) and put a cover slip gently on the slides; 
(23) Leave the slides in the fume for 2-3 days until they are dry to be stored in a dark 
box for photography. 
For frozen sections: 
(1) Dry slides over night at room temperature; 
(2) Wash slides with PBS 2 x 7 minutes; 
(3) Do exactly the same as the paraffin-embedded sections until step (19); 
(20) Add hydromount (Natural Diagnostics) and put a cover slip gently on the slides; 
(21) Leave the slides at room temperature for 1 - 2 hours until a little dry for 
photography or keep at 4 oC for storage. 
9.6 Immunohistochemistry using monoclonal antibody 1E11 
This experiment was performed following the steps below: 
(1) Fix the starfish arm tips lightly (up to 30 minutes in 4% paraformaldehyde/PBS; pH 
7.4) because immunostaining with the 1E11 antibody is fixation sensitive (R.D. Burke, 
personal communication); 
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(2) Dissect the fixed arm tips according to the procedure for frozen sections described in 
9.4; 
(3) Wash the slides in PBS (2 x 10 minutes) and then incubate for 20 minutes in PBS 
containing 1% hydrogen peroxide to quench endogenous peroxidases; 
(4) Wash the slides again with PBST (2 x 10 minutes) and block the tissues with 5% 
goat serum/PBST for 2 hour at room temperature; 
(5) Add antibody 1E11 (diluted 1: 3 with 5% goat serum/PBST) and incubate the slides 
overnight at 4°C; 
(6) After washing the slides with PBST (3 x 5 minutes) to remove the antibody, add 
goat anti-mouse horseradish peroxidase conjugated secondary antibodies 
immunoglobulins (Jackson Immuno Research) diluted 1: 500 in PBST containing 2% 
goat serum and incubate for 3 hour at room temperature; 
(7) Wash the slides with PBST 3 x 5 minutes to remove the secondary antibodies; 
(8) Add staining buffer (0.05% diaminobenzidine, 0.05% nickel chloride, 0.015% 
hydrogen peroxide in PBS) to each slide until desired staining is observed (about 5 
minutes); 
(9) Wash the slides sequentially in PBS and autoclaved water, 10 minutes each; 
(10) Add coverslips to mount the slides using Hydromount (Natural Diagnostics). 
9.7 Masson’s Trichrome staining 
To identify which kind of A. rubens tissues, Masson’s Trichrome staining was 
used to differentiates collagenous (blue) from non-collagenous (red) tissue in adjacent 
slide of the one fixed by Bouin’s solution for immunocytochemistry. The protocol is 
described below.  
(1) De-paraffinise using xylene (2 x 10 min) and rehydrate slides through different 
percent ethanols (100%, 100%, 90%, 70%, 50%; 10 min for each); 
(2) Washing the slides in distilled water (2 x 10 min), and rinse it in warm running tap 
water for 10 min; 
(3) Then washing the slides again in distilled water (2 x 10 min) followed by staining in 
Biebrich scarlet-acid fuchsin solution (0.9% Biebrich scarlet, 0.1% Acid fuchsin, 0.01% 
glacial Acetic acid) for 10 - 15 min; 
(4) Wash the slides in distilled water (3 x 5 min) to get rid of the Biebrich scarlet-acid 
fuchsin solution; 
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(5) Differentiate the slides in phosphomolybdic-phosphotungstic acid solution (2.5% 
Phosphomolybdic acid, 2.5% Phosphotungstic acid) for 10 - 15 min; 
(6) Transfer the slides directly (without rinse) to aniline blue solution (2.5% Aniline 
blue, 2% glacial Acetic acid, in Distilled water) and stain for 5 - 10 min; 
(7) rinse briefly in distilled water and differentiate in 1% acetic acid solution for 2 min 
and wash in distilled water (3 x 5 min); 
(8) dehydrate through 95% ethanol and two changes of 100% ethanol quickly to keep 
the Biebrich scarlet-acid fuchsin staining to xylene (2 x 10 min) and mount in DPX. 
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